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Introduction
Earl Y. Cheng, MD
Associate Professor of Urology
The Feinberg School of Medicine at Northwestern University
David B. Joseph, MD, FAAP
Professor of Urology
University of Alabama Birmingham
Timothy Brei, MD, FAAP
Associate Professor of Clinical Pediatrics 
Indiana University School of Medicine
The First World Congress on Spina Bifida Research and Care took place in March 2009 in Orlando, Florida. During this landmark meeting, 
researchers and clinicians from around the world gathered together to 
discuss clinical and basic science research aimed at improving the care of 
individuals with Spina Bifida. The roots of this meeting began in May 2003 
in Washington, DC when over 100 experts met to discuss the development of 
a research agenda for evidence-based practice in Spina Bifida. The proceed-
ings from this meeting were published by the Centers for Disease Control 
and Prevention (CDC) in what is now known as the Green Book. 
Following the Evidence-Based Research in Spina Bifida meeting in 2004, 
the wheels were put into motion for the First World Congress. Members 
of the Professional Advisory Council (PAC) of the Spina Bifida Associa-
tion (SBA) recruited several leading researchers in their respective fields to 
form the Program Planning Committee. This group worked diligently over 
several years to put this landmark conference together. The meeting was a 
tremendous success; more than 350 individuals from 30 countries attended. 
Over the course of three days, presentations included keynote talks, mul-
tidisciplinary panel discussions, and breakout sessions in eight separate 
disciplines including urology, neurosurgery, neuropsychology, orthopedics, 
developmental pediatrics, epidemiology/genetics/public health, transition, 
and nursing/allied health. A lifetime achievement award was presented to 
David McLone, MD. The format of the World Congress allowed further  
cross fertilization between individuals from numerous specialties and  
different research backgrounds to foster new collaborative research ideas  
for the future. 
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This publication summarizes the information from the plenary talks  
and abstract presentations from the First World Congress. Additional  
detailed information from the meeting can also be found on the First World 
Congress Web site (http://medicalconference.spinabifidaassociation.org).
This conference could not have taken place without the generous funding 
and support from numerous sources including the CDC, the Agency for 
Healthcare Research and Quality, the National Institutes of Health, as well 
as industry sponsorship. The collaborative efforts of these government agen-
cies and industry is greatly appreciated and represents the framework that 
will support future advancements in Spina Bifida research in the future. The 
success of this meeting was also a direct result of the efforts of numerous 
individuals who worked tirelessly behind the scenes. This includes members 
of the Board of Directors from both SBA and the Spina Bifida Foundation, as 
well as the PAC, staff of the SBA, and Site Solutions Worldwide.
As we proceed forward from this meeting, it is our sincere hope that the 
seeds have been planted for the growth of new and important research 
agendas in the future. With continued support, these research efforts will 
certainly result in developments that will improve the lives of individuals 
with Spina Bifida and their families. We would like to take this opportu-
nity to thank all of those individuals who attended this meeting and whose 
research comprises this volume. We look forward to working together with 
all our colleagues across the world to promote a worldwide Spina Bifida 
research agenda. 
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Neurosurgery
Observations on the Evolution of Management 
of Spina Bifida across an Academic Career
Marion L. Walker, MD
Professor of Neurosurgery
Department of Neurological Surgery
Division of Pediatric Neurosurgery
University of Utah
Salt Lake City, Utah
I have had the rare opportunity to see many changes in the way we manage patients born with myelomeningocele. Over the past 37 years, including 
my time as a neurosurgical resident, pediatric neurosurgical fellow, and an 
attending neurosurgeon, the philosophical approach and surgical man-
agement of myelomeningocele have changed dramatically. Some of these 
changes are due to technical advances in diagnostic testing, imaging, surgi-
cal instrumentation, and surgical technique. However, significant improve-
ment in the long-term outcome can be attributed to a change in our attitude 
regarding the importance of early and aggressive intervention.
Historical Perspective
In order to appreciate the changes in the management of myelomeningo-
cele during the past 30 years, it is important to look at how our approach to 
patients has changed. Before the ventricular shunt was available, very few 
patients survived. Once hydrocephalus became treatable, the decision to 
treat was based on the general neurological status of the patient. Since this 
is such a complex problem and so many of these children have obvious brain 
impairment in addition to spinal cord involvement, treatment was denied 
to many. They were left without surgical intervention to see if they would 
survive. Shunts were implanted in the survivors at a later date to provide 
“custodial care.” 
This approach might best be summarized by a lecture given by Dr. John 
Lorber in 1975. He was discussing the advances of medicine and technol-
ogy and pointing out that many diseases, such as prematurity and men-
ingitis, that were so difficult to treat before technical advances were now 
much more treatable. He commented, however, that, “Unfortunately, the 
indiscriminate use of advanced techniques of all types has also kept alive 
those who would have died but now live with distressing physical or mental 
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handicaps or both, often for many years, without hope of ever having an 
independent existence compatible  with human dignity” [1]. As suggested 
by this statement, Dr. Lorber favored treating only those myelomeningocele 
patients that survived with minimal deficits. This became known as selection.
As time passed, many neurosurgeons felt a desire to treat patients who had 
more substantial deficits. Approaches to treatment began to take a more 
moderate approach in some centers, and after Dr. David McLone began 
his practice of pediatric neurosurgery at Children’s Memorial Hospital in 
Chicago in the mid 1970s, more focused management came to be more fully 
accepted. Dr. McLone’s strong interest in these patients led him to ques-
tion the appropriateness of selection relating to treatment. He noted that 
the argument for selection had become a debatable issue, contingent on the 
answers to several questions:
• Do valid criteria exist that accurately predict the patient’s outcome?
• What percentage of inaccuracy is acceptable?
• How many children will die to ensure that no disabled child will survive?
• Are there universally accepted criteria below which death is preferable?
• Can one person choose death for another [2]?
Dr. McLone made a commitment to treat all patients and kept excellent 
records on each to study outcomes. His first study involved a group of 100 
consecutive nonselected patients with myelomeningocele. He has since 
published the long-term outcomes (20-25 years) on these patients [3]. It is 
now well established that most children born with myelomeningocele can 
have a meaningful and productive life. As complications from this disease 
have been minimized, further studies have shown that these patients do  
not deteriorate as they age solely because they have myelomeningocele. 
Instead, neurological deterioration is almost always due to a treatable cause 
[4]. In this section, I will discuss the approach to diagnosis and the ongoing 
assessment of these patients and point out how our approach to manage-
ment has changed.
Diagnosis
In the 1970s, a diagnosis of myelomeningocele in a newborn was almost 
always a surprise to physicians and the family. An understanding of the im-
portance of alpha fetoprotein (AFP) was only beginning, and ultrasound was 
in its early stages as a tool for fetal diagnosis. The understanding of associ-
ated brain anomalies and hydrocephalus was incomplete. Typically, physi-
cians used air ventriculography to diagnose hydrocephalus, but visualization 
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and understanding of the remaining brain 
anatomy were limited. It was necessary to 
perform a pantopaque myelogram to image 
the spinal cord, but this was impractable 
in most cases because of the low-lying 
and tethered spinal cord. The computed 
tomography (CT) scanner became avail-
able in the mid 1970s, and although its 
use greatly added to our understanding of 
brain anatomy in these patients, it was not 
significantly better than conventional my-
elography when studying the spinal cord.
Detection of myelomeningocele today often begins early in utero. The qua-
druple screen maternal blood test, which is usually performed at about 16-18 
weeks of gestation, can detect myelomeningocele in a significant percentage 
of pregnancies [5]. High levels of AFP suggest that the fetus has a neural 
tube defect. Prenatal ultrasound is also helpful and is very commonly done 
even for routine pregnancies. If there are questions regarding the accuracy 
of any of these tests, magnetic resonance (MR) imaging of the fetus can give 
definitive answers.
Imaging
Imaging patients with myelomeningocele has changed dramatically over 
the past three decades. Before the advent of CT scanning, imaging of the 
brain was accomplished through angiography, pneumoencephalography, or 
air ventriculography. Although we cannot discount the value of the imag-
ing obtained during those times, the advent of CT scanning and subsequent 
development of MR imaging have dramatically improved our ability to 
evaluate normal and 
abnormal states in 
the central nervous 
system (CNS). In the 
1970s, the approach  
to imaging was gener-
ally to wait and see if 
there was a need to 
intervene. 
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Routine cerebral angiography was not recom-
mended; nor was routine ventriculography. 
Pneumoencephalography was difficult–if not 
impossible–in patients with myelomeningocele 
because of associated tethered spinal cord and 
scarring at the site of the closure of the myelom-
eningocele. Today, it is common to obtain base-
line MR imaging of the entire CNS in patients 
with myelomeningocele. In our practice, we have 
often delayed baseline MR imaging until the 
patient is approximately one year of age because the anatomical structures 
of the brain and spinal cord can more easily be appreciated after one year 
of age. This baseline imaging is used to document associated brain and/or 
spinal cord abnormalities, which may include the Chiari II malformation, 
with partial or complete absence of the corpus callosum, and hemispheric 
interdigitation. [6-8]
Early MR imaging of the spinal cord shows tether-
ing, which is routinely present in patients because 
of closure of the open neural placode and result-
ing scarring. When we speak of  
“tethered spinal cord” in the patient with 
myelomeningocele, we are generally referring to 
the clinical diagnosis associated with deteriora-
tion of neurological function and the accompany-
ing damage to the distal portion of the spinal cord 
that may result from the scarring associated with 
the earlier surgery.
Neurosurgical Management
Neurosurgical management has likewise changed dramatically over the  
past 30 years. The closure of the placode at the time of the initial surgical 
procedure is far different than in the past; the management of hydrocepha-
lus is changing; and the prospect of intrauterine surgery is bringing new 
promise to the management of myelomeningocele. Ongoing evaluation and 
observation of patients with Spina Bifida has changed significantly through 
the years.
Closure of the neural placode at the time of the initial closure of myelom-
eningocele is now performed routinely [9]. Prior to 1981, the open neural 
placode was generally left open; however, this allowed scar tissue to adhere 
directly to the placode and made future untethering more difficult for the 
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surgeon and risky to the patient [10]. Today, the placode is reapproximated 
into the neural tube. This restores a more normal anatomical appearance 
to the lower spinal cord and allows the surgeon to visualize more normal-
appearing anatomy if a future untethering procedure is indicated.
Intrauterine Closure of Myelomeningocele
Preliminary clinical reports have demonstrated that intrauterine closure of 
myelomeningocele may be associated with a reduction in shunt-dependent 
hydrocephalus and the Chiari II malformation. [11-16] The Management of 
Myelomeningocele Study (MOMS) is an NIH-sponsored randomized trial 
of intrauterine closure of myelomeningocele being conducted in three dif-
ferent centers [http://clinicaltrials.gov/ct2/show/NCT00060606; accessed 
August 24, 2009]. The experimental arm involves fetal surgery to close the 
Spina Bifida defect prior to 26 weeks of gestation with delivery by Caesar-
ean section at approximately 37 weeks of gestation. In the other arm of the 
trial, the fetus is delivered normally and undergoes postnatal closure of the 
defect when medically stable. The primary outcome measures of this study 
are (1) infant death or need for ventricular shunt by 1 year of life and (2) the 
mental development index on the Bayley Scales of Infant Development and 
functional-anatomical level of the lesion at 30 months of age. Secondary 
outcome measures are (1) the presence of Chiari II malformation, (2) neu-
rodevelopmental status, (3) ambulation status, (4) presence of neuromus-
cular defects, and (5) grades of maternal, psychological, and reproductive 
functioning. To date, accrual is incomplete so no data are currently available 
for review.
Evaluation and Treatment
The initial evaluation of a newborn with myelomeningocele includes a gen-
eral physical examination in addition to documentation of the neurological 
findings. Although associated birth defects are relatively uncommon, it is 
important to ascertain whether other systems are involved. In particular, 
patients are evaluated for their cardiac and pulmonary status and for kidney 
and urogenital abnormalities. Ultrasound and/or CT scans of the brain are 
performed as a baseline study. We include an echocardiogram, ultrasound 
of the kidneys, and a voiding cystourethrogram for all patients. 
Management of Hydrocephalus
Despite improvements in other areas of care, shunts placed for the relief of 
hydrocephalus continue to fail at a very high rate [17], and hydrocephalus 
continues to be the most common serious long-term issue for myelomenin-
gocele patients and the most common reason for surgery. The management 
of hydrocephalus is obviously not a new concern. The fact that shunts con-
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tinue to fail at a high rate is only a part of the story of the difficulties of man-
aging hydrocephalus from a historical perspective. Perhaps Leo Davidoff, 
a neurosurgeon early in the 20th century stated it best in 1929: “Hardly any 
other pathological condition has been accorded more determined attention 
on the part of the medical profession…than has hydrocephalus and in hardly 
a single other condition have cures been so elusive or so often wrecked on 
purely mechanical obstacles.”
Eighty years after Davidoff’s statement, treatment failure remains the rule, 
not the exception, in the management of hydrocephalus. Approximately 
40% of new shunts fail within a year, 55% fail by two years, and approxi-
mately 80% fail within ten years [18]. In some large pediatric neurosurgi-
cal services the ratio of shunt revisions to new shunt placements is 2.5 to 
1. Troublingly, hydrocephalus is the one condition for which we have made 
very little progress in the last 60 years [17]. With the invention of the shunt, 
many felt that hydrocephalus had been “cured,” but the long-term outcome 
for hydrocephalus and shunt survival is still similar to that of the early 1960s, 
when shunts became routinely available. Our focus seems to have been 
more on controlling cerebrospinal fluid flow through valves than on correct-
ing the pathophysiology of the underlying hydrocephalus. Currently in the 
neurosurgical community, renewed focus is being placed on a better under-
standing of the underlying mechanisms of hydrocephalus and finding better 
treatment options [19-22].
Ongoing observation of shunt function is important and has changed 
dramatically over the past 30 years. We now take a more proactive approach 
to the patient with shunted hydrocephalus. Although ongoing baseline 
imaging is not necessary in most patients, a baseline image obtained after 
initial shunt placement and after shunt revision is important. We obtain 
images of patients several months after a shunt revision to establish a new 
baseline. This is extremely important when shunt failure occurs, especially 
when the patient may be under the care of a new physician or institution. 
Cognitive development is now recognized to be an important assessment of 
shunt function. Cognitive function, including an ongoing evaluation of the 
patient’s school performance, is now included as a part of the assessment of 
shunt function. 
We now recognize that neurological deterioration of a patient with myelom-
eningocele is not a normal progression of the disease [4]. Thirty years ago 
this process was not well understood. We also recognize that neurological 
changes almost always have an underlying treatable cause. The most com-
mon cause is shunt malfunction. The second most common is tethering of 
the spinal cord.
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Chiari II Malformation
When I entered neurosurgical practice in the 1970s, it was quite common 
to surgically decompress a Chiari II malformation when a patient showed 
neurological changes suggesting brain stem dysfunction. That approach has 
changed dramatically through the years. It is now well recognized that many 
symptoms suggestive of Chiari II deterioration are attributable to shunt 
malfunction. Even if a patient has stable ventricular size, a shunt revision 
will often result in neurological improvement. As a result, Chiari II decom-
pression is rarely performed now [4, 7, 23].
We have learned through experience that symptoms attributable to the 
Chiari II malformation fall roughly into three groups. In patients born with 
symptoms suggestive of Chiari II malformation, surgery is not helpful. In 
patients with no early signs of Chiari II dysfunction who later develop brain 
stem dysfunction during infancy, surgery may be useful in a small percent-
age if the shunt is eliminated as the underlying cause of the dysfunction. For 
the older patient who has never had Chiari II-like symptoms and who has 
not improved after shunt revision, surgical decompression may have a better 
chance of success. The fact that shunt revision so often results in improve-
ment of neurological status and Chiari II decompression has been much less 
successful has led to the mantra of the neurosurgery management of the 
patient with hydrocephalus: “It’s always the shunt.”
Tethered Spinal Cord
Tethered spinal cord is another neurosurgical condition that must be moni-
tored on a long-term and ongoing basis in patients with myelomeningocele. 
Between 25% and 35% of patients will require surgical untethering of their 
spinal cord at some point [4].
The clinical presentation of the tethered spinal cord is quite typical in 
patients with myelomeningocele. Patients often complain of a very specific 
type of pain, usually in the lower back. The pain is worsened with activity, 
like walking, and improves with rest. When the patients rest, the pain will 
go away. Once they start walking again, the pain recurs until they rest, and 
the pain goes away. There is a neurologic claudication component to the 
pain. Compared to 30 years ago, we have a much better understanding of the 
pathophysiology underlying this clinical presentation [24]. Other symp-
toms and signs associated with tethered cord include progressive orthope-
dic deformities, scoliosis, changes in bowel and bladder continence, motor 
weakness, sensory changes, disturbances of gait, and, rarely, disturbances in 
upper extremity function.
Progressive orthopedic deformities may be a sign of tethering. Orthopedic 
surgical repair in patients who have spinal cord tethering may not be main-
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tained. We have learned that repair of a deformity that “won’t stay fixed”  
is often an indicator of spinal cord tethering. Progressive scoliosis is also 
often related to tethering [4, 25-27]; however, scoliosis progression will  
often stop and the scoliotic deformity will often improved if untethering  
is performed early. 
The classic “red flag” sign for tethered cord is a change in bladder continence 
[28]. Most patients who have myelomeningocele can be socially continent 
using intermittent catheterization techniques. Losing the ability to remain 
continent when compared with previous abilities is a strong indicator of 
tethering. These changes can also be documented with urodynamic testing 
and repeated for comparison purposes over time.
Knowing the history of the patient’s neurological status is important in 
assessing whether tethering is occurring. Changes in urological function 
over time are usually associated with some degree of tethered cord. We 
have learned that manual muscle testing is a very reproducible test that 
can be used in a clinic setting to monitor patients through time. We believe 
it is also important to include upper extremity testing. Progressive loss of 
strength in upper or lower extremities is a common sign of deterioration 
secondary to tethering.
Genetics
Genetics is an area in which we will see the most significant advances in the 
prevention and treatment of myelomeningocele. Our understanding of the 
neurulation process, including normal and abnormal states, has changed 
dramatically over the past two decades. Advances in molecular genetics 
now lead us to a better understanding of the underlying mechanisms of the 
abnormalities associated with myelomeningocele and may, perhaps, lead to 
earlier diagnosis and treatment.
Conclusion
I have had the rare privilege of seeing significant changes in the diagno-
sis and management of patients with myelomeningocele. These patients 
routinely bring abundant love and closeness to a family. They are brave. I 
see them face their neurological and associated problems with uncommon 
courage. I continue to be amazed at their positive attitudes and the way they 
face their trials. I feel certain that we will see much more progress toward an 
effective treatment and, someday, a cure.
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Meeting of the Section of Neurological Surgery
The three core neurosurgical issues in caring for patients with Spina Bifida 
are hydrocephalus, tethered spinal cord, and the Chiari II malformation. 
Insights and advances have been made in each of these areas and central 
concepts have emerged. Yet much remains to be learned and ideas and ap-
proaches differ significantly between centers. The Neurosurgery breakout 
session centered on these ideas and incorporated two reports on the care of 
patients with Spina Bifida (SB) from around the world.
Hydrocephalus
Hydrocephalus and its multitude of manifestations in the patient with SB 
remain a great challenge. Eighty five percent of patients with myelomenin-
gocele develop hydrocephalus and require a ventricular shunt. Ventricular 
shunts were developed in the early 1960s and have saved thousands of lives 
of patients affected by hydrocephalus. Despite the tremendous contribu-
tions of ventricular shunts, however, they have a high rate of failure that is 
unpredictable. Forty percent of shunts fail within a year of placement, sixty 
percent within two years and 80 percent within a decade of placement. 
Shunt infection rates vary widely in reported series but repeated numbers 
from large experienced centers are around 6% to 8%. Sadly these statis-
tics are not significantly different from those reported 25 years ago, which 
indicates a discouraging lack of progress in this area of critical importance 
to the SB community. One of the reasons that little progress has been made 
is that shunt failure and shunt infection have multi-factorial etiologies. As 
such a large number of factors need to be controlled for in the construction 
of organized clinical trials. To date the neurosurgical literature has been 
remarkably sparse on organized clinical trials in hydrocephalus research. 
This in part results from a state of under-funding of hydrocephalus research 
in general and hydrocephalus in SB in particular.
The failure rate of ventricular shunts has prompted a search for alternate 
techniques to treat hydrocephalus. The endoscopic third ventriculostomy 
(ETV) is one such option. The principle of ventricular shunts is to give an 
alternative pathway for the spinal fluid to be shunted outside of the nervous 
system. The ETV by contrast opens an alternative pathway for the cerebro-
spinal fluid to flow to the outside of the brain where it is normally reab-
sorbed. Several papers addressed ventricular shunts and ETV at the First 
World Congress Neurosurgery breakout session.
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Roger Bayston from Nottingham, United Kingdom, who has dedicated a ca-
reer to studying CSF shunts and patterns and prevention of shunt infection, 
presented two papers. The first addressed the results of a survey obtained 
from patients with ventriculo-peritoneal (VP) shunts compared with those 
who have ventriculo-atrial (VA) shunts. VA shunts were developed first and 
direct the diverted spinal fluid directly back into the blood stream because 
the distal catheter is placed in the right atrium like a central venous line. VA 
shunts were essentially replaced by VP shunts over time as VA shunts were 
shown to have serious complications such as bacterial endocarditis, shunt 
nephritis (a cause of kidney failure) and thrombus propagation with risk 
for pulmonary embolus. The severity of these complications has prompted 
a rather sinister reputation within neurosurgery for VA shunts. Bayston’s 
paper addressed whether this reputation was well founded in the current 
era. The authors surveyed 405 adult patients from a large public health ser-
vice database with VA shunts and matched them with 405 patients with VP 
shunts. This retrospective survey found that the incidence of infection and 
obstruction were similar and that the severe problems of thrombus forma-
tion and nephropathy were extremely low. One limitation of this study is 
that if individuals with VA shunts had died already from complications, they 
would not be available for this retrospective evaluation. They concluded that 
VA shunts should remain a viable alternative when VP shunting is not pos-
sible. This is particularly important in the SB population as urologic proce-
dures can make placement in the peritoneum untenable. 
Bayston’s second paper addressed the role that antimicrobial impregnation 
of shunt catheter material plays in the prevention of shunt infection. This 
topic has been extensively discussed and widely contested at neurosurgical 
meetings for several years because different groups from around the world 
have found widely different results when shunts are constructed of materi-
als that have antimicrobials directly impregnated into them. Some groups 
have found little difference in shunt infection rates while others have found 
a pronounced reduction in shunt infection when antimicrobial materials are 
utilized. In this study, Bayston’s group showed the effectiveness of the anti-
microbial shunt catheter to kill three species of microorganism commonly 
implicated in shunt infection.
Outcome measures for children with SB who underwent shunting were 
reported by Robinson et.al. from Rainbow Babies Hospital in Cleveland. 
This study used a standardized, validated instrument (the Hydrocephalus 
Outcome Questionnaire) to survey outcomes of a group of 55 patients fol-
lowed in the SB clinic. In this survey the 55 patients, who did not differ from 
non-study patients followed in the clinic, reported lower physical domain 
scores if they had symptomatic Chiari II malformations or required spinal 
cord untethering. Interestingly the 85% of patients who required a VP shunt 
did not have lower scores; however, shunt revision beyond the age of 2 years 
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was associated with lower scores in cognitive domains. Infections slightly 
lowered physical domains with no difference in other domains. Limitations 
included the small sample size, multiple management strategies for address-
ing the different issues and lack of detailed neuropsychological evaluation.
Blount and colleagues reported in a retrospective series from Birmingham, 
AL, that intradural spinal surgery was associated with an increased rate of 
CSF shunt failure. This group worked cooperatively with their orthopedic 
colleagues who surveyed similar data for extradural spinal surgery. Intra-
dural spinal surgery was clearly associated with elevated shunt obstruction 
rates whereas extradural spinal surgery was not. The authors concluded that 
either the spine surgery was contributing to shunt obstruction via an un-
identified mechanism, or patients with blocked shunts were presenting with 
signs and symptoms of tethered cord as their initial and singular manifesta-
tion of shunt insufficiency.
Dr. Wakhlu and colleagues presented a large retrospective series from India 
that supported the contention that insertion of the shunt at the same time 
of  myelomeningocele closure in babies with open SB was not associated 
with increased shunt complications. This has been an issue of discussion 
and contention for some time and is particularly important in an era of 
increasing attention to resource utilization. A presentation by Dr. Jogi Pat-
tisipu from Orlando embraced the importance of a standardized protocol, 
rigorous attention to detail and contemporary technologies such as endos-
copy to manage the complex hydrocephalus that often accompanies SB.
The award for the best overall paper given at the First Annual Congress was 
awarded to Dr. Ben Warf, who presented outcome data on a series of pa-
tients treated with shunts who were compared with a matched group treated 
with endoscopic third ventriculostomy (ETV). The data were compiled 
from a large group of patients treated by Dr. Warf when he directed the 
neurosurgical program at CURE-the Children’s Hospital of Uganda. These 
authors emphasize the importance of choroid plexus coagulation (CPC) at 
the same time ETV is performed. Prior reports from their group had estab-
lished a high rate of effectiveness for the combined ETV-CPC procedure. A 
concern commonly expressed in the debate about ETV versus shunting is 
whether or not the larger ventricles tolerated after successful ETV are associ-
ated with cognitive impairments not seen with the smaller ventricles that 
typically accompany a successful shunt. Dr. Warf and team administered a 
standardized instrument of outcome (Bayley Scales of Infant Development) 
to three groups that they identified from their larger population. The first 
group required no treatment for hydrocephalus. The second underwent a 
VP shunt and the third group underwent ETV-CPC. No differences were 
found in outcome among groups. When these results were combined with 
prior findings from this group they concluded that ETV-CPC treats children 
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with hydrocephalus from SB with lower risk of failure and infection without 
compromising neurocognitive development.  The paper stirred significant 
interest and debate. The central issue was whether or not these results could 
be reasonably extrapolated to other populations of patients with SB. 
Chiari II Malformation
The diagnosis and treatment of the Chiari II malformation has undergone 
significant evolution over the past 25 years. Initially this hindbrain abnor-
mality was thought to arise as a result of insufficient space in the posterior 
fossa of the skull for the brainstem and the cerebellum. MRI images showed 
neural elements such as the medulla and pons to be caudally displaced and 
“pushed down” into the top of the spinal canal. The predominant concept 
initially was that insufficient physical space and crowding gave rise to the 
signs and symptoms of brainstem insufficiency that have become known as 
the symptomatic Chiari II malformation. In clinical terms these consist of 
altered swallowing, stridor (in infants), poor airway protection, poor secre-
tion management and poor respiratory drive in very young infants. Aggres-
sive surgical intervention aimed at making the physical space available to 
the brainstem and rostral spinal cord marked the earliest era of neurosurgi-
cal thinking about the Chiari II malformation. Results from that era were 
decidedly mixed and far less favorable than would have been anticipated if 
the pathophysiology of the Chiari II malformation were simply an issue of 
physical space for the neural structures. 
This led to a gradual evolution in thinking about the Chiari malformation 
that holds that the brainstem in children with myelomeningocele is funda-
mentally malformed to a variable degree (between patients) and that this 
fundamental problem is at the cellular level and hence not correctable by 
surgery. As a result of this condition the compromised brainstem in these 
children is uniquely sensitive to any other physiologic stressor. In children 
with myelomeningocele the overwhelmingly most common stressor would 
be hydrocephalus or insufficient shunt function. Therefore a recent interest 
and gradual evolution has occurred toward aggressively addressing shunt 
function as the first and most significant intervention in managing the 
symptomatic Chiari II malformation. 
Because of the centrality of hydrocephalus in the current thinking about the 
symptomatic Chiari II malformation, ongoing discussions about the Chiari 
II malformation occurred during the session on hydrocephalus. It is evident 
that significant differences between large experienced centers still occur in 
the use of posterior fossa decompression in the treatment of symptomatic 
Chiari II malformations. Dr. Trumble’s paper about management strategies 
for the symptomatic Chiari malformation served as a further forum in which 
these issues were debated.
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Tethered Spinal Cord 
The tethered spinal cord (TSC) is another issue of controversy in neuro-
surgery. While there is general agreement that all patients with myelom-
eningocele harbor some element of physical tether at the closure site due 
to normal routine scarring, differences occur among centers regarding the 
aggressiveness with which surgical untethering is pursued and in the tech-
niques utilized once surgery is undertaken. Olavarria and colleagues pre-
sented a large retrospective series of 70 children with TSC who underwent 
operative untethering. Some patients had lipomyelomeningocele or dermal 
sinus tracts. Results were excellent, with 90% relief of pain and >70% dem-
onstrating restoration of urologic function to preoperative levels. Less than 
1% demonstrated neurologic decline. This series echoed several larger but 
older series in the literature and reflected what appear to the most widely 
held beliefs within the neurosurgery community; namely that pain is largely 
relieved, neurologic decline arrested but not restored and operative risks of 
imparting severe lasting neurologic insult are low.
Meurrens from Leuven Belgium and Partington from Gillette Children’s 
Hospital in St. Paul, Minnesota both addressed the challenging issue of 
adult TSC. Meurren’s group reviewed a series of 33 adult patients who were 
evaluated for TSC. Twenty-six patients underwent surgical release. Adults 
most commonly undergo TSC release for relief of pain and are often found 
to have multiple neurologic anomalies of varying subtlety. Partington 
emphasized the role of trauma (especially seemingly minor trauma) in the 
onset of symptomatic TSC in adults. Often repetitive lumbar flexion maneu-
vers were implicated. When pulsed steroids failed to provide relief, surgery 
was advocated with good relief of pain and stabilization of neurologic 
decline.
The paper that challenged conventional concepts the most was presented by 
Robin Bowman from Children’s Memorial Hospital in Chicago. The paper 
was entitled “Does the ‘Benign’ Sacral Dimple Exist?” It addressed a com-
mon entity that neurosurgeons are called upon to evaluate, the coccygeal 
pit. These are small crevices that occur in the skin over the lower back and 
the top part of the gluteal crease. Current widely accepted concepts hold 
that these abnormalities are uniformly non-tethering lesions if they are (1) 
within the gluteal crease, and (2) not associated with any other abnormal-
ity of the skin such as excess hair, discoloration, hemangiomas or fat lumps. 
These lesions are known as “benign sacral dimples” or “coccygeal pits.” 
Those lesions that have those additional characteristics are known to be at 
high risk of traversing the space from skin to nervous system and produc-
ing a tether associated with a lipoma, lipomyelomeningocele, dermal sinus 
tract, or more rarely a diastematomyelia. Most pediatric neurosurgeons 
evaluate dozens of such patients in a year and do not routinely image those 
with lesions characteristic of benign sacral pits. 
First World Congress on Spina Bifida Research and Care 17
Bowman’s group at Children’s Memorial obtained MRI scans of the lumbar 
and sacral spine on patients treated in their clinic with these diagnoses.  Of 
75 patients enrolled, MRI scans were obtained on 70. Radiographic abnor-
malities were found in an alarming number. Twenty three percent had fat in 
the filum (a marker that can be associated with tethering but is not pathog-
nomonic per se). Ten percent had a low riding conus medullaris and 7% had 
either hydromyelia or an open canal. Those patients who had low riding 
cords were further evaluated with urodynamic studies; two-thirds were 
found to have sufficient functional abnormalities to warrant surgical explo-
ration and release. These results were worrisome to the collected audience 
of neurosurgeons who have all embraced similar principles in clearing these 
patients. These principles have been developed over time and repeated ob-
servations between large centers of excellence. If the results from the Bow-
man paper are taken at face value it may appear that a significant number 
of such patients have been missed by conventional screening criteria. The 
strongest evidence against the assertion of the paper may be that there has 
not been any such wave of adults with sacral dimples and symptomatic TSC 
observed in clinical practice. If indeed 20% of patients with sacral dimples 
developed symptomatic TSC then there would have to be a huge number of 
adults requiring surgery. Clearly this study requires further attention and 
repetition at other centers and will undoubtedly be a topic of lively discus-
sion in the future.
International Care
Finally we also gained some insight into the differences with which neu-
rosurgical issues are managed around the world with presentations that 
discussed the care of children with SB from Slovakia and Japan. Horn and 
colleagues presented a fascinating though brief review that showed the 
evolution of thinking and approach toward the surgical treatment of chil-
dren with open myelomeningocele in Slovakia. They performed a retrospec-
tive analysis of all children with meningomyelocele treated at their facility 
between 1988 and 2007 and defined groups as ‘open defect’ or ‘closed defect,’ 
and by the decade in which they were treated. In the earliest part of the 
study (1988-1997) 14/106 (13%) children born with an open defect did not 
undergo surgery to close the defect within the first month of life. By 1998 
56/57 (98%) were operated on within the first month of life. Ventricular 
shunts were only placed in a total of 36 patients.
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Inagaki and colleagues discussed the role in which ultrasound is used by the 
OB-GYN and neonatology community for pre-natal screening of severe con-
genital anomaly. Termination of pregnancy is considered an option until 22 
weeks gestation and is often recommended if a severe anomaly is detected. 
The Japanese Society of Pediatric Neurosurgeons is investigating ways that 
these studies and their results can be pursued with families in a more multi-
disciplinary fashion.
Conclusions
We had a wonderful seminar that featured 14 different presentations from 
6 different countries and several continents. This was a remarkable show-
ing given a steady decrease in the numbers of abstracts about Spina Bifida / 
myelomeningocele at recent neurosurgical meetings and the fact that this 
meeting was the first of its kind. The neurosurgical issues surrounding the 
care of the patient with myelomeningocele remain challenging. Principles 
have emerged based on organized observations of talented, experienced and 
disciplined observers. 
Hydrocephalus remains a core problem for which shunts have been the 
principle solution. Shunts have saved thousands of lives but are fraught with 
problems and limited progress has been made in solving them. Endoscopic 
third ventriculostomy may offer an alternative solution but results are mixed 
and SB patients fare poorly with ETV in many series. There has been an 
evolution away from direct surgical decompression of the posterior fossa in 
symptomatic Chiari II malformation. Surgical release of the symptomatic 
TSC improves pain; arrests neurologic decline and poses limited risk for per-
manent neurologic injury. Each of these principles is both widely embraced 
and under frequent thoughtful challenge. Much is known but much more 
needs to be known.
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Epidemiology/Genetics
Epidemiology: The scientific basis for creating 
political will to prevent Spina Bifida and  
improve the lives of persons with the condition
Godfrey P. Oakley Jr., MD, MSPM
Research Professor of Epidemiology
Rollins School of Public Health of Emory University
Email: gpoakley@mindspring.com
Disclosure Statement:
I am a co-inventor of a patent that covers adding folic acid to contraceptive 
pills. While at the CDC, compensation, if any, will be under the regulations of 
the CDC. I have been a paid consultant to Ortho McNeil/Johnson and John-
son on this issue and may in the future. I have not done paid consulting on 
this issue during the last two years.
Prevention is urgent!
I like the title of this conference–The Future Is Now. What we do–or do not do–now does create the future. I also like the statement “The Fierce Ur-
gency of Now.” Nowhere is there more urgency than the global elimination 
of folic acid-preventable Spina Bifida [1-3]. 
As a Spina Bifida community, we have collectively failed to tell our story 
effectively enough to create the political will for the resources we need to 
provide the best quality of care for persons with Spina Bifida, and to maxi-
mize the prevention of new cases of Spina Bifida. Epidemiological research, 
the key to providing the scientific basis for the prevention of folic acid-pre-
ventable Spina Bifida, can be the basis for tracking global prevention or lack 
of prevention.
Epidemiological Studies
Epidemiological studies can also improve the lives of persons with Spina Bi-
fida by showing us interventions that actually help. Epidemiologic research 
can improve the care of persons with Spina Bifida; several areas deserve im-
mediate action:
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1. Registry of all persons with Spina Bifida 
The cystic fibrosis community established a registry of most persons with 
cystic fibrosis many years ago. Analyses of data collected suggested that 
some patients did remarkably better than others. Investigations of the care 
given in those centers where children did better (positive deviants) provided 
the basis for improvement in the lives of all persons with cystic fibrosis. 
While it is not possible to predict exactly what benefit a registry of all 
persons with Spina Bifida would have, it is reasonable that clues to improve-
ment will come.
2. Registry of the cause of death in all with Spina Bifida
We know of too many deaths of young adults with Spina Bifida, but we have 
not documented them; nor have we determined the causes of these deaths. 
If we had a registry of all deaths of persons with Spina Bifida and if we knew 
the cause of these deaths, we could find scientific clues to prevent future 
deaths. 
3. Randomiz ed controlled trials of components of care for persons  
with Spina Bifida
Evidence-based medicine, i.e., using the best data to guide medical treat-
ment, is currently in vogue. The best evidence comes from randomized 
controlled epidemiological studies. Unfortunately, there have been few 
randomized controlled trials about the components of care for persons  
with Spina Bifida. These studies are critical to improving the lives of  
persons with Spina Bifida by showing whether or not a particular interven-
tion actually works.
Epidemiologic Research and the Prevention of Spina Bifida
1. The failure to prevent folic acid-preventable Spina Bifida
One of the most important research studies ever reported was the epide-
miologic study that showed in a randomized controlled trial that folic acid 
would prevent the majority of cases of Spina Bifida. I had assumed that  
this amazing scientific contribution would be immediately followed by  
the near total prevention worldwide in a few years. However, after 20 years,  
only about 10% of the Spina Bifida that can be prevented has been prevented 
[1]. The total prevention of folic acid-preventable Spina Bifida remains a 
dream because of lack of political will to provide sufficient resources for 
prevention.
It is instructive to look at the Polio Eradication Program. When it began in 
the late 1980s, approximately the same number of annual global cases of 
polio occurred as the current numbers of children born with Spina Bifida 
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and Anencephaly. The political will was created to give CDC an annual ap-
propriation of $200 million to provide scientific leadership and technical 
assistance and science-based advocacy for the polio eradication program. 
That program has been highly successful, preventing more than 99% of po-
lio in the world. The up-to-the-date status of the Polio Eradication Program 
can be found at http://www.polioeradication.org/. This web site shows the 
incidence of Polio in every country. For example, in the first six months of 
2009, 89 cases were reported in India. A reasonable estimate of the number 
of cases of folic acid preventable Spina Bifida in India annually is 20,000.  
Folic acid-preventable Spina Bifida is as preventable as Polio, but the po-
litical will for the leadership and resources is lacking; therefore, the Spina 
Bifida epidemic continues every day.
A well-funded center whose mission is the total prevention of folic acid-
preventable Spina Bifida is necessary. The CDC would be a logical institu-
tion, as it has shown it can provide the leadership to eradicate Smallpox 
and has provided considerable leadership and resources to bring about the 
near eradication of Polio. Given resources similar to those available for Polio 
eradication at CDC, the birth defects group at CDC could achieve within a 
decade the near global elimination of folic acid-preventable Spina Bifida. 
The political will to fund this center is lacking.
2.  Science-based advocacy to prevent Spina Bifida caused by  
valproic acid 
In the early 1980s, epidemiologic research produced the evidence to show 
that in utero exposure to valproic acid increased by 10-fold the risk of a 
woman having a baby with Spina Bifida. The drug remains on the market in 
many countries and in some countries it has been approved for new indica-
tions. Good data on the current global incidence of valproic acid induced 
Spina Bifida are lacking. Improved epidemiologic studies of the occurrence 
of valproic acid induced Spina Bifida would provide part of the science base 
to promote the prevention of these birth defects. 
3. Maternal Diabetes associated Spina Bifida
Maternal Diabetes increases the risk that the baby will be born with Spina 
Bifida. It is possible that folic acid fortification prevents this increase, but 
it has not been studied. Women who have better control of their Diabetes 
have a lower prevalence of birth defects, suggesting that improved care of 
women with Type 1 diabetes would lead to a decrease in Spina Bifida. The 
prevention of the birth defects, including Spina Bifida, associated with 
Maternal Diabetes is an area rich in prevention possibilities; it is likely to be 
realized only when the political will is created to fund a center to maximize 
the prevention of birth defects associated with Maternal Diabetes.
First World Congress on Spina Bifida Research and Care 23
4. Finding other causes of Spina Bifida
Although folate deficiency, the use of valproic acid during pregnancy and 
Maternal Diabetes are the causes for most cases of Spina Bifida, children 
continue to be born with Spina Bifida who do not have these risk factors. 
Epidemiological research, such as the research that found the folate defi-
ciency, valproic acid and Maternal Diabetes associations should be conduct-
ed to find the other causes of Spina Bifida.
Conclusions
Epidemiologic research can improve the lives of persons with Spina Bifida 
by identifying the most effective forms of care and the preventable causes 
of young adult deaths. Ample opportunity exists for significantly decreasing 
the occurrence of Spina Bifida by preventing Spina Bifida associated with fo-
lic acid deficiency, prenatal valproic acid exposure, and Maternal Diabetes.
The pace at which the lives of persons with Spina Bifida can be improved 
and the pace at which the prevention of Spina Bifida can be improved 
require the identification of substantial, new resources devoted to these 
priorities. The CDC has shown that, when it had sufficient resources, it was 
able to provide the leadership and technical assistance to eradicate Smallpox 
and to nearly eradicate Polio. An annual CDC appropriation of 200 million 
dollars could be expected to increase dramatically the pace of the improve-
ment in the lives of persons with Spina Bifida as well as increase the pace of 
the prevention of Spina Bifida.
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Meeting of the Section of Epidemiology,  
Public Health, and Genetics
This session consisted of presentations grouped in the following areas: epi-
demiology of Spina Bifida, outcomes for persons with Spina Bifida, public 
health initiatives concerning Spina Bifida, and the genetic basis of Spina 
Bifida. The session was moderated by Godfrey P. Oakley, Jr., MD, MSPM, 
whose keynote lecture remarks appear earlier in this report.
Joseph Mulinare, MD, provided an international perspective on efforts to 
prevent neural tube defects through flour fortification with folic acid. The 
presentation began with a brief overview of the epidemiology of neural tube 
defects (NTDs), and a discussion of guidelines for reaching women of repro-
ductive age to prevent NTDs. Data from the US and globally on the impact 
of folic acid fortification and supplementation on prevention of NTDs were 
presented. Dr. Mulinare provided a brief perspective on issues about ben-
efits and potential harms related to the use of folic acid.
From the perspective of primary prevention of NTDs in the US, a major 
challenge is how to reach Hispanic women. This group has both a higher 
risk of NTDs than other race/ethnic groups (WilliamsL et al. Pediatrics 
2005) and lower folic acid (FA) intakes than white non-Hispanic women 
(Yang QE et al. Am J Clin Nutri 2008). Current public health strategies are 
focused on reducing the prevalence of NTDs and increasing FA intake of 
Mexican American women, modeling folic acid intakes for corn masa flour 
and evaluating the pros and cons of adding folic acid to corn masa flour.
The available evidence demonstrates that blood folate levels among women 
of reproductive age have increased substantially in the US since folic acid 
fortification. The decreasing NTD numbers are consistent with an increase 
in folic acid content in flour and foods. Current decreases in NTD preva-
lence do not necessarily reflect the full prevention potential of folic acid. 
Fortification of foods with folic acid is feasible, economical, and effective 
public health policy. At the present time, there are no proven adverse effects 
of folic acid fortification.
Yet, from the perspective of primary prevention and public health, the 
unanswered question remains. How will we know when we have reached the 
point at which all folic acid-preventable NTD have been eliminated? Will 
this be when NTD rates stabilize at some specified level, or when all women 
reach a specified consumption of folic acid or blood level for folate, or per-
haps, when we fully understand the underlying biology of prevention?
Dr. Mulinare’s presentation was followed by a series of four presentations 
examining patterns of Spina Bifida health care utilization and expenditures, 
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coordinated by Judy Thibadeau, RN, MN. This portion of the agenda began 
with an overview of the National Spina Bifida Program, which broadens the 
public health agenda for Spina Bifida in terms of treatment, health status 
and outcomes, and secondary prevention initiatives. The four presentations 
included data on the most frequent and costly outpatient medical condi-
tions utilized by people with Spina Bifida stratified by age. They compared 
the percentage of people affected by these conditions among those with 
and without Spina Bifida, calculated expenditures for these conditions for 
people with Spina Bifida, and provided estimates of medical expenditures 
for Medicaid-enrolled children and adolescents with Spina Bifida in the 
United States. They compared these findings with previously estimated ex-
penditures for privately insured children and adolescents with Spina Bifida 
(Ouyang et al (2007) using the 2003 MarketScan Commercial Claims and 
Encounters database. The Veterans Administration Spina Bifida Health Care 
Program Database was also described.
Melissa Danielson, MSPH presented an analysis of patterns of mortality 
associated with Spina Bifida in the United States for the years 1979 to 2005. 
Median age at death has increased among individuals with Spina Bifida dur-
ing this period. Decubitus ulcers and conditions of the nervous and urinary 
system are much more frequent causes of death among individuals with SB 
than general population. 
The oral session concluded with two presentations concerning the genet-
ics of Spina Bifida. Michelle O’Byrne, MS, examined the association of 
folate metabolic pathway genes with meningomyelocele in humans. Allison 
Ashley-Koch, PhD, provided a summary of current knowledge of the genetic 
basis of Spina Bifida, addressing three general questions: are NTD’s genetic, 
can animal models help to disentangle NTD genetics, and what specific 
genes are involved? Genetics research uses several approaches to focus in-
vestigations, including patterns of familial clustering, increased recurrence 
risks, twin studies, and patterns of NTD co-occurrence with chromosomal 
abnormalities and other genetic syndromes.
Approaches to identifying disease susceptibility genes include genomic 
screens, candidate gene analysis, and genomic screen and linkage analy-
sis. Genomic screens begin with no a priori hypothesis, look across entire 
genome. Linkage analysis studies families that have more than one person 
with a disorder. Genome wide association studies (GWAS) examine families 
of all types, even subjects in case/control studies. Candidate gene analysis 
involves an a priori hypothesis that a gene is involved due to either biology 
or position. Persons with the disorder of interest are compared to people 
without the disorder. Study subjects may be unrelated, or individuals from 
the same family. Genomic screening with linkage analysis involves studying 
many families that have multiple family members with NTDs. It can take 
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years to collect families and months to complete laboratory work. Previous 
work has identified several promising leads for further analysis. However, 
because of the complexities involved with this approach, candidate gene 
analysis is currently the most commonly used strategy for research examin-
ing the genetics of NTDs.
Clearly many genes are involved in NTDs. NTDs are so complex, however, 
that some genes may cause certain types of NTDs, but other genes cause 
other types of NTDs. For example, it is probable that different genes cause 
anencephaly while others cause myelomeningocele. Similarly, different 
genes may be involved in thoracic (upper) myelomeningocele, lumbosacral 
(lower) myelomeningocele; genetic mechanisms may be different for closed 
NTDs (lipomyelomeningocele) and open NTDs (myelomeningocele).
Summary
Public health approaches must continue to focus both on primary and 
secondary prevention of NTDs. While folic acid holds considerable promise, 
additional research is needed to determine whether there are other etiologic 
pathways to primary prevention as well as to determine how to optimize the 
effectiveness of health promotion strategies aimed at improving preconcep-
tional folate levels through fortification, supplementation and diet. Re-
search into secondary prevention strategies will require additional study of 
treatment, co-occurring conditions, and long-term outcomes, focusing not 
only on infancy and childhood but across the lifespan. Studies of the role 
of genetics in NTDs should expand to consider genetics within the broader 
milieux of epigenetics and epigenomics.
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Where to from here? Transition to Adult Heath 
Care for Young People with Spina Bifida
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The landscape of health and well-being for children with complex devel-opmental disabilities such as Spina Bifida has dramatically changed over 
the past 50 years. Much of the knowledge and skills required to manage the 
challenging life and health issues facing children with Spina Bifida and their 
families has risen as a result of the critical mass that has accompanied the 
development of multidisciplinary clinics within specialist pediatric settings. 
When coupled with multiple technical advances in surgery, imaging, and 
pharmacology, the resultant reduction in mortality has been striking. In 
contrast to 50 years ago when over 90% of infants with Spina Bifida were not 
expected to survive childhood, the overwhelming majority of infants born 
in high-income countries can now expect to mature through adolescence to 
face the rigors of adult life [1].
What sort of future might this growing adolescent and young adult cohort 
face? Notwithstanding the impressive limitations in physical, cognitive, 
and emotional functioning that continue to be the hallmark of Spina Bifida, 
the challenge for families and health care professionals alike is to promote 
young peoples’ capacity to live fulfilled, meaningful lives. A wider challenge 
for the health care system is to ensure that as young people mature they are 
equipped to look after their health as independently as they can, and that 
appropriate health care services continue to be available to manage the in-
creasing complexity of health problems they experience with age [2].
Adolescent Development
Adolescence refers to the critical period of development that lies between 
childhood and adulthood. The World Health Organization considers 
adolescence as the time between 10 and 19 years, and youth as that period 
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between 15 and 24 years. While the term young person is commonly used 
without any particular definition, it formally refers to the combination of 
terms that encompass the age from 10 to 24 years. More recently, the term 
adolescent and young adult (AYA) is increasingly used; in relationship to 
specialist health services, this can include young adults up to the late 20s or 
even early 30s. 
Adolescent development is commonly conceptualized around three de-
velopmental domains: physical, cognitive, and psychosocial. The physical 
changes of puberty have long been considered to mark the start of ado-
lescence, while social milestones such as completing education, achieving 
financial independence, marriage, and parenting typically mark the end 
of adolescence and acceptance into adult life. Over the past 50 years, the 
changing social context of adolescence has resulted in an upward extension 
of the age at which many of these milestones have been achieved. This re-
sults in the ‘end’ of adolescence becoming less distinct. What is clear is that 
the onset of puberty in early adolescence signals a transition into greater 
health risk, whether from mental disorders (especially in girls [3]), from 
risky behaviors such as substance use and unsafe sexual behaviors, or from 
higher rates of participation in risky behaviors that increase the likelihood 
of accidents and injuries [4].
Recent developments in neuroimaging have provided a scientific explana-
tion of those aspects of cognitive development that our grandparents and 
their grandparents have long recognized as typical of adolescence. It is now 
known that the brain continues to develop during adolescence with ‘prun-
ing’ and myelination leading to more efficient processing and a greater 
capacity for executive functions (responsible for high level organization and 
planning skills) as well as emotional regulation [5,6]. These same processes 
are no doubt also responsible for the greater capacity of adolescents first, 
to imagine an ideal world (or body), and second, to more critically compare 
themselves with others as well as to this imagined ideal. 
Psychosocially, middle to late adolescence is a time during which healthy 
young people become more focused on educational achievement with even-
tual transitions to the work environment and financial independence. Dur-
ing this time, peer relationships become more critical to the ways in which 
young people view themselves. 
Adolescents with Spina Bifida
In addition to the usual developmental challenges faced by adolescents, 
young people with Spina Bifida face an additional set of challenges that 
relate to the presence of the developmental disorder and its associated co-
morbidities. For example, young people with Spina Bifida are more likely to 
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experience a disturbed trajectory through puberty; early onset (idiopathic 
precocious) puberty is far more common in girls with Spina Bifida than in 
girls without disabilities. While lack of physical dexterity can be challenging 
for menstrual management, broader repercussions relate to early puberty 
being a risk factor for poor mental health. A challenge for health profession-
als and families alike is not to assume that the various aspects of adolescent 
development occur synchronously. Thus, it cannot be assumed that the 
earlier physical maturity that accompanies precocious puberty is accom-
panied by equally mature cognitive and social functioning. Indeed, young 
people with Spina Bifida have been shown to be less socially engaged than 
their healthy peers [7]. This is likely to be related to the impact of motor 
disability on opportunities for recreational, sport, and other social relation-
ships, as well as deficits of cognitive functioning, like non-verbal learning 
disability. These factors may also at least partially explain why young people 
with Spina Bifida and other childhood disabilities have over twice the rate of 
sexual abuse as children without disability [8].
Many aspects of Spina Bifida affect learning. The impact of cognitive deficits 
commonly becomes more pronounced in adolescence due to the greater 
importance of learning and independent problem solving expected at this 
time, and the more nuanced and sophisticated patterns of social interaction 
that occur [9]. In addition, youth with physical disabilities risk being treated 
by parents and by others as younger than their years because limitations in 
physical mobility and activities of daily living require greater parental sup-
port (e.g., managing continence). It is likely that lower social acceptance and 
lower romantic appeal in young people with Spina Bifida [10,11] is a reflec-
tion of many different factors including neurocognitive deficits, physical 
appearance, and disability, and a range of accompanying social challenges 
including social stigma. 
Studies of mental disorder suggest that young people with Spina Bifida are 
at greater risk of depressed mood and low self-worth [12]. Some studies 
paint a picture of young people with chronic illness and disability struggling 
to come to terms with “normal” adolescent development through reduced 
opportunities for ordinary social engagement (e.g., schooling, recreation, 
and intimate relationships) [7]. However, increased family conflict and less 
emotional engagement by adolescents with Spina Bifida with their parents 
may also simply reflect normal adolescent development. Beyond this, family 
responses are equally critical in terms of balancing an understandable desire 
to protect young people against the need for young people to learn by doing. 
One challenge for parents and health professionals is appreciating that what 
in early and mid adolescence might initially feel reassuring (for example, 
that their child is not yet sexually active) becomes more concerning by late 
adolescence and young adult life if it reflects poor social skills, limited op-
portunities for social engagement, and greater emotional dependence on 
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family. It is sobering to appreciate that, in general, young people with special 
health care needs have more rather than fewer health risk behaviors and 
mental disorders [13].
Quality Primary Health Care for Young People  
with Special Health Care Needs
Since 1967, the American Academy of Pediatrics has promulgated the notion 
of a “medical home” as a framework for providing quality primary health 
care to children, young people, and increasingly to adults with special 
health care needs [14]. Responding to decades of research showing substan-
tial unmet health care needs in children and youth with special health care 
needs (CYSHCN) [15], the attributes of care provided through an ideal medi-
cal home are that it is accessible, family centered, continuous, comprehen-
sive, coordinated, compassionate, and culturally effective [14]. Endorsement 
of this approach, which arguably is the same as quality primary health care, 
has come from the American Academy of Family Physicians, the American 
Academy of Pediatrics, the American College of Physicians, and the Ameri-
can Osteopathic Association, with support from the Maternal and Child 
Health Bureau (MCHB). 
The principles developed by the MCHB in support of the medical home that 
are most relevant to the care of young people with Spina Bifida are that:
 • F amilies of CYSHCN are partners in decision-making and are  
satisfied with the services they receive
 •  CYSHCN receive ongoing comprehensive care within  
a medical home
 • F amilies of CYSHCN have adequate private and/or public  
insurance to pay for the services they need
 •  Community-based services for CYSHCN are organised so  
families can use them easily
 •  Youth with SHCN receive the necessary support to make transitions  
to all aspects of adult life including adult health care, work, and  
independence [16].
A systematic review of the attributes of a medical home suggests that CY-
SHCN experience better outcomes when receiving care that incorporates 
aspects of the medical home [15]. More specifically, children who can iden-
tify a medical home are about half as likely to experience delayed or forgone 
care and to have unmet health needs [17]. Within this framework, questions 
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of particular interest are how youth can be supported to make the required 
transition to adult health care, and what linkages are required to support 
access to appropriate specialist health care. 
Transition to Adult Health Care
Universally, multiple life transitions occur for young people in and around 
late adolescence and early adulthood. These include changes in social roles 
(e.g., greater expectations of independence, greater capacity for intimate re-
lationships), changes in civic and legal roles (e.g., ability to vote, drive a car), 
and changes in economic roles (e.g., completion of education and training, 
expectations of financial independence). Just as important for young people 
with complex health conditions are the changes within the health care 
system that accompany the transfer from specialist child oriented to adult 
focused health care. 
As children mature into adolescence, their health care generally continues 
to be coordinated within the specialist child health system. As the life expec-
tancy of young people with Spina Bifida has improved, so too has the need 
to develop specialist health services within the adult health care system. 
Internationally, adult specialist services are now well developed for various 
disorders such as cystic fibrosis that equally require multidisciplinary care; 
as with Spina Bifida, until the last few decades little demand for adult ser-
vices had been seen due to patterns of childhood mortality. Models of adult 
health care have been much slower to develop for young people with devel-
opmental disabilities such as Spina Bifida, for whom the added complexities 
of more pronounced functional disability would render the need for com-
prehensive specialist health services even more critical. 
Making a successful transition to adult health care is increasingly recog-
nized as an important health outcome for young people with chronic disease 
and disability. Regardless of where they are managed or by whom, the no-
tion of transition to adult health care is one that embodies a change in place 
from pediatric to adult services and a change in orientation from family-cen-
tered to more individually focused services [18]. The American Academy of 
Pediatrics and the Society for Adolescent Medicine maintain that the goal of 
transitional care is to maximize lifelong functioning and potential through 
the provision of high quality, developmentally appropriate health care 
that continues uninterrupted as the individual moves from adolescence to 
adulthood [19,20]. This planned movement of adolescents and young adults 
with chronic conditions from child centered to adult orientated health care 
systems is distinct to the event of transfer, which simply refers to the physi-
cal move from pediatric to adult services [21].
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A set of principles has been developed by the Society for Adolescent  
Medicine in support of transition to adult health care [20].  
In summary, these are that:
 •  Health care services need to be age and developmentally appropriate
 •  Health care services need to be able to address the common concerns 
of young people, including growth and development, sexuality, mood, 
and other mental health disorders, substance use, and other behaviors
 •  Successful transition to adult health care will help increase personal 
responsibility and facilitate self-reliance
 •T ransfer of health care should be individualized to meet the specific 
needs of young people and their families
 •  A designated individual must be responsible for coordinating and 
streamlining transition to adult health care
More specifically, this consensus statement identified six critical first steps 
to ensure successful transition to adult health care [20]. These were:
 •  Assurance that all young people with specific health care needs have  
a designated health care professional who takes specific responsibility 
for transition in the broader context of care coordination and health 
care planning
 •  Identification of the core competencies required by health care  
providers to render developmentally appropriate care and health  
care transition, and assurance that these are taught to primary health 
care providers and are an integral component of their certification 
requirements
 • Dev elopment of a portable, accessible medical summary to facilitate 
the smooth collaboration and transfer of care among and between 
health care professionals
 • Dev elopment of up-to-date detailed written transition plans, in  
collaboration with young people and their families
 • Assur ance that the same standards for primary and preventive health 
care are applied to young people with chronic conditions as to their 
healthy peers
 •  Assurance that affordable, comprehensive, and continuous health  
insurance is available to young people with chronic conditions  
throughout adolescence and into adulthood
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Models of Young Adult Health Care
Broadly, four models of health care for young adults with Spina Bifida are 
currently being used. The first model is for young people simply to remain 
within the specialist pediatric health care system, continuing to be man-
aged by various child health specialists into their adult years. The experience 
from other conditions is that when more typically “adult” complications 
such as pregnancy or drug addiction arise, pediatricians risk precipitously 
transferring young people to specific adult services (e.g., obstetric or drug 
and alcohol services) without putting in place an approach for more com-
prehensive and coordinated care. While some may view continuing access 
to pediatric services as the only reasonable response to the absence of more 
appropriately specialized services for young adults, this “propping up” of 
adult specialist services equally risks downplaying the extent of demand for 
comprehensive, coordinated adult services. Furthermore, while this model 
may be manageable for medical professionals who consult privately with 
young adults, the intersection of increasing survival of young adults with 
the upper age policies of children’s hospitals will at some stage render this 
model unsustainable. 
The second model is to transfer young people to an adult specialist service. 
This may be a specialty Spina Bifida service or, more commonly, an adult 
developmental disability or rehabilitation service. Within these services 
rehabilitation specialists such as physiatrists, rather than pediatricians or 
pediatric surgeons, are more likely to take the clinical lead. The key features 
of this approach are that (a) a critical mass of patients exists to ensure the 
acquisition of specialist skills, (b) access to allied health as well as medical 
care is available, and (c) care coordination occurs. Typically, transfer to adult 
health care is deemed most appropriate once secondary education has been 
completed [22]. The major challenge with this model in many parts of the 
world is a lack of capacity. Many adult hospitals and specialists lack interest 
in developing an appropriate clinical response to the complex health care 
needs of these young people. This commonly reflects limitations imposed 
by models of health care funding and health insurance, as well as a lack of 
training for adult health providers about chronic conditions of childhood 
onset and about adolescent health. 
The third model is to transfer young people at an earlier age (commonly 15-
17 years) to a young adult service, which may be based within either a pedi-
atric or an adult program. This is effectively the same approach as model two 
but without the expectation of ongoing care beyond young adulthood, at 
which time transfer to an adult services (model 2) or primary care (model 4) 
is still required. In comparison to models 1 or 2, the goals of young adult ser-
vices (which have most commonly been developed to support young people 
with diabetes and cancer) are more explicitly about facilitating healthy ado-
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lescent development and managing complex medical issues. This is equally 
critical for young people with Spina Bifida and their families.
The fourth model is to transfer young people to primary care, with the 
primary care physician responsible for care coordination and linkage to 
specialist health care and allied health care. While each of the first three 
models implicitly includes the primary care provider as a member of the 
multidisciplinary team, the key difference in this model is that the primary 
care provider is the clinical lead and care coordinator. A challenge for this 
model is whether the primary care provider has sufficient time and capac-
ity to undertake these roles. A further challenge for the system is whether a 
sufficient critical mass can be developed for any member of the adult “team” 
to gain the necessary understanding of the many different impacts of Spina 
Bifida, whether this is the primary care provider or any of the other medical, 
surgical or allied health specialists within the adult health care sector. 
Almost no evidence is available to support one model over another. What 
is clear is that many of the acute and chronic health issues affecting young 
adults with Spina Bifida are at least to some extent preventable [23], and 
that lifelong coordinated care is strongly recommended. In this context, 
it is highly concerning that in one study, 76% of adults with chronic and 
complex disabilities of childhood did not have a primary care provider [24]. 
Equally concerning is that admission rates were nine times higher than in 
the general population in one study, [24] with medical expenditures for 
youth with Spina Bifida estimated to be 13 times higher than for healthy 
youth [25]. Data like these no doubt raise immediate concerns for health 
care funders about the cost of managing this cohort. However, that nearly 
half of all hospital admissions for this lifelong complex condition are po-
tentially preventable [23] and that the cessation of a multidisciplinary clinic 
resulted in significantly worse (and more expensive) health outcomes [26], 
suggests the value of health economic modeling in determining the benefits 
as well as costs of comprehensive multidisciplinary health care for adults 
with complex and expensive conditions. 
Equally critical is the need for health care professionals to think develop-
mentally and to anticipate future health care needs. Disappointingly, in a 
population-based study of parents of 5,533 adolescents with special health 
care needs, only 50% reported their child’s doctor had talked about chang-
ing needs in adulthood, and only 21% had ever discussed transferring their 
child’s care to an adult provider in time [27]. Whatever future model of care 
is available, early and repeated discussions with the young person and fam-
ily are required to build their support and increase both the young person’s 
and the family’s capacity to move forward with confidence into the adult 
health care sector. A stronger focus on supporting young people and families 
to acquire self-management skills that would enable them to function more 
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independently as they mature is required. Programs that help young people 
with chronic conditions learn from each other, whether by participating in 
peer support groups, through social networking sites, or through recreation-
al activities such as camps, are but some of the ways of achieving this. 
Measuring Health and Life Outcomes
As with other complex conditions, the nature of Spina Bifida and its impact 
on the individual and family change with age and development. A recent lit-
erature review of the health care needs of adults with Spina Bifida highlights 
the incredible range of health concerns, including both disease specific (e.g., 
neurological, bladder and bowel functioning, mobility and musculoskeletal 
function, sexual functioning) as well as generic (e.g., obesity, mental disor-
der, skin care, pain) [2]. Whether in relationship to the general principles 
supporting children and youth with special health care needs, the more 
specific principles supporting transition to adult health care, or the models 
of healthcare for young people with complex conditions, a broader require-
ment is the development of a framework for monitoring and evaluating 
both health and life outcomes for people with Spina Bifida. In the United 
States, the recent development by the Spina Bifida Association of a Spina 
Bifida Database Registry is a very positive step towards supporting a research 
and evaluation framework.
Currently, a distinct risk exists for young people with complex health and 
developmental needs that maturation beyond the purview of specialist pe-
diatric services will result in reduced access to developmentally appropriate, 
quality health care. To date, determined individuals who appreciated the 
lack of access to future adult health care for their patients and who devel-
oped good relationships between themselves and adult colleagues have been 
largely responsible for the success of most services for adults with develop-
mental disability around the world. However, the complexity of contempo-
rary health care for young people with Spina Bifida means that more system-
atic approaches to the development of adult services and to approaches for 
supporting the necessary linkages between pediatric and adult services are 
required. Many children’s hospitals and rehabilitation programs would ben-
efit from hospital-wide transition policies to support these tasks. Many parts 
of the world would equally benefit from regional health planning that would 
help identify or prioritize the development of developmentally appropriate, 
accessible, quality health care for young adult with complex disabilities. 
A further risk is that the absence of the critical mass that would result from 
the development of specialist adult services leads to a failure to invest in a 
research framework for adults with Spina Bifida. Among other things, one 
might expect that with time, we would have a better understanding of the 
changing health care needs with age and what models of care might work 
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best to support the ongoing health care needs of this complex population as 
they mature. Investment in a training agenda for those who work with ado-
lescents and young adults also is required, whether in the pediatric or adult 
health care settings. 
Failure to invest in systematic approaches to monitoring health outcomes, 
in research, and in clinical training would sadly mean that by the year 2020, 
we may have no better understanding of how to improve the health and 
well-being of adults with Spina Bifida than we do today. The health care 
needs of young people with Spina Bifida do not lessen with age. If anything, 
the reverse is the case. Investment in more systematic approaches to clinical 
service development, research and training are required in order to improve 
both the health and life outcomes of these young people. 
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Meeting of the Section on Transition
Transitioning from Pediatric to Adult Medicine for Adolescents and Young 
Adults with Spina Bifida: Research and Programmatic Developments
Introduction
Since the 1970’s, survival in Spina Bifida has steadily increased; currently 
over 85% of children with neural tube defects are expected to reach adult-
hood. With longevity comes the need for adult-oriented services and prepa-
ration for the transfer of care out of pediatrics. The Spina Bifida Association 
and affiliated multi-specialty clinics have been addressing these issues for 
the last decade. At the First World Congress on Spina Bifida in March 2009, 
researchers and practitioners presented twenty-five abstracts on adolescent-
to-adult transition from the United States, Canada, Australia, and the 
Netherlands. 
The abstracts were divided into two main categories: 1) research, and 2) 
programmatic development. Several research abstracts examined the rela-
tionships between the medical, cognitive, academic, executive functioning, 
and psychosocial characteristics of adolescents and young adults (AYA) 
with Spina Bifida and their self-management abilities, community living 
skills, and health-related quality of life (HRQOL). Other research examined 
barriers and facilitators to participation in social, community, and physical 
activity and how participation impacted HRQOL. The process of transition 
in certain multi-specialty programs was studied, examining patient/family 
satisfaction and how well the process is documented in the medical record. 
Finally, research was presented that evaluated the average timeline for trans-
fer of self-management responsibility from parent to AYA. 
Programmatic abstracts described pilot projects in lifespan training cur-
riculums, adolescent transition services, adult multi-specialty clinics, 
camp-based training programs, and a teleconference mentoring program. 
Other presentations described assessment tools for transition programs and 
Internet-based care coordination and educational resources for healthcare 
providers, families, and AYA self-advocates. 
Transition Research
Most of the research presented was from regional, convenience samples of 
fewer than 100 subjects; however, several multi-site studies were presented, 
which included subjects attending one of several multi-specialty Spina Bi-
fida programs. Two national studies were presented: one from a self-selected 
sample of conference attendees, and one randomly-selected, nationally rep-
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resentative population. Most of the research included validated measures 
and the majority utilized the constructs of activity and participation from 
the World Health Organization International Classification of Function. 
One measure under development, the Adolescent Self-Management Inde-
pendence Survey - version II (AMIS-II), was used in several of the transition 
research studies. The development of this instrument has been presented 
at previous conferences and the current abstract evaluated the measure’s 
psychometric properties using a sample of 135 parent-child dyads from four 
Spina Bifida clinics. The age range of the participants was 12 to 25 years. The 
17-question AMIS-II demonstrates construct validity and reliability. The 
instrument has two factors: 1) Self-management: Independent Living, and 
2) Self-management: Condition. The tool is administered by interview and 
measures the amount of independence across multiple domains, including 
personal care skills such as toileting and taking medications, and indepen-
dent (community) living skills such as making and keeping appointments 
and refilling prescriptions. The AMIS-II was offered as a reliable tool to as-
sess clinically relevant self-management skills in AYA with Spina Bifida [1]. 
Using validated instruments including the AMIS-II, a study of a convenience 
sample of 26 young adults and 13 parents attending a transition program 
in Wisconsin found most of the young adults (ages 18 to 35 years (mean 23 
years)), needed supervision with managing their personal health needs and 
with independent (community) living skills. The greatest needs were in the 
areas of finances, vocational rehabilitation, health care, independence, and 
socialization [2]. 
Also using the AMIS-II, a convenience sample of 61 young adults was evalu-
ated for the association between self-management skills and psychosocial 
functioning and health outcomes. Overall the young adults had greater 
independence of self-care skills directly related to their daily Spina Bifida 
needs than overall independent (community) living skills. Higher self-man-
agement skills were associated with community living outcomes, but not 
with being employed or having a higher quality of life. No association was 
found between higher self-management skills and health outcomes, such 
as having pressure sores, urinary tract infections, hospitalizations, or conti-
nence [3].
Cognitive ability and executive functioning were compared to independent 
living skills in a sample of young adults in Chicago. Scores on standardized 
scales of functional academic skills, cognition, and academic achievement 
were more likely to be significantly associated with money management, 
transportation independence, health and safety abilities, and memory than 
with parental report of the adolescents’ independence skills. The number of 
shunt revisions was not associated with any of the outcomes [4].
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Self-management ability, depression, and quality of life were compared to 
mobility status in a multi-site study of 61 young adults with Spina Bifida. 
Mobility status (full-time wheelchair, part-time wheelchair, ambulatory) 
was not associated with QOL or depression. Trends were found towards 
lower self-management scores and greater need for assistance for full-time 
wheelchair users compared to those with some ambulation [5].
The overall findings in these studies indicate an ongoing need for assistance 
with self-management skills into young adulthood particularly for com-
munity living skills. Physical factors such as shunt revisions and mobility 
status do not appear to impact self-management skills, but intellectual and 
executive function may affect independent living skills. Self-reported quality 
of life does not appear to be affected by self-management skills or mobility 
status. 
The timeline for transfer of self-management responsibility was examined 
in two abstracts. A concordance study about who is responsible for medical 
tasks conducted with a convenience sample of adolescents and their moth-
ers in Chicago revealed that transfer of responsibility generally begins at 12 
to 13 years with significant increases in the adolescent taking charge at 16 
to 19 years of age [6]. A survey of a convenience sample of 62 parents and 41 
young adults measuring the time of transfer of responsibility for medical 
care revealed the majority of care is shared between adolescent and par-
ent between 12 and 17 years of age; 2/3 transfer care during the young adult 
years. While most personal care management transferred to the young adult 
after age 18 years, medication management and appointments tended to 
stay with the parent. Nutrition and bowel management were more likely to 
remain shared with the parent by young adult [7].
The process of transition was evaluated in two abstracts. In a descriptive 
cohort study of a pilot transition program in Wisconsin 21 young adults and 
12 parents were interviewed using a qualitative telephone questionnaire 
two weeks after their initial transition visit. Over 80% responded that the 
process, which included a pre-transition visit with the nurse, a tour of the 
adult health facility, and a transition visit with the physiatrist and urologist, 
was “better than expected” and was reassuring. Persistent concerns included 
access to neurosurgical consultation and the need for non-medical transi-
tion services [8].
A retrospective chart review of one Spina Bifida clinic evaluated the extent 
to which transition plans were documented in the patients’ medical records. 
Plans related to education, employment, and recreational activities were 
documented in more than 70% of the charts. Bowel continence and activi-
ties of daily living were documented in greater than 50% of the records. Less 
than half of the charts, however, had transition plans for social relation-
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ships, health care, living arrangements, and urinary continence [9]. These 
studies indicate that a planned process that includes anticipatory guidance 
and coordinated visits alleviates patient and parental anxiety, but that more 
work is needed to help facilitate transition to adult community living.
Community participation, including post-secondary school education, em-
ployment, and transportation-independence were examined in several ab-
stracts. A retrospective chart review of a Spina Bifida clinic in Ohio revealed 
that 45% of adolescents remain in high school past the age of 18 years. Sixty 
percent of 22+ year olds are still not working or attending any kind of train-
ing program despite 82% receiving vocational-educational rehabilitation 
services. Over 70% of these adults are receiving supplemental security (SSI) 
or disability income and over 60% have public health insurance. The ma-
jority of adults were not driving, which was associated with hydrocephalus 
status but not lesion level [10].
Barriers to community participation were studied in 101 adolescents and 
young adults in Chicago. Initially only 30% of the subjects participated in 
community activities at least weekly. After an intervention by a transition-
coordinator a 17% increase occurred in those who participated in weekly 
activities, with the greatest impact on the 15 to 17 year age group. Subjects 
over 21 years who were not in school, not working, and initially had no 
community activities were least likely to increase their participation. Over-
all, two-thirds of the adolescents maintained their participation for 6 to 12 
months. The most frequently reported barriers were language (non-English 
speaking) and the lack of motivation, information, and transportation [11].
Physical activity participation was examined in 51 adolescents and young 
adults in the Netherlands and compared to fitness, body fat percent, cardio-
vascular disease risk factors, social roles, social support, and health-related 
quality of life. Physical activity and fitness had positive effects on partici-
pating in daily activities and physical HRQOL but not body fat percent or 
mental HRQOL. Participation in sports activities did not depend on ambu-
latory status but was associated with greater perceived athletic competence, 
physical appearance, and family social support [12].
Based on the classification system and domains of the World Health Orga-
nization (WHO) International Classification of Function (ICF), a nationally 
representative sample of 129 youth with Spina Bifida were studied for bar-
riers and facilitating factors for community participation. As an example, 
communication problems, taking medications, and upper extremity prob-
lems were significant barriers to social participation with friends. This study 
is a rare example of a randomly selected, national sample of individuals with 
Spina Bifida, which can provide needed insight about those individuals who 
are not followed by multi-specialty clinics or attending national conferences 
[13].
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Overall, participation and independence in the adult group was low, but 
could be facilitated by an adult transition coordinator. Barriers included 
physical and medical constraints, but lack of motivation was a significant 
variable. More research into identifying barriers to community participation 
and effective interventions is needed. 
Transition Programs
Several pilot programs to facilitate self-management skills, physical activ-
ity and community participation, and transfer of care to adult services were 
described. Multiple modalities including a lifespan approach, camp training 
programs, teleconferencing, and internet-based tools have been tried.
A program from the Spina Bifida Association in Cincinnati uses an “effective 
mentoring model” via nine weekly one-hour teleconferences with 10 to 12 
participants. A syllabus that addresses self-care topics and negotiating the 
health care system has been developed, and includes guest moderators with 
expertise in Spina Bifida. The program has served 99 older adolescents and 
young adults of diverse backgrounds, but with an emphasis on those who 
are geographically isolated or financially challenged [14].
The Shriners Hospital in Chicago presented their first SPINABILITY Camp, 
which is designed for participants at least 13 years of age with independent 
transfer and bowel and bladder self-care abilities. The camp lasts one week 
and is staffed by an interdisciplinary team that utilizes a “challenge by 
choice” philosophy, meaning that campers participate at the level of their 
choice for each sports-oriented physical activity. The inaugural camp was 
well received and will be repeated [15]. 
Several presentations outlined the successes and challenges of regional 
transition programs, including those in Alabama, Illinois, Wisconsin, and 
Ontario, Canada. Important features of these programs believed to facilitate 
successful transition include a lifespan approach with specific training and 
mentorship for the child/adolescent; collaboration among pediatric and 
adult healthcare providers; family education and support; and dedicated 
transition coordinators to set developmentally appropriate goals, and to 
manage scheduling, transportation, as well as the transfer of health infor-
mation from one team to the other. These pilot programs identified gynecol-
ogy, family planning, bowel continence programs, adult surgical specialists, 
and quality health insurance as the greatest needs for an adult Spina Bifida 
clinic [16-19].
Gillette Lifetime Specialty Healthcare summarized five years of experiences 
with their adolescent and adult clinic, which uses an interdisciplinary team 
of urological, rehabilitation, and neurosurgical specialists to address the cog-
nitive, socio-emotional and physical needs of their patients. The ages of their 
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clientele range from 16 to 74 years, with equal participation of males and 
females. They reported high patient satisfaction based on customer satisfac-
tion surveys. Parents and youth prioritized different areas. Teens chose Medi-
cal and Jobs as first priorities and parents chose Insurance and Medical [20].
A state government funded program from New South Wales, Australia 
utilizes a case management system to help young adults negotiate the more 
complex adult health care system. A Clinical Nurse Consultant and an Oc-
cupational Therapist who coordinate transitions from the three pediatric 
multidisciplinary Spina Bifida clinics to the two adult Spina Bifida clinics or 
to regional adult rehabilitation service providers staff the Adult Outreach 
Service. The transition service has facilitated regular attendance at the adult 
Spina Bifida clinic, decreased hospitalizations for pressure sores, reduced the 
incidence of renal impairment, and increased community participation [21]. 
Several transition tools are being developed. The Center for Disease Control 
and Prevention is developing a Preparation for Adult Participation logic 
model based on the principals of the World Health Organization Interna-
tional Classification of Function and using input from Spina Bifida experts 
and consumers. The transition pathway has three domains: 1) Self-manage-
ment/Health, 2) Personal and Social Relationships, and 3) Employment/
Income Support. A web-based Transition Preparation Checklist will list key 
developmental milestones in each of these domains and offer patient educa-
tional materials and assessment tools [22].
Another assessment tool, Assessment of Spina Bifida Care for Adolescents 
and Youth, was piloted by six Spina Bifida clinics in New York, New Hamp-
shire, North Carolina, Ohio, and Pennsylvania. This health-care team self-
assessment tool is adapted from a validated quality improvement measure 
from the Institute for Healthcare Improvement and is based on the Chronic 
Illness Care Model. Completed by medical directors, nurse coordinators, al-
lied health professionals, and surgical sub-specialists, this pilot study found 
no significant differences in ratings across centers or provider types. The 
mean overall grade for the five centers was a “C” [23].
 An Internet-based, interactive care coordination tool, which includes 
a video-format curriculum, has been piloted by SUNY Upstate Medical 
University. The content of this website, www.HealthyTransitionsNY.org, is 
adapted from the University of Washington Adolescent Health Transition 
Project; the curriculum was prioritized by consumer focus groups. Several 
ADA-accessible formats are available, which can be used for self-study or by 
using a moderator guide. The website includes a transition readiness check-
list, goal setting guides, a search engine, health care guidelines, a transition 
medical history form, and an interactive video that demonstrates health 
care encounters [24].
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Overall, the transition presentations highlighted common issues across all 
Spina Bifida providers. Interestingly, challenges in access to adult provid-
ers were similar regardless of the health care system. Young adults are still 
dependent on parents for management of their medical condition, particu-
larly for administrative tasks such as appointments, finances, and medica-
tion refills. Community participation remains low but can be facilitated by 
a transition coordinator. Multiple tools are being developed to help with the 
assessment, coordination, and patient/family education during the transi-
tion process. More research is needed in understanding how to maximize de-
velopment of self-management independence and community participation. 
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Introduction
This keynote address is delivered worldwide to nurses and allied health (AH) care professionals (physical therapists, occupational therapists, 
certified orthotists, social workers, recreational therapists, child life  
specialists, school health teams, and others) committed to a lifespan  
approach to improving the health-related quality of life of individuals living 
with Spina Bifida. 
We have been called … “Nurse, Sister/Brother, Doctor, Therapist, Auntie/
Uncle, Teacher, and Friend” in a multitude of languages. I think of all the 
journeys we have had with our patients and families, and share this as a 
colleague on the state of the art and science of the care provided today. I 
was brought up with a child with cerebral palsy and readily knew disability, 
braces, wheelchairs, etc. as a normal part of day to day life and “culture.” I 
started working with families with Spina Bifida in 1977 on the neurology/
neurosurgery unit at Boston Children’s Hospital. In 1981, with nursing col-
leagues, I formed the North Eastern Myelodysplasia Association (NEMA). 
Over the years, the highlight of my career has been collaborating with col-
leagues across the USA; visiting Dr. Menelaus at the Spina Bifida Clinic at 
the Royal Children’s Hospital in Australia in 1982; and more recently visiting 
others at programs in Italy, Chile, and India. 
Nurses/AH who demonstrate a commitment to Spina Bifida care have an 
ability to grasp the complexity of this multisystem, and potentially pro-
gressive, disabling condition and facilitate or develop interventions that 
have both practical and long term effects that support patients across care 
environments. In short, they combine critical thinking with a passion for 
making a difference in the lives of their patients. While recently re-reading 
Mohandas K. Gandhi’s autobiography [1], I found that the following quotes 
resonated with both a feeling of familiarity and a regard for the spirit of the 
First World Congress on Spina Bifida Research and Care 49
nurses/AH world-wide who care for people living with Spina Bifida: “. . . like 
loyalty, an aptitude for nursing was also deeply rooted in my nature. I was 
fond of nursing people, whether friends or strangers [p.173]. My aptitude for 
nursing gradually developed into a passion. …Such service has no meaning 
unless one takes pleasure in it. … But all other pleasures and passions pale 
into nothingness before service which is rendered in a spirit of joy [p. 175].”
Past, Present, and Future 
A historical context of disability, genetics and chronic illness is beneficial 
in understanding the complexity of providing care and impacting policy for 
families affected by Spina Bifida. A recent monograph, Genetics and Ethics 
in Health Care [2], is relevant to the issues of survival (morbidity and mor-
tality), stigma, access to health care and social policy issues faced by families 
living with Spina Bifida. The following highlights a few critical documents 
and cases [3]: 
 •  In the 1700s, Diderot edited a lexicon of congenital anomalies, titling 
the section “Monstre” or monstrosities in a supplement to Encyclope-
die (France). 
 • In  1971 Lorber’s selection criteria to decide whether or not newborns 
with Spina Bifida are treated became controversial (England) [4]
 • In  1983 “Baby Jane Doe” a neonate with Spina Bifida and hydrocepha-
lus prompted further dialog and new regulations under Section 504 of 
the Rehabilitation Act forbidding discrimination based on handicap 
related for federal funds (USA) 
 •  Recent documents addressed the scarcity of resources for individuals 
living with Spina Bifida in African and impoverished nations [5, 6] 
 •  Currently in the USA and worldwide adults living with Spina Bifida 
are struggling to access health services and care coordination; many 
are failing to find providers interested and knowledgeable about their 
health care needs 
 •  The 2008 signing of the Genetics Information Non-discrimination 
Act (GINA) should further reduce discrimination of health insurance 
coverage for individuals with disabilities (USA)
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Although policies are changing, preventing disparities in health care across 
settings and the impact of stigmatization remain challenges for patients, the 
chronic health care needs and potential risks for secondary conditions in 
Spina Bifida [7-10] require additional diligence in supporting:
 • A multidisciplinary, comprehensive team approach to care 
 •  Continuity of services over time and episodes of care and care  
coordination [11]
 • Family centered social support [2, 12-16]
 •  Transition services and transfer of care across the lifespan and from 
pediatric specialty programs and/or medical homes to adult providers 
and/or medical homes (this may take two or more years to accomplish 
in an individual) [17-24]
 •  Utilization of other chronic illness management models such as the 
Wagner Chronic Condition Model [25], and adaptation to the lifespan 
healthcare needs in Spina Bifida to challenge the disparities in health 
dollars and services
 •  Research, collaboration, evidence-based practice, guidelines, and dis-
semination [3, 20, 24, 26-29]
The Art and Science of Spina Bifida Care
The profession of nursing is described as both an art and science and in-
cludes a vast number of roles and practice domains that are needed in a 
lifespan approach in the care of individuals living with Spina Bifida and to 
meet the needs of their families and communities. Beyond language and 
cultures, roles include: bedside/hospital based nursing; counseling/sup-
port; outpatient care; care coordination and triage; advocacy; education 
and mentoring; school health [18]; public health; consultation; collabora-
tion; research; policy development; program development and evaluation; 
and publication and dissemination of evidence. Nurses and therapists are 
critical in the ongoing assessments and education for family members in the 
habilitative techniques of: positioning, donning and doffing of bracing/or-
thotics and adaptive equipment, skin care, mobility and functional skills in 
the home and community, and skills and activities needed for recreational, 
social, vocational and sexual health [30, 31]. 
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Select clinical competencies and domains of practice of nurse/AH clinicians 
working in Spina Bifida include
 •  Maintaining and providing safety (emergency management and pre-
vention) and comfort–the #1 priority!
 •  Providing education on folic acid and strategies for optimizing daily in-
take for both females and males [32] of reproductive age across health 
and community environments
 • Preventing secondary conditions [8, 9] while promoting health [33-35]
 •  Optimizing growth and development while minimizing the impact  
of disability
 •  Addressing neurological/neurosurgical issues, including hydrocepha-
lus and signs of shunt malfunctions, seizures, tethered cord syndrome, 
and Chiari symptoms [36]
 • Addressing orthopedic and mobility issues [37, 38]
 • Addressing habilitation and rehabilitation [39-44]
 •  Managing bowel and bladder function to promote continence and 
hygiene; maintain renal and gastrointestinal health; promote skin care, 
nutrition; and prevent obesity [45-50]. 
 •  Continuing research into and preventing latex allergy. Latex allergy 
research and precautions were spearheaded by nurses working with 
Spina Bifida clinics and changed practice worldwide [26, 27, 51-59]
 •  Promoting health-related quality of life (HRQOL) in Spina Bifida  
[9, 60. 61]. 
An Invitation to Participate in Global Strategies
In this time of electronic highways and rapid communication we need to 
take advantage of our ability to develop partnerships and collaborate on 
research and policy development with people around the world. It is impor-
tant to form these partnerships with community-based organizations, the 
individuals living with Spina Bifida and their families and to adopt commu-
nity-based participatory research methods as a principal and methodology 
[10, 62]. We can develop the leverage to change policy, decrease disparities in 
health services and diminish gaps in care and research. 
You are invited to share your best stories and exemplars of care; best prac-
tice scenarios and guidelines; case examples and successful strategies at 
advocating or policy formation. Invite others to visit your program, travel, 
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give grand rounds, consult, share your knowledge and be political (in the 
best sense of the word). Inspire and mentor the young professionals in your 
environment or the students you encounter, and support one another! Work 
to improve opportunities for all individuals with Spina Bifida; promote 
inclusive environments of acceptance and value, free of discrimination and 
stigma; facilitate and ensure the development of access to services and care 
coordination; protect those at risk for neglect or abuse; and know your value 
when discouraged. 
We need to continue to “think outside the box” or re-visit programs that 
were effective but have fallen by the wayside. For example, many of our 
patients deserve to have a comprehensive rehabilitation program to gain in-
dependence skills similar to individuals with an acute/traumatic spinal cord 
injury. This could be accomplished at a camp, rehabilitation program, or in 
hospital for a week during their elementary school years and again in their 
teen years to further refine skills. Yet insurance coverage and systems of care 
have provided this in only a few rare cases. 
Nurses/AH are often the architects and the bricks that build bridges to 
schools, communities, public health agencies, home health, employee 
health, recreational and sports opportunities, and if necessary palliative and 
hospice care. The nurse coordinator roles in Spina Bifida have been drasti-
cally reduced by health care redesign and by efforts to reduce costs. Many  
of us (nurses and allied health care professionals) have lost our positions 
or are required to take on other patient populations or roles that reduce 
our time and roles with patients who have Spina Bifida. At this First World 
Congress Meeting on Spina Bifida Care and Research let us renew our com-
mitment, and support one another. You are welcome to join in and read the 
following [63]. 
The Nightingale Declaration for Our Healthy World
We, the Nurses [Allied Health Professionals] and concerned citizens of the 
global community, hereby dedicate ourselves to the accomplishment of a 
healthy world by the year 2020.
We declare our willingness to unite in a program of action, sharing informa-
tion and solutions to resolve problems and improve conditions -- locally, 
nationally and globally -- in order to achieve health for all humanity.
We further resolve to adopt personal practices and to implement public 
policies in our communities and nations, making this goal for the year 2020 
achievable and inevitable, beginning today in our own lives, in the life of our 
nations and in the world at large.
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Meeting of the Section on Nursing  
and Allied Health 
The section on Nursing and Allied Health (NAH) includes nurses, social 
workers, physical therapists, occupational therapists, dietitians, and “inter-
ested others.” The NAH podium and poster presentations were placed into 
one of two categories, Childhood Transitions or Promoting Positive Out-
comes for People with Spina Bifida and Their Families. Acknowledging that 
those categories frequently overlap, the following summaries combine the 
key themes of all the presentations.
General Themes
Understanding the perceptions of people with Spina Bifida and their fami-
lies is key to helping healthcare providers develop proper teaching-learning 
interventions and programming. Most of the following information was 
generated by qualitative studies, starting with younger children and ending 
with the late teen/young adult aged person.
In Jean Brown’s description of self-management of the neurogenic bladder, 
she emphasized the importance of timely interventions based on the pro-
cess model of developmental stages. This is a sequential “stepping process,” 
resulting in successful transition to independent social continence. Parents 
and healthcare providers need to provide opportunities for this sequential 
developmental process to occur. 
When Pat Braun interviewed primary care givers about their perspectives on 
transitioning care of neurogenic bowel management to their pre-adolescent 
children with Spina Bifida, barriers and facilitators were identified. Those 
responses led to the development of a practice model to facilitate the transi-
tion process. When healthcare providers are knowledgeable about barriers 
and facilitators on an individual level as well as collectively, appropriate in-
terventions can be planned and implemented, resulting in pre-adolescents 
assuming their own bowel care.
In a study reported by Kathy Sawin on adolescents’ perspective of how their 
family managed the chronic condition of Spina Bifida, it was concluded that 
adolescents were knowledgeable about the management behaviors needed 
by the family (skills, strategies for the routine as well as the non-routine). It 
was suggested that adolescents be included in family studies about chronic 
illnesses, as they are likely to contribute to the family’s management of the 
condition.
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Melissa Bellin reported on the experience of self-management of adolescent 
females with Spina Bifida. Barriers to participating in self-management 
activities included limited opportunities to manage money, build job skills, 
and develop autonomy in self-care decisions. Adolescents with Spina Bifida 
require planned, incremental responsibility for decision-making relative to 
their self-management experiences. 
Analysis by Christine Kinavey of commonalities in narrative accounts given 
by adolescents with Spina Bifida imply that the biopsychosocial challenges 
faced by children born with Spina Bifida may interfere with normative de-
velopmental processes, including self-identity. Greater efforts need to be put 
forth to maximize developmental opportunities and foster identity not only 
as an individual, but as a member of a family, the immediate community 
and the global community.
Teen mentoring projects reported by Karen Rauen emphasized that these 
projects can significantly contribute to the teen’s socialization skills, inde-
pendence and participation in the community. Group activities as well as 
one-to-one activities with an adult mentor foster the achievement of in-
dividual teen goals as well as group goals. Outreach efforts to teens living 
outside of metropolitan areas can also achieve these goals through creative 
programming.
Transitions
The summary themes that resulted from the combination of presentations 
and discussions regarding transitions are: start early, offer opportunities, use 
repetition, and celebrate successes. 
More specifically, the group agreed to the following:
 •  Pre-natal counseling is important in terms of providing information 
and starting a trusting relationship. This type of counseling should be 
encouraged.
 •  Start early to transition to the next steps toward self-management. 
Transitioning often takes more time and more repetition for children 
with Spina Bifida.
 •  Help parents learn to “let go” and to see the benefits for their child 
regarding involvement in decision making. Parents need to involve the 
child in chores and raise the bar on expectations.
 •  While respecting different cultures, it is important that families are 
taught the consequences of not doing recommended activities, such as 
catheterizations.
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 •  Help families understand the critical times of transition in growth 
and development, such as entering school and puberty; provide them 
insights on normal adolescent behaviors. 
 • M entoring programs can facilitate teen transition into adulthood by 
increasing socialization skills, self-management skills, and community 
participation.
The quest to find better interventions based on scientific evidence for 
people with Spina Bifida and their families is perpetual. Reports on the fol-
lowing studies and interventions offer evidence of what can help promote 
positive outcomes for this population. 
Two presenters reported on innovative pilot studies to promote the tran-
sition process. Rachel Neff Greenley presented a study of two tailored 
problem solving interventions focused on enhancing adaptive family com-
munication and child involvement in decision making. Families completed 
pre- and post-intervention questionnaires. Over 70% of parents reported 
that the intervention was useful in improving key areas of functioning, 
including child self-management skills, problem solving skills, and family 
communication. Children’s responses paralleled those of their parents. 
Findings from a prospective controlled trial, the Transition Training Prepa-
ration (TPT) Program, were presented by Kathryn Smith. The study is 
examining whether the TPT cognitive-behavioral program in combination 
with Spina Bifida management will lead to improved transition of self-
management as well as physiologic and psychosocial outcomes in adoles-
cents. Specifically, pre- and post-intervention measures were collected on 
role mastery, well-being of relationships and self-care agency. Outcomes of 
the TPT data are being analyzed and may indicate the usefulness of simi-
larly designed programs in facilitating the transition of teens to responsible 
adulthood. 
Promoting Positive Outcomes for People  
with Spina Bifida and Their Families
Prevention of latex sensitization for people with Spina Bifida remains a 
major concern. Eric Levey reported on a study conducted to determine the 
prevalence rate of latex sensitization in children with Spina Bifida. Forty-
four percent of those born before 1994 were found to be sensitized, while 
only 14% of those born after that time were sensitized. The substantially 
lower prevalence in sensitization is believed to be related to latex avoidance 
measures. While data continue to be analyzed, the question of continuing 
latex precautions for newborns with Spina Bifida remains.
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Treatment methods to promote continence for the neurogenic bowel were 
presented. Use of the Cone Irrigation Enema was reported by Jean Brown as 
an acceptable alternative to other non-surgical methods, resulting in a high 
level of continence for many children and adults. Using a standardized tool 
that assesses functional independence, Drew Davis presented a study on the 
degree to which the Antegrade Continence Enema (ACE) promoted bowel 
management independence in children with Spina Bifida. Results indicated 
that children were more independent in their bowel programs following  
the ACE.
A study to determine the effects of chronic health conditions on families 
that have a child with Spina Bifida, a rheumatological condition, epilepsy or 
asthma was reported by Karen Rauen. Instruments were used that measured 
family conflict and family impact. Despite the visual aspects of Spina Bifida 
and its complexities, families with Spina Bifida reported less problematic 
impact on the family than those with epilepsy and asthma.
Several presentations focused on pressure ulcer development in people with 
Spina Bifida. In a retrospective chart review reported by Patricia Beierwal-
tes, 76% of the subjects with Spina Bifida had had a pressure ulcer (48% 
sacral; 45% foot). While 10% of the ulcers were caused by burns, the rest 
(90%) were caused by pressure. The researchers correlated ulcer develop-
ment with incontinence and program adherence. They found that program 
non-adherence was the only significant variable related to ulcer develop-
ment. It was concluded that developing ways to promote adherence with 
healthcare regimes is critical to the prevention of pressure ulcers and their 
associated complications and costs. Laura Gueron reported that a survey 
of Spina Bifida clinics regarding lower extremity assessments revealed that 
responders did not use any type of formal evaluation or educational tools. 
Subsequently, Gueron’s group developed foot screening and foot evaluation 
forms, a teaching DVD, and a lower extremity education packet about skin 
care for patients. The instructional Skin Care DVD includes how to inspect, 
wash, and care for the lower extremities as well as proper sock and shoe 
selection and orthotic wear. Pre-tests were administered to subjects before 
they watched the DVD. Post-tests showed significant improvement in un-
derstanding the care needed for lower extremity health and pressure ulcer 
prevention.
Sexuality of adolescents and young adults (AYAs) is a topic rarely discussed 
with parents or people with Spina Bifida. However AYAs are interested in it 
and have many unanswered questions. Dealing with the sexual consequenc-
es of having a disability offers unique challenges. Susan Labhard reported 
that to address the “need to know,” a Sexuality Workshop for Adults with 
Spina Bifida was developed and implemented in a Spina Bifida clinic and 
a transition camp. Topics included relationships and sexuality, options to 
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traditional sexual expression, useful references and the use of appropriate 
media. Labhard concluded that clinical research has demonstrated that 
young adults can improve their knowledge of socialization and sexuality by 
attending a one hour workshop on the topic.
The summary themes that resulted from the combination of presentations 
and discussions regarding interventions to promote positive outcomes are: 
develop useful tools–and test them, use what works best, find ways to moti-
vate, and address all relevant topics. 
More specifically, the group agreed to the following:
 • L atex precautions need to be continued for people with Spina Bifida, 
with a common sense approach regarding sensitivity.
 • Bo wel continence is critical to medical issues (constipation, skin ul-
cers), mental health issues (self-esteem), and social issues (isolation).
 •  Use what works best. The Cone Irrigation Enema may result in  
bowel continence for some, while others do best to achieve that  
goal via the ACE.
 • Dev elop a concrete plan for advancing self-management skills and 
independence that is really understood. Terminology can be barriers to 
success, and repetition and practice are essential.
 •  Recognize that sometimes parents and providers do all the right inter-
ventions to move a child toward greater independence, but the child’s 
cognitive issues and need for external motivation may be the problem; 
acknowledge this and change the approach.
 •  When written tools and return demonstrations do not show under-
standing of a newly learned skill, a DVD that can be repeated many 
times may be helpful.
 •  Regarding sexuality and the person with Spina Bifida, families need 
to understand privacy issues, friendships, relationships, and the ap-
propriateness of wanting to be sexually active. The person with Spina 
Bifida needs to be aware of the risk of sexual exploitation and how to 
prevent it from happening. 
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Future Directions for Research and Care
More research and care initiatives are needed in the following arenas:
 • Helping parents of a child with Spina Bifida to see the benefits of 
  o Giving the child age-appropriate choices 
  o Involving the child in household chores
  o Promoting self-care management
  o Raising the bar on expectations
  o Incrementally increasing the child’s responsibility
  o Seeing the child as a sexual being
  o Involving the child in his/her larger community
 •  Participating in innovative health promotional/self-management  
opportunities and programs
 • E valuating latex sensitivity in the Spina Bifida population to determine 
which precautions are necessary and which ones are not
 •  Developing appropriate tools to address the sexuality-related educa-
tional needs of this population
 •  Identifying strategies to motivate the person with Spina Bifida to ad-
here to self- management and healthcare recommendations
 •  Encouraging greater sponsorship of multisite studies to increase sub-
ject numbers and, therefore, increase the generalizability of findings to 
the greater Spina Bifida community.
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XIAO Procedure to Refunctionalize Bladder and 
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Abstract
An artificial somatic-autonomic reflex pathway procedure for restoring voluntary bladder and bowel control in patients with Spina Bifida was 
introduced. Clinical application and the results of the new procedure are 
reviewed in detail. 
Introduction
Neurogenic voiding dysfunction is a major problem for children with Spina 
Bifida, which affects approximately one per thousand newborns [1]. Despite 
rigorous pharmacologic and surgical treatment, incontinence, urinary tract 
infections, and upper tract deterioration remain problematic. The combina-
tion of pharmacological agents, surgical bladder augmentation, and clean 
intermittent catheterization has limited success [2].
History
In 1989 we proposed to establish an artificial “skin-CNS-bladder” reflex 
pathway below the spinal cord lesion (or just above the lesion for sacral 
cord injury) as a means of restoring controllable micturition after spinal 
cord injury (SCI) [3]. The assumption underlying this work is that the mo-
tor axons of a somatic reflex arc may be able to regenerate into autonomic 
preganglionic nerves and thus reinnervate the bladder parasympathetic 
ganglion cells, thereby transferring somatic reflex activity to the bladder 
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smooth muscle. This reflex pathway, which is basically a somatic reflex arc 
with a modified efferent branch that transfers somatic motor impulses to 
the bladder, has been designed to allow patients with SCI to initiate voiding 
by scratching the skin. 
The new concept was tested first in rats [4]. An artificial cross over “skin-
CNS-bladder” reflex pathway was established by intradural microanasto-
mosis of the left L4 ventral root to the L6 ventral root, which innervates the 
bladder and external urethral sphincter in rats, while leaving the L4 dorsal 
root intact as a starter of micturition. After axonal regeneration, 15 of the 
24 rats with the new pathway underwent electrophysiological study. Single 
stimuli (0.3-3 mA, 0.02-0.2 ms duration) to the left L4 nerve resulted in 
evoked potentials (0.5-1 mV) recorded from the left L6 nerve distal to the 
anastomosis. The bladder detrusor contraction was very quickly initiated by 
trains of the stimuli and bladder pressures increased rapidly to levels similar 
to controls. Neural tracing study of the pathways with horseradish peroxi-
dase (HRP) on six rats demonstrated that the somatic motor axons regener-
ated successfully into the pelvic nerve, and the bladder was reinnervated 
by the L4 somatic motor neurons. The bladder contraction could also be 
initiated by electro stimulation of left sciatic nerve as well as by scratching 
the L4 related skin. A new concept was derived from the skin-CNS-bladder 
reflex pathway: i.e., that the impulses delivered from the efferent neurons of 
a somatic reflex arc can be transferred to initiate responses of an autonomic 
effector [4].
Continued animal experiments were focused on the underlying mechanism 
of the somatic-autonomic reflex pathway for micturition. The skin-CNS-
bladder reflex was established in the cat by intradural microanastomosis 
of the left L7 ventral root (VR) to the S1 VR while leaving the L7 dorsal root 
(DR) intact to conduct cutaneous afferent signals that could trigger the new 
micturition reflex arc [5]. 
After allowing 11 weeks for axonal regeneration, urodynamic, pharmacologi-
cal, and electrophysiological studies were conducted in pentobarbital or 
chloralose anesthetized animals. Results showed that a detrusor contrac-
tion was initiated at short latency by scratching the skin or by percutaneous 
electrical stimulation in the L7 dermatome. Maximal bladder pressures dur-
ing this stimulation were similar to those activated by bladder distension in 
control animals. Electrophysiological recording revealed that single stimuli 
(0.3 to 3 mA, 0.02 to 0.2 msec duration) to the left L7 spinal nerve in which 
the efferent axons had degenerated evoked action potentials (0.5 to 1 mV) 
in the left S1 spinal nerve distal to the anastomosis. In addition, increases in 
bladder pressure were elicited by trains of the stimuli (5 to 20 Hz, 5 seconds) 
applied to the L7 spinal nerve. 
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Urodynamic studies including external sphincter EMG recording demon-
strated that the new reflex pathway could initiate voiding without detru-
sor-external urethral sphincter dyssynergia. Atropine (0.05 mg/kg, i.v.) or 
trimethaphan (5 mg/kg, i.v.), a ganglionic blocking agent, depressed the 
bladder contractions elicited by skin stimulation. The skin-CNS-bladder 
reflex could also be elicited after transecting the spinal cord at the L2-L3 or 
L7-S1 levels. 
In summary, the cross-wired somato-autonomic bladder reflex was effec-
tive in initiating bladder contractions and coordinated voiding in cats with 
an intact neuraxis and could also induce bladder contractions after acute 
transection of the lumbar spinal cord. The new pathway is mediated by  
cholinergic transmission involving both nicotinic and muscarinic receptors. 
The somatic motor axons can innervate bladder parasympathetic ganglion 
cells and thereby transfer somatic reflex activity to the bladder smooth 
muscle [5].
Clinical Trials
A clinical trial of the artificial somatic-CNS-autonomic reflex arc procedure 
was started in 1995 with very promising results [6]. By the end of 2004, a 
total of 92 patients with SCI who had hyper reflexic or acontractile bladders 
in our hospital had been treated with the somatic and autonomic reflex arc 
procedure; 81 of them regained bladder control one year postoperatively 
[7]. The National Institutes of Health (NIH) at New York University Medi-
cal Center sponsored a clinical trial of the somatic-autonomic reflex arc for 
micturition after SCI; this has also produced similar satisfactory results for 
the first two SCI volunteers [8]. 
Encouraged by the ability to surgically establish a somatic-autonomic reflex 
pathway in patients with SCI with restoration of bladder storage and empty-
ing, we started a trial of this procedure on 20 children with Spina Bifida and 
neurogenic bladder in 2000 [9]. The neurological principals underlying the 
procedure were the same as for the patients with SCI, though the specific 
details were different due to the neural abnormalities associated with Spina 
Bifida. 
All the children underwent limited laminectomy and a lumbar ventral root 
(VR) to S3 VR micro-anastomosis. The L5 dorsal root (DR) was left intact to 
serve as the afferent branch of the somatic-autonomic reflex pathway after 
axonal regeneration. All patients underwent urodynamic evaluation before 
and after surgery. Preoperative urodynamic studies revealed two types of 
bladder dysfunction: areflexic bladder (n=14) or hyperreflexic bladder with 
detrusor external sphincter dyssynergia (DESD) (n=6). All children were in-
continent. Seventeen of the 20 patients gained satisfactory bladder control 
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and continence within 8 to 12 months after VR microanastomosis. Twelve 
(71.4%) of the 14 patients with areflexic bladder showed improvement. In 
these cases, the bladder capacity increased from 117 to 208 mL, and the 
mean maximal detrusor pressure increased from 18.35 to 32.57cm H20. Five 
of the 6 patients with hyperreflexic bladder showed improvement with reso-
lution of incontinence. Urodynamic studies in these cases revealed a change 
from detrusor hyperreflexia with DESD and high detrusor pressure to nearly 
normal storage and synergic voiding. In these cases, mean bladder capacity 
increased from 94.33 to 177.83 ml, post void residual urine decreased from 
70 to 24 mL. Overall, three cases failed to exhibit any improvement. 
Like the patients with SCI, the children who gained bladder control also 
gained bowel control. Five patients had signs of partial loss of the left L4 
or L5 motor function after surgery, variable from slight muscular weak-
ness to visible foot drop in two children. Otherwise, no short or long term 
complications or adverse events were observed. The most fascinating and 
unexpected result of this trial, however, was that the children who gained 
bladder storage and emptying functions also gained bladder sensory func-
tion. Pre-existing sensory infrastructure may have been activated by stretch 
as the detrusor tone and bladder storage function improved. Since spinal 
cord continuity was not interrupted as in SCI, the central nervous system at 
both spinal and supra-spinal levels may have plasticity to accommodate the 
artificial somatic-autonomic reflex pathway for micturition. Thus, it appears 
that the artificial somatic-autonomic reflex arc procedure is an effective and 
safe treatment for patients with Spina Bifida to restore bladder continence 
and reverse bladder dysfunction [9]. 
Thus far, we have performed the procedure for bladder and bowel control 
safely on 1520 children with Spina Bifida [10]. Of these, 640 have had follow-
up with urodynamic testing at one year postoperatively. The “effective” rate 
is 87%, compared to the 85% for the first 20 cases reported. The criteria to 
determine “effectiveness” includes: 1) voluntary voiding without catheteriza-
tion, 2) post void residual urine less than 100 mL, 3) No urinary tract infec-
tions (UTI), and 4) freedom from anticholinergics. A small portion of the 
patients did have mild stress incontinence at the one-year follow-up, but 
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they usually needed no more than one diaper per day. This kind of stress 
continence likely will disappear or be reduced within two years postopera-
tively, according to our experience with the first 20 patients who had had at 
least two-year follow-up. The rate of partial loss of left-sided L4 or L5 motor 
function after surgery, which had a rate of 25% in the first 20 cases, has been 
reduced to 5%; this decrease in the complication of weakness likely is due 
to a change in procedure in which only half the lumbar ventral root is used 
[10].
Neurogenic bowel disorders, another major problem for Spina Bifida pa-
tients, are also improved by the procedure. Follow-up of 640 patients at the 
one-year post surgery who had manometry testing showed an improvement 
rate of 87%. In general, those who gained bladder function also gained 
bowel with improvement in continence or constipation; also, both bladder 
and bowel sensory function were improved. Interestingly, most patients 
felt bowel function improvement one month earlier than bladder function 
[10]. In summary, the artificial somatic-autonomic reflex pathway procedure 
(XIAO Procedure) can improve bladder continence and reverse bladder dys-
function for patients with Spina Bifida effectively and safely.
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Meeting of the Section on Urology
Xiao Procedure in the United States
The Urologic session began with a provocative report by Kenneth Peters, 
MD from William Beaumont Hospital in Bloomfield Hills, Mich., describing 
his experience using the Xiao procedure for rerouting functioning lumbar 
motor nerves to sacral root motor neurons that innervate the lower urinary 
tract. Nine children underwent this procedure and were followed for at least 
one year. Their evaluation revealed that one child was able to volitionally 
void to completion with no incontinence or urinary infections. Six other 
children had bladder contractility and were able to initiate a reflex contrac-
tion by scratching or rubbing the appropriate ipsilateral sensory dermatome 
but neither could fully empty their bladder or totally control when urination 
occurred. In two children no improvement in bladder function occurred fol-
lowing this surgery. Dr. Peters raised concerns about the procedure because 
eight children experienced some degree of transient weakness in the ipsi-
lateral lower extremity after surgery; however, this change resolved in seven 
children by 6 months postoperatively. One child, however, has a persistent 
foot drop at last follow-up. 
Cancer in Adults
J. Christopher Austin from Iowa discussed an alarming finding of 10 adults 
with carcinoma in their augmented bladder at a mean interval of 11 years 
post surgery. All tumors were invasive cancers and all had local metastases 
at the time of diagnosis, revealing their aggressiveness. This was succeeded 
by a lecture from Richard Rink from Indiana who found an overall incidence 
of bladder tumor formation following augmentation cystoplasty with in-
testine or stomach in his patients of 3%. A discussion ensued regarding the 
best way to screen patients with a prior augmentation; although no consen-
sus was reached, it was felt that at least a renal and ‘bladder’ ultrasound was 
necessary every year beginning five years after the cystoplasty. 
Co-morbidity
Several reports dealt with co-morbidity factors and Spina Bifida. Dominic 
Fimberger from Oklahoma noted that body mass index (BMI) had a posi-
tive predictive value with regard to complication rates following surgery in 
children with Spina Bifida. Unfortunately, most patients with myelodyspla-
sia are overweight or obese and this may contribute to their higher rate of 
complications. 
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In a study of factors leading to renal failure in children with neurogenic 
bladder dysfunction, Michele Torre from Genoa, Italy, found that vesi-
coureteral reflux and upper urinary tract dilation were most often associ-
ated with renal functional impairment in these children. John Weiner from 
Duke studied a nationwide sample of patients with Spina Bifida discharged 
from the hospital; 82% undergoing bladder rehabilitation surgery had an 
augmentation compared to 18% with an ileal conduit diversion. The major-
ity of the former were female and younger than those having an ileal loop. In 
addition, the diversion group required fewer health care resources, shorter 
hospital stays and less use of home health care aids. In another study, Alum 
Williams from Nottingham, England, concluded that patients had better 
continence outcomes if a caecostomy was performed in conjunction with 
augmentation cystoplasty, because this enhanced the effectiveness of the 
postoperative bowel management program. 
Basic Science
Dominic Frimberger from Oklahoma found that (1) canine small intestine 
submucosa (SIS) bladder constructs did better when incubated with hy-
aluronic acid polylactic co- glycolic nanoparticles, (2) urothelial regenera-
tion over SIS expressed normal proteins uroplakin and ZO-1 by two weeks 
postoperatively suggesting a normal urothelial barrier to urine infiltration, 
and (3) distal SIS tissue produced less inflammatory response than proximal 
SIS with more macrophage and fewer eosinophil infiltrates, producing less 
of a destructive reaction in the bladder constructs. 
Several papers dealt with the new field of stem cell research and autologous 
bladder augmentation. Yusuf Kibar from Ankara, Turkey, assessed the fea-
sibility of injecting bone-marrow-derived mesenchymal stem cells into rat 
bladders subject to increased outlet obstruction; they found that the dec-
ompensated bladders had increased muscle mass, contracted in response to 
M3 receptor stimulation and showed improved urodynamic parameters for 
compliance and capacity. 
Earl Cheng from Chicago, Ill., showed that bone marrow-derived mesen-
chymal stem cells grown in tissue culture expressed properties similar to 
smooth muscle cells and that epithelial progenitor cells grown in tissue 
culture had the ability to induce vascular in-growth. Thus, the combined 
harvesting of these “primitive” cells has the potential for being used in tis-
sue engineering of neo-bladders in the future. 
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Surgical Techniques
New surgical techniques for improving urinary continence were proposed. 
Gregory Dean from New York successfully employed a polypropylene 
perineal sling for incontinence in males with neurogenic bladder dysfunc-
tion, and reported an 80% complete continence rate. The Oklahoma group 
(Dr. Fimberger et al) found that bulking agents injected into either the con-
tinent urinary or fecal stoma to relieve persistent incontinence after surgery 
was successful in 78%, thus reducing the need for an extensive re-operative 
procedure. Finally, this latter group noted an 85% continence rate with 
urethral lengthening to achieve dryness and only a 7% incidence of difficulty 
with subsequent catheterization. 
Warren Snodgrass from Dallas, Texas evaluated the long-term effects of a 
bladder neck sling procedure on detrusor compliance. Initially he found 
only five children had improved compliance at one year post-surgery, but an 
additional six improved subsequently. Only one child’s bladder compliance 
worsened with time. Thus, he discussed the need for early augmentation 
cystoplasty after bladder neck surgery because his observations suggest that 
it takes time for the bladder to adjust to increased outlet resistance. All the 
remaining children in his study had no change in their bladder compliance.
Timothy Bertram from Winston-Salem studied bladder constructs for 
trigone-sparing augmentation cystoplasty in juvenile canines. At two years 
following surgery he found that three distinct layers of “normal” tissue had 
developed in these augments over time along with good detrusor compli-
ance and capacity. He concluded that the bladders grow as these animals 
mature into adults. All these research efforts are beginning to show progress 
in the ability of surgeons to replace severely diseased bladders with autolo-
gous tissue, thus reducing the need for bowel augmentation.
Antegrade Colonic Enema (ACE)
The Malone antegrade colonic enema (MACE) procedure was discussed by 
Anthony Balcom from Milwaukee, Wis., who evaluated various irrigating 
solutions for cleansing the bowel using the antegrade continent stoma. He 
found that baby shampoo mixtures, followed by polyethylene glycol solu-
tions were the most efficacious in reducing “toileting time” while other 
additives led to increased seepage from the stoma. The site of the ACE (left 
versus right) did not affect this finding. Many confounding variables af-
fected the response, however, including the state of hydration, degree of 
ambulation, type of diet, degree of motivation, as well as the number of 
co-medications.
Jonathan Kaye from Atlanta, Ga., described similar findings regarding left 
versus right-sided ACEs in 34 patients. No differences in toileting time, ease 
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of use, incidence of stomal stenosis or other complications were found when 
one side was compared to the other. John Park from Ann Arbor, Mich., per-
formed 45 ACEs (20 right-sided and 25 left-sided) and again found no dif-
ference in amount of irrigation solution needed to achieve a good response. 
However, he did note a significant increase in toileting time, more abdomi-
nal colic and less effective emptying with the caecal versus the sigmoid ACE. 
In both instances he cautioned for the need to create a good continence 
mechanism due to troubling seepage from the stoma that may occur if this 
has not been attained. 
Earl Cheng presented a simple yet effective way to prevent stomal stenosis 
using the “L-stent,” a shortened catheter tied into a knot to prevent seep-
age through its lumen but more importantly to create an “L” shape so it can 
be inserted into the stoma and easily taped to the surrounding skin when 
an individual is not using the ACE; 17% of stomas developed stenosis in his 
series, but following placement of the “L-stent” and a daily application of 
betamethasone cream to the surrounding tissue, 87% reported improved 
ease of catheterization with no further need for any corrective surgery. 
Quality of Life
In recent years there has been increasing interest in assessing quality of life 
in children with incontinence and Spina Bifida. Jenna Brand from Rich-
mond, Va., conducted face-to-face interviews with 39 children (between the 
ages of 5 - 11 and 12 - 21 years) and their families. Parents and children had 
differing views about their quality of life. The degree of cognition and con-
tinence impacted positively on children, especially in the older aged group. 
Parents had more negative feelings about their child’s quality of life than 
their child did. In another study by Ann Neville-Jan from Pasadena, Calif., 
similar findings were noted: namely that urinary and fecal continence issues 
affected how older children performed in school and interacted with peers. 
Incontinence issues had a greater impact on teenagers than on pre-adoles-
cents. The implications of using intermittent self-catheterization were not 
addressed in either study; however, this warrants further research.
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Continence
Tera Bartelt from Milwaukee, Wis., evaluated the effectiveness of a conti-
nence program, which led to changes in both bladder and bowel function in 
children with Spina Bifida. She showed that efforts to improve continence 
in both systems simultaneously produced better outcomes than when either 
organ system was dealt with independently. The patient’s level of lesion and 
extent of assistance needed, correlated positively with effectiveness of the 
response.
Urodynamic Testing
Andrew Coombs from Manhattan, attempted to improve the quality, repro-
ducibility, and predictability of urodynamic studies in children with Spina 
Bifida by more accurately measuring detrusor leak point pressure (DLPP). 
He compared the DLPP (1) at the end of a cystometrogram with the cath-
eter in place with DLPP (2) after the catheter was removed and reinserted, 
following cessation of all leakage. If the DLPP dropped below 40 cm H2O 
with the second measurement, then upper urinary tract deterioration was 
substantially less likely to occur (15% of the sample) than if both pressure 
recordings remained above that level (44% of the sample). No child devel-
oped renal insufficiency in the former group whereas 11% did so in the latter 
group. In another study Mr. Coombs noted that at Columbia University, uro-
dynamic studies are being performed at an earlier age than previously done 
in Spina Bifida children–primarily as a baseline to characterize lower urinary 
tract function and to treat children at risk proactively. On the other hand, 
children followed in community settings are being referred for lower urinary 
tract evaluation only after deterioration has occurred. The practice of utiliz-
ing urodynamic testing by community based physicians has not changed in 
the last 15 years and begs the question for developing standards of care for 
the Spina Bifida population. 
Michael Carr from the Children’s Hospital of Philadelphia presented the 
results of urodynamic testing in 54 children who had undergone prenatal 
closure of their myelomeningocele defect at 22 to 24 weeks of gestation prior 
to initiation of the MOMS trial. At five years of age, 10 children (18.5%) were 
voiding volitionally and were continent; two additional children were almost 
continent. As the assessment of these children is ongoing, it will be instruc-
tive to compare the findings in this group with children from the MOMS 
trial in the future.
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Medications
Israel Franco from Long Island Jewish Hospital in New York evaluated the 
safety and efficacy of a new alpha-blocking agent, Alfuzosin, in children 
with Spina Bifida. At 0.2 mg/kg per dose, this drug proved to be safe and 
well tolerated without any drop in blood pressure while it lowered the leak 
point pressure, increased bladder capacity and improved compliance in 
most of the children who received the medication. 
Paul Austin from St. Louis, Mo., reviewed the current literature on safety 
and efficacy of all drugs that affect lower urinary tract function in Spina 
Bifida. Most anticholinergic agents have a positive response in reducing over 
activity and increasing bladder compliance, but side effects are not uncom-
mon. Some newer antimuscarinic agents (e.g., propiverine HCl) have greater 
selectivity towards detrusor muscle receptors with fewer systemic adverse 
effects; but these have not been tested extensively in children and are cur-
rently not approved by the FDA for use in the pediatric age group. 
Summary
These exciting developments and the discussions that ensued during the 
breakout session speak to the high degree of interest as well as the need for 
better ways to manage the lower urinary tract in children with Spina Bifida 
and neurogenic bladder dysfunction. Overall, 43 abstracts were submitted, 
with several from centers outside the United States, including the United 
Kingdom and Turkey; 29 were given as either oral only or oral-poster presen-
tations with the remaining 14 as poster only displays. The spectrum and the 
quality of the clinical, translational, and basic science research promoted at 
this meeting sparked thoughtful commentary and, hopefully, new avenues 
of research for future meetings. 
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Summary
In the context of Spina Bifida, hydrocephalus is usually caused by crowding of the posterior fossa with obstruction to cerebrospinal fluid flow from the 
fourth ventricle, and less often by malformation of the cerebral aqueduct. 
Some of the brain dysfunction is reversible by shunting, probably through 
restoration of cerebral blood flow and normalization of the extracellular 
environment. However, beyond a certain point, enlargement of the cerebral 
ventricles causes gradual destruction of periventricular white matter axons, 
especially the fimbria-fornix pathway and the corpus callosum. The clinical 
syndrome of hydrocephalic brain dysfunction is thus a syndrome of subcor-
tical disconnection.
Meningomyelocele occurs in 3 to 7/10,000 live births with up to 50% of af-
fected pregnancies terminated in some regions [1-3]. Hydrocephalus can be 
defined as a primary pathologic enlargement of the intracranial cerebrospi-
nal fluid (CSF)-filled spaces. At birth approximately 2/10,000 live births have 
meningomyelocele with established hydrocephalus [4], and eventually 90% 
of individuals with meningomyelocele have enlarged cerebral ventricles and 
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50% to 80% develop hydrocephalus requiring surgical intervention [5-7]. 
In the context of meningomyelocele, hydrocephalus is usually caused by 
crowding of the posterior fossa with obstruction to CSF flow from the fourth 
ventricle (i.e. the Chiari-II (a.k.a. Arnold-Chiari) malformation), and less 
often by malformation of the cerebral aqueduct [8].
Most CSF is produced by the choroid plexus while approximately 20% is 
water derived from the brain as product of glycolysis [9] and an unknown 
quantity by free exchange of water across the blood brain barrier [10]. Ab-
sorption of CSF is via arachnoid villi into the venous system and lymphatics 
associated with cranial and spinal nerves; the relative contribution of each is 
debated [11]. CSF has multiple functions including cleansing of potentially 
noxious byproducts of brain metabolism, a vehicle for molecular communi-
cation, and protection of brain by cushioning from vascular and extraneous 
shock waves [12].
The pathology of brain damage caused by hydrocephalus has been de-
scribed in detail in several previous reviews [13-16]. Briefly summarized, 
the changes include destruction of the ependymal lining of the ventricle 
surface, stretching and compression of axons and small blood vessels in the 
periventricular white matter, secondary reactive changes including activa-
tion and proliferation of astrocytes and microglia, and destruction of axons 
with loss of connections between neurons. In humans and other species the 
major white matter targets are the fimbria-fornix, which connects the hip-
pocampus to subcortical regions, and the corpus callosum. Long pathways 
extending to the spinal cord can also be damaged [17]. A threshold effect 
seems apparent and ventricular enlargement is tolerated to a limit; but the 
limit has not been well defined anatomically. The magnitude of damage is 
affected by the age of onset, the rate of ventriclular enlargement, the size of 
the ventricles, the intracranial pressure (which in turn dictates the cere-
bral perfusion pressure), and coexisting pathological changes (especially 
cerebrovascular disease in older individuals [18]). In very immature brains 
with active cell proliferation, hydrocephalus can disturb development [19]. 
In infantile brains, ventricular enlargement can cause delayed myelination, 
which can recover after shunting [20-23]. However, axonal damage is not 
reversible.
The pathogenesis of the brain damage is multifactorial. At the most simple 
level, enlarging ventricles cause damage by mechanical stretching of axons. 
However, more complex processes are at work. In experimental animals, a 
reduction in the quantity of patent capillaries in the periventricular white 
matter occurs [24-26] with associated reductions in cerebral blood flow 
(CBF). CBF and related parameters have been measured in human hydro-
cephalus using a variety of techniques including positron emission tomogra-
phy, transcranial Doppler, and radionuclide angiography; most have dem-
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onstrated CBF reductions especially in white matter [27-29]. Improvement 
of blood flow after shunting correlates with clinical improvement in many 
studies [30-32]. Decreased blood flow is associated with local increases in 
glucose utilization [23], oxidative stress including lipid peroxidation and 
protein nitrosylation [33, 34], and activation of calcium-dependent pro-
teolytic enzymes that destroy axons, similar to the molecular processes in 
stroke and head injury [35]. 
In addition to the cascade of damage caused by diminished blood flow, 
the alterations in extracellular fluid movements must be considered. Bulk 
flow of fluid occurs through interstitial spaces at a rate of 0.1 to 0.3µL/
minute-gram of tissue [36]. Metabolic byproducts that cannot be recycled 
or extruded across the blood brain barrier flow to the ventricles from which 
they are washed away with CSF flow [37]. In hydrocephalus the extracellular 
spaces of gray matter are compressed [38, 39] and extracellular fluid flow is 
reduced [40, 41]. As a consequence, waste products accumulate in CSF and 
brain tissue [42, 43]. This imbalance of fluid outflow likely disturbs the deli-
cate extracellular environment of neurons thereby impairing their function. 
However, with shunting this change is likely reversible.
Many studies have shown tissue changes in various neurotransmitters as a 
consequence of hydrocephalus [13, 44, 45]. Some of the neurotransmitter 
changes may be reversible by shunting [46]. However, when axons are lost, 
the density of synapses and the complexity of dendrites are reduced mainly 
in the cerebral neocortex but also in the hippocampus [47-57]. The upregu-
lation of growth-associated protein (GAP-43) in hydrocephalus might be 
associated with synaptic remodeling [58]. Although neuronal changes in the 
striatum are not typically identifiable at the microscopic level, some imag-
ing evidence supports functional changes in dopamine receptors [59].
Brain function is ultimately determined by the integrity, connectivity, and 
function of neurons, and hydrocephalus is associated with considerable 
impairments of function. This can be measured in humans and experimen-
tal animals electrophysiologically [60-70], by tests of learning and memory 
function [71-76], and by tests of motor function [68, 77-82].
The mainstay of treatment for hydrocephalus is CSF shunting, which is 
usually capable of reducing the ventricle size and may stop the progression 
of the damage [13]. However, the benefits of shunting need to be balanced 
with potential complications, particularly in premature infants and the 
elderly. Therefore, there may be a role for a pharmacologic supplement to 
treat hydrocephalus. The potential targets for pharmacologic intervention 
include reducing CSF production [83], enhancing CSF flow/absorption, 
“neuroprotection,” axonal protection, improving blood flow, and improving 
recovery after shunting. For reasons previously discussed [15], reducing CSF 
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production might not be feasible. We have shown that the calcium channel 
antagonists nimodipine and MgSO4 improve the behavioral and structural 
outcomes of juvenile rats with hydrocephalus, likely through improvement 
of blood flow [84-86]. Others have shown that antioxidant therapy is worth 
investigating at the experimental level [87]. However, given the lessons 
learned in the treatment of strokes, we must not rush into drug therapy 
without adequate preclinical investigation [88].
Future investigation of the pathophysiology of hydrocephalus will depend 
on the use of optimal animal models [89-91], proteomic studies of cerebro-
spinal fluid [42], and the use of advanced imaging methods [92]. Interdisci-
plinary cooperation will be the key to understanding and optimally treating 
hydrocephalus and Spina Bifida [93]. 
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Meeting of the Section on Neuropsychology
The Neuropsychology Breakout Session consisted of two oral presentations 
and a poster session. The first set of oral presentations was devoted to the 
application of contemporary functional and structural neuroimaging meth-
ods to Spina Bifida. The second presentation addressed psychosocial fac-
tors in Spina Bifida. The posters were predominantly neuropsychology and 
cognitive neuroscience studies. 
Neuroimaging
In the first session, Dr. Roozbeh Rezaie discussed applications of magne-
toencephalography to children with meningomyelocele and age-matched 
controls. Dr. Rezaie described the assessment of brain functioning using 
magnetoencephalography, which is a whole head neurophysiological meth-
od that assesses the biomagnetic fields generated by electrophysiological 
changes in the brain. In the first study, Dr. Rezaie described a study in which 
cortical oscillatory rhythms were assessed in children with meningomyelo-
cele and shunted hydrocephalus who varied in the integrity of the corpus 
callosum. This study found a significant reduction in the power spectrum in 
posterior and temporal brain regions and not in anterior and central areas. 
Significant correlations occurred between the quantitative measurements of 
the corpus callosum and alpha spectral power. The results suggested re-
duced regional transcallosal connectivity in these children. 
Dr. Rezaie then described assessments of touch perception in children with 
Spina Bifida. Magnetoencephalographic recordings were made in response 
to a vibrating stimulus held on the fingers. The results demonstrated that 
both the ipsilateral and contralateral components of this somatosensory 
evoked potential were present in all controls. Many children with meningo-
myelocele showed only the ipsilateral component. Again, these results sug-
gested reduced regional transcallosal connectivity in these children. 
In the third study, Dr. Rezaie presented assessments of language and read-
ing in children with meningomyelocele and controls. On a word reading 
task, controls exhibited significantly greater engagement in the left hemi-
sphere, whereas children with Spina Bifida demonstrated more bilateral 
activation. This difference was especially apparent in the middle temporal 
gyrus. There were no differences on a language task that required listening 
to words. Since children with meningomyelocele are often proficient word 
decoders, these findings suggests that bilateral activation, even when it 
involves greater activation of the right middle temporal gyrus, is a compen-
satory pattern that supports proficient word recognition.
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In the second neuroimaging discussion, Dr. Khadar Hasan addressed the ap-
plication of diffusion tensor imaging (DTI) to children with Spina Bifida. He 
described how diffusion tensor imaging is conducted and analyzed, empha-
sizing that it is a method for assessing the diffusion of water molecules in 
the brain that is particularly sensitive to the integrity of cerebral white mat-
ter. Dr. Hasan presented new applications of DTI that permit assessments of 
regional brain volumes as well as gray matter structures. Dr. Hasan showed 
that in some gray matter structures, such as the caudate nucleus, fractional 
anisotrophy is actually higher, which is suggestive of delayed or aberrant 
synaptogenesis. In addition, he showed reductions in both gray and white 
matter volumes. Dr. Hasan also presented assessments of several white fiber 
pathways including the corpus callosum and different association fibers, 
which demonstrated lower fractional anisotrophy consistent with reduced 
myelination. 
The third presentation by Dr. Jenifer Juranek discussed the application of 
voxel-based morphometry to MRI scans in children with Spina Bifida and 
controls. Dr. Juranek described a pattern of increased cortical thickness in 
the frontal lobes and reduced cortical thickness in the posterior regions. 
She also assessed cortical complexity in cortically thinned regions, showing 
that cortical complexity in the brains of children with meningomyelocele is 
markedly increased when thinning is greater. 
In the discussion, Dr. Marc Del Bigio presented a neuropathologist’s per-
spective. He noted the value of examining the brain from a quantitative 
neuroimaging perspective. However, he also noted that imaging only pro-
vides a window to the brain and that correlations of MRI assessments with 
post-mortem studies tend to be weak. Dr. Del Bigio emphasized the impact 
of hydrocephalus on the brain, noting that each time the ventricules expand 
and reduce, damage to the white matter likely occurs. He argued that in 
order to understand imaging changes, the complete history of shunt failure 
history is critical. He asked about the effects of ventricular enlargement on 
brain development, noting that enlarged ventricules in utero usually affects 
the germinal matrix and this affects on brain weight, synaptogenesis, and 
myelin production.
Psychosocial Factors
In the session on psychosocial factors in Spina Bifida, Dr. Grayson Holm-
beck presented a series of studies that evaluated a biopsychosocial model 
of Spina Bifida. In presenting this model, he emphasized a developmental 
perspective on the adjustment of adolescents with Spina Bifida. He also 
discussed a multi-finality model that addressed why some children with 
Spina Bifida do well and others do more poorly when they have same start-
ing point. He presented assessments of different models for psychosocial 
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adjustment in Spina Bifida, including a higher stress model, a strength of as-
sociation model, an additional stress model, and differential developmental 
growth model. He also presented evidence in support of mediational mod-
els of adjustment (e.g., Spina Bifida status  • neuropsychological functioning 
• social adjustment). The evidence supported a disruption-resilience model 
of adjustment in which family support ameliorated some of difficulties as-
sociated with Spina Bifida, but that lower social class was an exacerbating 
factor for some families of youth with Spina Bifida. Finally, he presented a 
model that is being tested in a new study that examines neuropsychological 
functioning and peer relations in youth with this condition. 
Dr. Heather Taylor presented a study evaluating the impact of parenting 
and motor skills on the development of cognitive, language, and daily living 
skills in inference in children with Spina Bifida and controls from 6 to 36 
months of age. Dr. Taylor reported that the development of motor abilities 
was associated with cognitive, language, and daily living skills, with children 
who showed better motor development scoring higher on all domains. In 
addition, higher quality of parenting was associated with higher levels of 
development and faster growth in cognitive skills. 
Dr. Melissa Bellin addressed issues related to the transition of adolescents 
and young adults with Spina Bifida into adulthood. Over 40% of a transi-
tion-age group of young adults indicated psychological distress. Factors 
related to individual, family, and environmental measures explained vari-
ability in psychological health. These rates of self-reported psychological 
distress are much higher than population rates in young adults. 
Posters
The poster session addressed a variety of issues related to neuropsychology 
and cognitive neuroscience in Spina Bifida. Dr. Jackson addressed the rela-
tion of the Chiari malformation to intellectual functioning. In a comparison 
of 30 patients with shunted hydrocephalus and 17 with no hydrocephalus, 
the people with no hydrocephalus scored higher on IQ and most cognitive 
measures. In addition, the people with no hydrocephalus generally per-
formed within the average range. 
Dr. Andrew Zabel presented a poster regarding methods for quick and ef-
ficient clinic-based screening and monitoring that included assessments 
of executive functions, adaptive functions, processing speed, and working 
memory. He emphasized that the collection of neuropsychological data using 
measures that involve questionnaires was effective for clinic-based screening. 
Dr. Heather Taylor presented a study on early information processing in 
18-month-old infants with Spina Bifida and controls. An assessment of 
visual attention skills showed that attention difficulties observed in other 
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studies of school-age children with Spina Bifida can be documented in 
younger children as well. In addition, the findings supported the hypothesis 
that more impairment occurs in attention processes involving stimulus con-
trol and orienting than in response control and monitoring. 
Dr. Paul Cirino assessed different aspects of mathematics performance in 
children with meningomyelocele; significant differences occurred relative 
to controls in a number of mathematic abilities, but differences were most 
apparent on small sum problems. Math performance was accounted for by 
basic foundational skills involving fact retrieval as well as more conceptual 
aspects of math ability; the latter was closely related to reading ability. In a 
study of reaction time in children and adults with meningomyelocele, Dr. 
Maureen Dennis found that individuals with Spina Bifida were slower to re-
spond than controls. The degree of difficulty increased as the reaction time 
test increased; no interactions occurred with age. 
Altogether, these three sessions provided new results and approaches to  
the assessment of children and adults with Spina Bifida. Dr. Fletcher noted 
the importance of insuring homogeneity within the sample, observing that 
only meningomyelocele is associated in a systematic way with malforma-
tions of the brain. Differences within children and adults with meningo-
myelocele also may be present depending on whether hydrocephalus is 
shunted. He highlighted Dr. Del Bigio’s discussion of the effects of recurrent 
hydrocephalus on the brain, noting that even children with arrested hydro-
cephalus who have never been shunted tended to show motor and cognitive 
difficulties. However, these difficulties are typically not seen in children 
who have Spina Bifida without hydrocephalus. This session featured con-
tributions from eight different disciplines, highlighting the value of multi-
disciplinary approaches to research on complex neurogenetic disorders like 
meningomyelocele.
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Without a doubt, the overall care of the child with Spina Bifida has changed considerably in the last 30 years, in particular, orthopedic 
care. Before we outline and discuss these changes, we should give credit to 
a number of outstanding pediatric orthopedic surgeons who established 
the basis for the care of Spina Bifida. I would like to give credit here to Drs. 
Mihran Tachdjian, Burr Curtis, Jack Banta, Earl Feiwell, J W Sharrard, Klaus 
Parsch, Malcolm Menelaus, Norris Carroll, Richard Lindseth and Douglas 
McKay. Their outstanding work for the last 50 years is well recognized.
Our involvement in Spina Bifida care started back in 1976 at the Children’s 
Memorial Hospital in Chicago. The team has been together for the last 33 
years. I would also like to recognize the leadership of Dr. David McLone in 
neurosurgery and Dr. William Kaplan in urology. In 1989, with the establish-
ment of the Motion Analysis Center at Children’s, the use of this technology 
became an important tool in the decision-making process for the manage-
ment of the patient with Spina Bifida. Table 1 lists the areas in which motion 
analysis has helped in the care of individuals with Spina Bifida. We will be 
discussing the benefits of motion analysis and how much we were able to 
learn about the Spina Bifida gait pattern and pathology and how much the 
use of gait analysis influenced our decisions for functional procedures. The 
knowledge obtained from gait analysis in the last 20 years has significantly 
changed our approach to some of the orthopedic pathologies. At the or-
thopedic division of The Children’s Memorial Hospital and at our Motion 
Analysis Center, an extensive number of research projects were undertaken 
resulting in the publication of numerous papers.
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Functional Mobility Scale
In 2004, Kerr Graham introduced the Functional Mobility Scale for patients 
with cerebral palsy. We have been using this classification for the last 5 years 
and we find it to be quite useful in Spina Bifida. Basically it classifies the pa-
tient according to their ability to walk with support or without support over 
three different distances: 5 meters, 50 meters and 500 meters. The child’s 
abilities are rated on a 6-point scale–see box. 
For instance, if a child with Spina Bifida is classified as a FMS 3,2,1 this 
means that the child can walk with forearm crutches for 5 meters, uses a 
walker up to 50 meters and beyond that a wheelchair. If another child is 
classified as a FMS 6,6,6 it means that the child can walk without support 
for 5 meters, 50 meters and 500 meters.
Functional Motor Level
We feel that it is more appropriate and easier to classify patients with Spina 
Bifida into four main functional motor levels, rather than using specific 
vertebral levels (like L4).
(1)  The first functional level is the high lumbar-thoracic level in which the 
child lacks quadriceps strength, and may or may not have hip flexor 
power; this child will require a high brace such as a RGO or HKAFO for 
walking. In some instances, due to lack of trunk balance, walking ability 
is quite difficult and the high level child will then use a parapodium for 
standing. Most patients with a high level will be able to walk for short 
distances indoor and so would be classified as a FMS 2,1,1 or 2,2,1. Usually 
between the ages of 11 and 13 years, the child will elect to use a wheelchair 
for mobility because of the high energy costs of standing and walking. 
Exceptions, of course, are seen especially for the child without a ventricu-
lar shunt, or for a child who is not obese, has good upper extremity func-
tion and no joint contractures. These individuals can retain their walking 
ability for a longer time through adolescence and early adult life.
(2)  The second functional level is the low lumbar. Here hip flexors, knee ex-
tensors and medial hamstrings are present. The child can walk with AFO 
braces and forearm crutches. Most walk at a speed of between 55-60% of 
normal. As an adult they typically will be classified in the FMS system as 
a 3,3,1.
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(3)  The third functional level is the high sacral in which the gluteus muscles 
are present, but weak; the gastrocsoleus strength is below grade 3. These 
individuals require AFOs to stabilize the ankle and foot; they walk with-
out support with a gluteus lurch that will be more or less severe accord-
ing to the strength of the gluteus. Their walking velocity is about 70-75% 
of normal. As an adult they would be in the FMS classification a 6,6,6 
or 6,6,3. In our experience, about 94% of these children will retain good 
walking mobility as an adult.
4)  The fourth functional level is the low sacral in which the gluteus muscles 
are strong; the gastrocsoleus is also strong, so they do not require AFOs. 
They walk without support and their gait is nearly normal or normal with 
the velocity being at 100%. Less than 5% of Spina Bifida children are clas-
sified as having a low sacral level.
Ventricular Shunt vs. No Shunt
Recent studies at our Motion Analysis Center have clearly shown that a child 
with Spina Bifida without a ventricular shunt walks faster and longer than a 
child with a shunt. Based on gait analysis parameters, the walking speed of 
the child without a shunt is 94.4% of normal; the walking speed of the child 
with a shunt, who has the same functional level, was 76.4%. This represents 
a 20% difference in speed, which is significant. We also found that the most 
important issue affecting the walking velocity is shunt infection and not the 
number of shunt revisions. When we examined sacral level children clas-
sified at the FMS 6,6,6 level, 71% were in the no-shunt group, while only 
55% were in the shunted group. Again, these numbers are quite significant 
statistically. We believe that neurosurgeons need to have strong, precise 
indications for treating hydrocephalus with a shunt. Clearly, child who has 
Spina Bifida without a shunt functions at a higher level than those who are 
shunted.
Crutch-walking: 4 Point vs. Swing-thru Gait
We had been taught that the 4 point gait is more functional than a swing-
thru gait. So, years ago we undertook a study at MAC; this study showed 
that the swing-thru gait is 33% faster than the 4 point gait and, what is even 
more important, the swing-thru gait is 33% more efficient (less oxygen cost) 
than the 4 point gait. In addition, studies done on upper extremity pain in 
adults with Spina Bifida have shown that the most common issues are shoul-
der problems related to patients using a wheelchair and not related with 
patients using crutches. In conclusion, the swing-thru gait is more efficient, 
faster and with lower energy cost.
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The Effect of Trunk Movement and Valgus Stress  
at the Knee Joint
Because of gluteus weakness, the child with sacral level meningomyelocele 
has excessive pelvic and trunk movement, the well-known gluteus lurch. In 
a study done at MAC, we were able to demonstrate clearly that a significant 
amount of valgus stress in the knee joint is related to the abnormal trunk 
movement. The only way to decrease this abnormal stress, which can lead 
to arthritis and knee pain in adult life, is with the use of forearm crutches. 
In so doing, the excessive pelvic movements and the excessive trunk lurch 
decrease. Based on these studies we have attempted to introduce some 
crutch-walking for long distances in the child with sacral level at an early 
age, advising that the use of crutches will prevent problems with the knee 
joint during adulthood.
AFO Brace
About 95% of patients with Spina Bifida do not have enough strength in the 
calf musculature to stabilize their ankle-foot during gait. For this reason 
they will require the use of solid AFO braces. Studies done at MAC, as well 
as at other centers, have shown that the use of the braces allows the ground 
reaction forces to be more normal, passing in front of the knee joint and 
in so doing, prevent a crouched gait which, as we know from the energy 
standpoint, is quite ineffective. Previous studies have shown that an exces-
sive external tibial torsion of more than 20 degrees will prevent the AFO 
from achieving full extension of the knee at mid-stance. For this reason, and 
others on which we will comment later, surgical treatment of external tibial 
torsion is indicated when greater than 20 degrees. Unlike the child who has 
cerebral palsy child, there is no place for hinged AFO braces in the child 
with Spina Bifida. The use of the AFO also allows a more normal firing of 
the musculature above the knee, in particular the vastus and rectus muscles. 
As mentioned earlier in our presentation, the use of gait analysis has pro-
vided us with a major insight for the gait patterns in Spina Bifida, especially 
children with a low lumbar or sacral level. We have learned, for instance, 
that the excessive pelvic rotation is an attempt to increase stride length and 
any time that this pelvic rotation is decreased, it may affect the child’s walk-
ing ability. Therefore, in patients with low lumbar and sacral levels, a spinal 
fusion down to the sacrum will affect the child’s gait and, in some children, 
will take away their walking ability.
Another important lesson from the use of gait analysis concerns the muscles 
that generate power when walking, in particular the gastrocsoleus, gluteus 
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and hip flexors (iliopsoas). Since most children with Spina Bifida do not 
have good gastrocsoleus strength and the gluteus muscles are weak, they 
need to have strong hip flexors. Any surgery that takes away this flexor 
power will make gait more difficult. Thus, the iliopsoas transfer (the Shar-
rard procedure that was quite popular in the 70s) is a procedure that should 
not be used in Spina Bifida since it will considerably decrease the hip flexor 
power and make walking more difficult (Duffy).
Hip Dislocation and Subluxation in the Child  
with Low Lumbar Level
It is taught during orthopedic training that the treatment of a dislocated hip 
is surgical reduction with bone procedures at the pelvis and femur. So, for 
many years in the past hip dislocations in Spina Bifida were treated surgi-
cally and in some instances and, I must say, even quite frequently, with very 
poor functional results and somewhat fair radiological results. Back in the 
late 70s, Feiwell at Rancho Los Amigos emphasized that children with Spina 
Bifida with a dislocated hip did not require surgical relocation. It was more 
important to have a normal or nearly normal range of motion, i.e., a hip free 
of contractures. The work in Philadelphia by Ames also supported Feiwell’s 
statements.
In the 90s at MAC we undertook a retrospective study of gait in individuals 
who had low lumbar level with a unilateral dislocation of the hip. We found 
that the gait symmetry was present when the dislocated hip had a nearly 
normal range of motion; however, gait asymmetry was present if the hip 
had either a flexion or adduction contracture. Clearly this study well docu-
mented Feiwell’s statements in the late 70s, that the hip motion was more 
important than the dislocation of the hip. For the last 15 years we have taken 
a very conservative approach to the dislocated hip in the child with low 
lumbar level. If a contracture(s) is present leading to an asymmetrical gait, 
surgical correction of the contracture(s) is done, using a procedure such as 
an adductor myotomy or hip flexor lengthening and, occasionally in a more 
severe deformity, a valgus osteotomy of the proximal femur. However, we do 
not feel that there is a need to surgically relocate the hip. On the other hand, 
for the sacral level child who presents with a unilateral dislocation where 
the gait asymmetry is quite severe and the gluteus lurch on the located side 
also is quite severe, we feel, based on the knowledge from the gait analysis, 
that surgical relocation is indicated through pelvic procedures such as the 
Dega osteotomy and the varus derotation osteotomy of the proximal femur. 
However, it must be said that no papers have been published to substantiate 
this latter statement.
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Crouched Gait
A crouched gait is quite common in Spina Bifida secondary either to a 
combination of  hip flexion and knee flexion contractures or to an excessive 
external tibial torsion (over 20 degrees). The knee flexion contracture in 
Spina Bifida develops gradually. Most of these children have weak gastrocso-
leus and weak gluteus muscles. They walk with a mild degree of knee flexion 
initially. With time, the posterior knee capsule gets tighter and shorter and 
the crouched gait becomes more severe, usually between the ages of 10 to 14 
years. We found that the degree of flexion contracture at the knee on the ex-
amining table doubles when the patient is walking. For instance, if a patient 
has a knee flexion contracture of 20 degrees, during gait the knee will be in 
a flexed position at mid-stance at 40 degrees. A 40 degree crouched gait is 
very inefficient and the oxygen cost is quite high, usually 40% more than 
normal. Therefore, surgical treatment for the crouched gait is indicated 
when a knee flexion contracture is about 15 to 20 degrees or greater. A poste-
rior capsulotomy is required in order to achieve full extension. The posterior 
cruciate ligament is left intact. If any contracture of the medial hamstrings 
or biceps is present, a selective lengthening is also indicated. A recent study 
at our Motion Analysis Center has shown an average improvement of at 
least 20 to 25 degrees when this surgery is performed. Occasionally, in an 
older patient who has a low lumbar or sacral level with a severe knee flexion 
contracture, a supracondylar osteotomy of the femur may be required in 
addition to the knee flexor release. We do not have any experience with the 
patellar advancement procedure that is used in patients with cerebral palsy.
Valgus Stress at the Knee Joint
Valgus stress at the knee joint in Spina Bifida is quite common in the low 
lumbar and sacral level, especially the sacral level child who walks without 
support. As mentioned before, the excessive pelvic/trunk movement is a 
major cause of this stress. The valgus stress is multi-factorial. A number of 
deformities can increase the stress including: (1) excessive pelvic rotation; 
(2) abnormal trunk movement; (3) femoral antetorsion; (4) knee flexion 
contracture; (5) external tibial torsion; (6) valgus deformity of the hindfoot. 
The use of gait analysis, especially the kinetics can demonstrate quite clearly 
this abnormal internal varus moment at the knee. When present, surgical 
treatment is indicated such as a derotation osteotomy of the tibia, a knee 
flexor release, and correction of the hindfoot valgus with a medial sliding 
osteotomy of the os calcis. For the excessive pelvic rotation and trunk move-
ment, the only solution is the use of external support, i.e., crutches. Dero-
tation osteotomy of the tibia for either excessive external or internal tibial 
torsion should be done over the age of 5 years. We recommend that the 
osteotomy be done in the distal third together with a fibular osteotomy; we 
also advise the use of internal fixation with a DCP AO plate. Complications 
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can occur such as delayed union and wound dehiscence. A very well planned 
surgical procedure and post-operative care is important.
Foot Deformities in Spina Bifida
To conclude, I would just like to give a few thoughts about foot deformities 
in Spina Bifida. About 95% of children with Spina Bifida will have some type 
of foot deformity. In some it is mild and does not require any surgery. Oth-
ers will have severe deformities requiring surgical treatment. The main goal 
of our treatment for foot deformities is to have a flail, flexible, plantigrade 
and braceable foot. Whenever possible, any kind of fusion such as a subtalar 
joint fusion or triple arthrodesis should be avoided. For established, severe 
bone deformities osteotomies can be done in the hindfoot and midfoot 
area, while still preserving motion at the joints. For contractures, simple 
tenotomies with tendon excision can be performed. Rarely should a ten-
don transfer be done unless the child has a low sacral level and is walking 
without AFOs. The most common foot deformities are talipes equinovarus 
(TEV) and the calcaneovalgus foot. For TEV the procedure to achieve full 
correction is the posteromedial-lateral release through a Cincinnati inci-
sion. For the calcaneovalgus foot, the anterolateral release is a quite effective 
procedure. For the cavus or cavovarus deformity, which is more common in 
patients with lipomeningocele , bone procedures such as the Dwyer calca-
neus osteotomy, the cuboid osteotomy and medial cuneiform osteotomy 
in association with soft tissue procedures can achieve a very braceable and 
plantigrade foot.
Ankle Valgus and Hindfoot Valgus
A common deformity seen in Spina Bifida is valgus deformity of the ankle 
joint; this is related to a gradual shortening of the fibula. With the lack 
of lateral support at the ankle, the distal tibial physis develops in a wedge 
shape. This leads to the development of a valgus deformity at the ankle. At 
the same time, quite frequently the valgus at the ankle is also associated 
with a valgus deformity of the hindfoot. A very effective procedure for cor-
recting the mild to moderate degree of ankle valgus is the hemi-epiphys-
iodesis with a cannulated screw and, for the hindfoot valgus, the medial 
sliding osteotomy of the os calcis is the procedure of choice. In order to 
prevent pressure problems from the brace, we must have some flexibility at 
the joints, ankle, subtalar and midfoot joints. Again, this is why the arthro-
desis will make the foot too rigid resulting in a higher incidence of pressure 
problems.
In summary, we have been able to outline most of the areas in which ortho-
pedic care has changed in the last 30 years. I want to emphasize one more 
time the value of motion analysis for achieving a better understanding of 
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the Spina Bifida gait pattern and thus improved decision-making in the 
selection of procedures that will improve function and not just improve the 
radiological picture.
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Table 1. 
 1. Reciprocal and swing gait in Spina Bifida
 2. Ener gy cost on distance of walking for the high level, low lumbar 
and sacral level children
 3. Trunk kinematics and knee valgus stress
 4. Knee valgus stress and its relationship with external tibial torsion
 5. Crouched gait: surgical treatment and results
 6. The effect of shunt and no shunt on the walking velocity and  
FMS classification
 7. Rotational deformities of the femur
 8. Rotational deformities of the tibia
 9. The Shanz valgus osteotomy for hip dislocation in Spina Bifida
 10. Unilateral hip dislocation in the low lumbar level
 11. Results of surgical treatment for clubfoot deformities
 12.  Results of surgical treatment for calcaneus deformity:  
the anterolateral release
 13. Surgical treatment for vertical talus
 14. Talectomy: surgical results
 15. Foot deformities in lipomeningocele
 16. Fibular growth and ankle valgus
 17.  Surgical treatment for hindfoot valgus: the medial sliding osteot-
omy of the os calcis
 18. Knee flexion contractures and surgical treatment
 19. Knee extension contractures and surgical treatment
 20. Hip dislocation/subluxation in the low lumbar level
 21. Surgical treatment for external tibial torsion
 22. Surgical treatment for internal tibial torsion
 23. Shunt revisions and their effects on gait
 24. Tethered cord: surgical results
 25. Kyphosis: natural history
 26. Surgical treatment of kyphosis
 27. Surgical treatment of scoliosis
102 The Future is Now
Meeting of the Section on Orthopedics
General Themes
The care of children with Spina Bifida and musculoskeletal problems con-
tinues to evolve.  Major themes presented included the increasing use of 
motion or gait analysis, the need for improved evidence-based literature, 
and the awareness and prevention of musculoskeletal problems encoun-
tered by patients transitioning into adulthood. Presentations on gait 
analysis (including the plenary lecture) from two centers provided differ-
ent perspectives on the role of gait analysis for clinical evaluation, decision-
making, and evaluating outcomes of therapeutic procedures. The use of 
motion analysis in Spina Bifida as a research tool has provided objective 
assessment for our interventions. The body of literature using the highest 
grades of evidence-based interventions (levels of evidence and grades of rec-
ommendation) for musculoskeletal disorders such as hip dislocations and 
spinal deformities in meningomyelocele remains limited. To date no ran-
domized clinical trials for orthopedic interventions in Spina Bifida has been 
published. Spina Bifida is no longer a “disease of childhood” as this unique 
patient population transitions into adulthood. Coordination of care includ-
ing education to promote independence must begin long before adulthood 
is reached. Orthopedic treatments during childhood have long-term impli-
cations for and impact upon quality of life issues for adults. 
Historical Perspective
Recent advances in the orthopedic management of Spina Bifida are best 
understood in a historical context. This perspective was given in the pre-
sentation entitled, The History of Orthopedic Care and Spina Bifida by Jack 
V. Banta, MD. Innovations and advances in surgical care have depended on 
the close collaboration between orthopedists and neurosurgeons. These 
include the development of the ventricular shunt to control hydrocephalus 
and the recognition of neural pathology such as tethered cord and syringo-
myelia. Early treatment strategies for hip dislocation in Spina Bifida targeted 
the same techniques used for developmental dysplasia of the hip (DDH). 
However, lack of sensation in children with Spina Bifida led to poor results. 
Recognizing the relative importance of hip stability versus mobility has led 
to a reversal in surgical philosophy. Evolving from the polio era, treatment 
strategies such as arthrodesis of an insensate extremity resulted in Charcot 
changes in adjacent joints in children with Spina Bifida. 
The early concept that the “quadriceps is the passport to ambulation,” based 
on the contributions of Williams and Menelaus from the Royal Children’s 
Hospital in Melbourne, Australia, is now recognized as only applicable to 
the first decade of life. The basic tenets of orthotics for ambulation include 
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low energy cost at a reasonable rate of speed (at least 30% to 60% of normal 
for age), independence in donning and doffing the braces, and indepen-
dence with transfers. The priority of walking changes as children enter ado-
lescence and the concept of efficient mobility (e.g., wheelchair ambulation 
being less energy demanding) takes precedence over independent ambula-
tion. The treatment of spinal deformities in meningomyelocele has made 
significant progress since the introduction of Harrington instrumentation 
fifty years ago. Advances in both anterior and posterior spinal instrumenta-
tion such as pedicle screw fixation have improved the outcomes for scoliosis 
and kyphotic deformities. 
Gait Analysis
The routine use of gait analysis in meningomyelocele is relatively new. In ad-
dition to the plenary lecture, Jeff Thomson, MD provided key points in the 
management of ambulatory patients in his presentation, Motion Analysis 
Today for Patient Evaluation and Decision-making. Gait analysis has been 
beneficial in surgical decision making, provides objective information on 
pre-operative abnormalities, and allows for the post-operative assessment of 
orthopedic interventions, including the use of orthotics and surgical pro-
cedures designed to improve a child’s overall gait and energy efficiency. It is 
thought to be the best tool we currently have to measure outcomes. Hip ab-
ductor weakness impacts a person’s ambulatory skills more than quadriceps 
weakness. Excessive motion of the pelvis in all three planes, as a result of hip 
abductor weakness, results in decreased function of the lower extremities 
and the knee in particular. Increased truncal lean produces a ground reac-
tion force lateral to the knee, a net adduction knee moment and a kinetic 
knee valgus thrust that could result in premature degenerative changes. 
Ankle foot orthoses (AFO’s) may increase transverse plane motion, and gait 
analysis has shown that the use of crutches and higher bracing above the 
knees sometimes are necessary in ambulatory patients. Gait analysis has 
been important in recent studies evaluating surgical procedures such as 
rotational osteotomies for dysfunctional lever arm, hip surgery, and tendon 
transfers about the ankle. 
Physical Therapy
Colleen Krombach, PT, presented Physical Therapy: Advances in the Evalu-
ation and Treatment of Meningomyelocele. The importance of the manual 
muscle test (MMT) was emphasized in the presentation. Monitoring the 
motor examination annually can be invaluable in detecting any deteriora-
tion in CNS function, determining muscle imbalance and, potentially, iden-
tifying a tethered cord. Asymmetry in the MMT is suggestive of a tethered 
cord, whereas a symmetric decrease in the MMT is more consistent with 
shunt problems. 
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Surgical Procedures
The controversial subject of hip surgery and the lack of evidence-based 
guidelines for orthopedic interventions in Spina Bifida was presented in 
depth by James Wright, MD from the Hospital for Sick Children in Toronto. 
A thorough literature review failed to find a single randomized clinical trial 
(RCT) for orthopedic studies in Spina Bifida. The five levels of evidence and 
the four grades of recommendation used to evaluate peer-reviewed papers 
were applied to the current literature on hip and spine surgery in meningo-
myelocele. The World Health Organization International Classification of 
Function provides a method of assessing whether treatments like hip and 
spine surgery improve function. The majority of studies were retrospective 
and not long-term. Based on studies with levels of evidence of one to three, 
the overall recommendations for both hip and spine surgery were grade B. 
Evidence was insufficient to determine if reduction of unilateral hip dislo-
cations improved function. Also, an all pedicle screw approach for spinal 
deformity was found to have insufficient evidence to support its efficacy in 
the current body of literature. 
Conklin et al. [1] reported on the incidence of ventriculo-peritoneal (VP) 
shunt failure following extradural spinal procedures. The authors found 
that four patients (20%) required a shunt revision within 12 months, while 
one patient required shunt revision within three months. Their data sug-
gest that extradural surgery, unlike intradural surgery, is not associated 
with an increased rate of shunt failure. Martin et al. [2] reported a higher 
rate of complications (35%) and revisions (31%) than previously had been 
described in ambulatory patients with lumbar level MMC following tibial 
rotational osteotomies.
Hip Surgery
Emlinger and Mazur [3] presented a meta-analysis on the efficacy of treat-
ment for hip dysplasia in ambulatory children with meningomyelocele. 
Forty-seven papers published between 1964 and 2008 that had a level of 
evidence of grade 4 or higher were reviewed. In patients with motor levels 
of L3 or higher (thoracic/high lumbar), 33/37 papers recommended against 
treatment except for soft tissue release due to high complication rates; no 
difference in ambulation was found in dislocated vs. reduced hips, and 
energy expenditure for ambulation was high. In patients with L4 or below 
(low lumbar/sacral) 28/41 papers recommended hip reduction to help bal-
ance muscle forces, maintain reduction, and to develop more normal hip 
anatomy and mobility for ambulation. Thirteen of the published articles not 
supporting hip reduction cited the potential surgical risks and complica-
tions, the potential for further weakening hip musculature, and the finding 
that dislocated hips had little effect on ambulation compared to surgically 
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reduced hips. For unilateral hip dislocations, three papers advocated hip re-
duction as a way to reduce the subsequent risks of limb length discrepancy, 
pelvic obliquity, and scoliosis. Controversy still remains concerning the best 
approach for the management of hip dysplasia in patients with meningomy-
elocele. 
Scoliosis and Kyphosis Repair
B. Stephen Richards, MD, presented advances in the management of sco-
liosis. A recent study by Wai et al. [4] discussed by both Dr. Wright and Dr. 
Richards, evaluated function and deformity following spine deformity in 
meningomyelocele. The benefits of surgery included improved sitting bal-
ance, fewer pressure sores, and, questionably, the avoidance of pulmonary 
problems. However, the paper also noted that no relationship existed be-
tween the Cobb angle and function, and that surgery did not improve overall 
function based on the Activities Scale for Kids (ASK) questionnaire. The pa-
per put into perspective the need for careful patient selection, and the need 
to thoughtfully weigh the benefits vs. risks for each patient. Surgery should 
Child’s walking ability:
1. Uses wheelchair, stroller or buggy
2.  Uses K-Walker or other walking frame without help from 
another person
3. U ses two crutches without help from another person
4.  Uses one crutch or two calipers without help from  
another person
5. Independent  on level surfaces: does not use walking aids  
or need help from another person
6.  Independent on all surfaces: does not use any walking  
aids or need any help from another person when walking, 
running, climbing and climbing stairs 
be avoided in patients who are functionally ambulatory with lumbar scolio-
sis, and individuals with extensive posterior scarring and rigid deformities 
with abnormal posterior elements. Pre- and intra-operative traction should 
be considered for rigid curves greater than 100 degrees. Also anterior fusion 
should be considered and may take on additional importance to maintain 
correction if the posterior instrumentation becomes infected and requires 
removal to control and eradicate the spinal infection.
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The benefits of correcting sagittal plane spinal deformity in meningomyelo-
cele were addressed by John Sarwark, MD in his presentation, Advances in 
the Management of Kyphosis. Uncorrected kyphotic deformity may result 
in the reduction of the anterior abdominal wall that may make urinary 
diversion procedures more difficult. Severe kyphosis also may compress the 
abdominal contents upward, potentially limiting pulmonary function and 
result in the recently described secondary thoracic insufficiency syndrome. 
Costo-pelvic impingement may also occur from severe kyphotic deformi-
ties. The optimal age to consider surgery is when the children are younger, 
when the benefits outweigh the risks. The technique has previously been 
described by Nolden et al. [5] Preserving the thecal sac, decancellation of 
the apical vertebral bodies, instrumentation distally to the sacral alae with 
limited arthrodesis decreased morbidity and allowed continued growth of 
the thoracic spine. 
Adult Care
As with many other conditions that we treat, it cannot be overemphasized 
that Spina Bifida is not a “disease of childhood.” Shubra Muhkerjee, MD, 
emphasized the importance and timeliness of this statement in her presen-
tation, Coordination of Care and Transitioning of Children with Meningo-
myelocele. Education as part of care coordination should begin early before 
the critical adolescent phase. Preventive measures should be directed to 
minimize the risks of obesity, pressure sores, and to maximize functional 
independence. Children by the age of twelve years should be well versed 
in their own care and independence. A new concern noted among adult 
patients with Spina Bifida is lymphedema. The cause of lymphedema is 
unclear; no signs of deep venous thrombosis are present. Presently the treat-
ment requires the careful use of compression stockings. Specific orthopedic 
issues for adults include achieving a plantigrade foot in non-ambulatory 
patients, and proper fitting orthotics to address valgus deformities of the 
knee and ankle in adult ambulatory patients. 
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Future Directions for Research and Care
1.  Evidence-based treatment guidelines 
Current treatment guidelines for musculoskeletal problems in meningomy-
elocele are based on only a few studies that have higher levels of evidence. 
The external demand for evidence-based outcomes and increased awareness 
of the need for well-designed clinical studies such as prospective multi-cen-
tered studies, should improve the quality of research. 
2. Gait analysis as a clinical and research tool 
Gait analysis remains the best objective tool to measure present and future 
therapeutic orthopedic interventions. Evidence-based studies using gait 
analysis provide better-defined treatment guidelines. Improvement in the 
reliability and validity of gait analysis should increase their acceptance for 
more widespread use. Functional analysis of alternative forms of mobility 
and movement used by children and adults (wheelchair ambulation, stair 
climbing, sit to stand) is an important future direction of research in menin-
gomyelocele.
3. Transitioning to adulthood 
The body of literature addressing musculoskeletal issues in the adult patient 
with Spina Bifida is quite sparse. Future research should identify and define 
the musculoskeletal problems confronting adults, examine treatments used 
during childhood and their effects on adults, and develop strategies to pre-
vent orthopedic problems in adults. 
108 The Future is Now
Developmental Pediatrics
Health Care and Spina Bifida:  
The Canary in the Coal Mine
Gregory S. Liptak, MD, MPH
Professor of Pediatrics
Director, Center for Development, Behavior and Genetics
Upstate Medical University




This presentation was inspired by the deaths of two young adults with Spina Bifida that occurred in the past year, as well as the care of several 
adults in regional hospitals. The first death occurred in a 29-year-old man 
who had thoracic level meningomyelocele with shunted hydrocephalus. 
He graduated from high school, attended a community college for a year, 
and then lived with his parents. He developed a relationship with a young 
woman and moved away from home in an apartment that was supported by 
his family, his ‘significant other’ and payments from the SSI (Supplemental 
Security Income) program. His romance failed, though he continued liv-
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ing in the apartment by himself after his companion left him. He became 
depressed and developed a decubitus ulcer that was not identified early. The 
ulcer became infected, he developed osteomyelitis, and subsequently died 
from sepsis. 
The second death occurred in a 27-year-old woman who had thoracic level 
meningomyelocele, shunted hydrocephalus and obesity. She had sustained a 
pulmonary embolus after urological surgery when she was 19-years-old and 
was maintained on anticoagulants. She lived at home with her parents. She 
died from hemorrhage, presumably related to an adverse interaction be-
tween ibuprofen and warfarin.
Meanwhile, a urologist in a nearby community told a young adult that she 
does not screen adults with meningomyelocele for bladder cancer because 
“she does not believe that it is a major concern.” Around the same time, an 
adult with meningomyelocele was admitted to a community hospital with 
new onset headache with neck pain. The neurosurgeon interpreted the pain 
as radiculopathy and did not consider the possibility of shunt malfunction. 
Canaries in Coal Mines
Coal mines are dangerous places, subject to gases like carbon monoxide and 
methane, which are potentially fatal but cannot easily be detected. From the 
mid 19th century to the mid 20th century (1986 in the UK [1]) canaries were 
brought down into coal mines in the United States and United Kingdom 
to warn the miners of unsafe conditions. Canaries are much more sensitive 
to carbon monoxide than humans [2]. The miners would observe the birds 
as they worked. If the canaries stopped singing, became unsteady on their 
perches or died, the miners immediately would evacuate the shaft. 
Spina Bifida
Meningomyelocele (Spina Bifida) has been described as ‘the most complex 
birth defect compatible with life” [3]. Individuals with this condition have 
impairments of the spine (e.g., scoliosis), spinal cord (e.g., neurogenic bowel 
and bladder, sexual dysfunction, paralysis and decreased sensation), and 
brain (e.g., hydrocephalus, Chiari II malformation with hypoventilation, 
seizures, strabismus, learning disabilities) [4]. Furthermore, children do not 
‘outgrow’ these impairments or disabilities. As Woodhouse noted, “Sadly, 
nothing in Spina Bifida gets better with age.” [5] In an evaluation of ado-
lescents and young adults (AYAs) with Spina Bifida, we [6] found that the 
percent reporting excellent health decreased from 29%, when their average 
age was 15 years (Wave 1), to 11% four years later (Wave 3); 44% of the sample 
who had reported excellent health at Wave 1 reported fair or poor health at 
Wave 3. These findings are troubling, especially since health and well-being 
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typically do not decline during adolescence and young adulthood in people 
without a chronic condition. Previous studies also reported declining health 
among young adults with Spina Bifida. For instance, Guarnieri and Vinchon 
[7] found that adults lost ambulation and continence and developed renal 
failure as well.
The thesis of this paper is that canaries in coal mines are analogous to 
people with Spina Bifida in the healthcare system. People with Spina Bifida 
are more sensitive to changes in the healthcare environment, and the cur-
rent medical environment is dangerous and becoming more so. They are 
bellwethers for outcomes of care that will be coming to the rest of society.
Changes in the Care of People with Spina Bifida
In the 1950s an effective ventricular shunt system was developed by Holter 
and Spitz [8]. At that time the ileal conduit was the standard for urological 
care until Lapides’ [9] paper on clean intermittent catheterization. Prior to 
the 1960s, many newborns with Spina Bifida in the USA and UK were not 
treated surgically; many who were had complications including shunt infec-
tions and mental retardation. Because the prognosis was felt to be so poor, 
Lorber [10] recommended criteria for deciding who to treat and who to allow 
to die; this approach eventually was abandoned. Figure 1 shows survival by 
year of birth for four cohorts of children; the 30-year survival in the Hunt 
and Oakeshott cohort was only 50% [11]. 
Table 1 lists changes in the treatment of individuals with Spina Bifida since 
the 1970s. Significant technological improvements in care have improved 
survival, although the improvements seem to be smaller with every cohort 
(see Figure 1). Also, significant variations in the treatment of people with 
Spina Bifida exist, reflecting uncertainty and disagreement about standards 
of care. For example, Zegers et al. [12] reported, “The responses from 41 cen-
ters in 14 European countries confirm that . . . there is no consensus among 
European centers in terms of protocols for preventing, diagnosing and 
treating UTIs in children with NBSD [neurogenic bladder sphincter dys-
function] and for CIC [clean intermittent catheterization].” Also, the effects 
of care on quality of life, daily activities and social participation are not well 
established. For instance, studies examining the effects of enterocystoplasty 
have not been uniform or always of the highest grade. According to Scales 
et al. [13], “Almost all studies are retrospective, single institution case series 
of a relatively small number of patients. Few uniform or validated outcome 
measures for enterocystoplasty exist. . . . Interinstitutional variability in uro-
dynamic measurements and in definitions of continence make comparisons 
of outcomes difficult.” 
First World Congress on Spina Bifida Research and Care 111
Outcomes in adults with Spina Bifida continue to be less than optimal. For 
example, in a study of Dutch AYAs, where the mean age was 21 years, only 
16% were living independently, more than one-third went to special second-
ary education, 53% of those who finished education did not have a regular 
job, and 71% did not have a partner [14].
Health Care in the United States
Health care in the United States has been described as medical care de-
livered through a patchwork of public and private entities and paid for by 
another patchwork of public and private insurers [15]. Insurance coverage 
is usually tied to the workplace or to government programs that often seem 
Byzantine in their intricacy. The current fee-for-service system is based 
on encounters with patients and favors volume; the focus is on illness not 
wellness. Acute care interventions and procedures are rewarded financially 
rather than prevention or longer chronic care interventions. According to 
Gladwell [16], “The United States has opted for a makeshift system of in-
creasing complexity and dysfunction.” 
Government insurance often pays less for care than private insurers. For ex-
ample, according to the Wall Street Journal, “Currently, Illinois payments to 
such specialists are so low—estimated at 30% of what the care actually costs 
the doctors—that many pediatric specialists in Illinois refuse to treat indi-
gent Medicaid children.” [17] In many communities it is extremely difficult if 
not impossible to get certain specialty care, like plastic surgery and gynecol-
ogy, for children on Medicaid. [18].
Persons with disabilities who have health insurance often are unable to get 
equipment, supplies and services not covered by their plans. They experi-
ence more problems than others with follow-up care, availability of special-
ists, getting to doctors, and obtaining help during off hours. In order to save 
money, insurance plans may exclude individuals with disabilities like Spina 
Bifida, enrolling only healthier people. They may stint on care, denying nec-
essary services to individuals who are enrolled. Both exclusion and stinting 
deny access to care for people with Spina Bifida. 
Because of the complexity of Spina Bifida, a multidisciplinary care model 
that provides care coordination [19] has been recommended. Several or-
ganizations, including the American Academy of Pediatrics [20] and the 
Spina Bifida Association [21], have advocated a multidisciplinary approach 
to these individuals. Although this has not been studied formally, it appears 
that programs providing multidisciplinary care to children with Spina Bifida 
are shrinking in size as providers, especially surgeons, find that they cannot 
justify their salary by working in these clinics. 
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Even though the impairments of Spina Bifida do not disappear, adults 
with Spina Bifida get relatively less health care compared to adults without 
chronic conditions than is the case with children. For example, Ouyang et 
al. [22] compared health expenditures for people with Spina Bifida to expen-
ditures for people without Spina Bifida; while the ratio of expenses was 13 
in those from 1 to 17 years of age, it was only 6.3 in those aged 18 to 44 years. 
While AYA with Spina Bifida continue to need long-term follow-up by urolo-
gists, neurosurgeons, orthopedists, therapists, orthotists, and others, find-
ing such experts who are willing and able to take care of adults is difficult 
[23]; finding programs that can coordinate their care is even more difficult.
Many countries currently are experiencing an economic recession; some 
hospitals are closing or laying off employees [24]. Because a multidisci-
plinary care program that treats people with Spina Bifida cannot make a 
profit or even break even, the threat to these programs, and to the health-
care of the individuals treated by them, have been magnified by the reces-
sion. Furthermore, in March 2009 the jobless rate in the USA exceeded 8%, 
the highest it has been in 26 years [25]. Because health insurance coverage 
is tied to employment, increasing unemployment means that fewer people 
and families will be covered by insurance. Thus, like coal mines, the health-
care environment is dangerous, with optimal care being increasingly diffi-
cult to find.
The Future
Table 2 lists some interventions that should improve the care of people with 
Spina Bifida in the near future. These interventions rely on technology and 
are not sufficient by themselves. A system of care is required to be able to 
deliver the complex care that people with Spina Bifida need and to integrate 
care within the community. An effective disease-management program [26] 
that uses evidence-based clinical practice guidelines and provides care coor-
dination as well as integration with community systems of care is necessary 
to allow improvements in technical care to be delivered to people with Spina 
Bifida. 
The population in the United States is aging [27]C:\Documents and 
Settings\adarnley\Local Settings\Temporary Internet Files\Content.
Outlook\3S9FIZC9\[http:\www.ofm.wa.gov\pop\gma\default.asp] and indi-
viduals with Spina Bifida are surviving longer. However, more physicians are 
becoming subspecialists and hospitalists at the expense of general internal 
medicine [28]. Thus, it is not clear who will provide a medical home in the 
community for adults with Spina Bifida.
First World Congress on Spina Bifida Research and Care 113
Conclusions
Canaries warned coal miners of the dangers in mines. People with Spina Bi-
fida are medically fragile, and, like the canaries, are warning us of problems 
with our healthcare system. It is one thing for a canary to die to warn others 
that conditions are dangerous. It is quite another for a child or young adult 
to die to warn us about our healthcare system. Our current system is unable 
to provide adequate treatment for everyone with Spina Bifida, coordinate 
care and achieve high quality outcomes [29-31]. Adolescents and young 
adults have declining health; young adults are dying. Yet, unlike the national 
program established for people with cystic fibrosis [32] we do not monitor 
even the death rates of people with Spina Bifida. The ability of the health-
care system to provide optimal care to people with Spina Bifida is a critical 
test of the system. There is of course the human concern; there also is the 
concern that the care that people with Spina Bifida receive now will be an 
indication of the care that the rest of us will receive in the near future. 
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Meeting of the Section on  
Developmental Pediatrics
Focusing on the common goal of improving the care provided to individu-
als with Spina Bifida, the Developmental Pediatrics session introduced both 
general and disease-specific concepts of chronic care management. Incor-
porating these strategies is currently difficult because of poor care coordina-
tion and limits on resources for health care utilization. In the past, the focus 
of discussion frequently was on acute management and the care of expected 
secondary conditions; insufficient emphasis was placed on preventive care 
or on care across the life span.
To address these broader issues, a series of questions were proposed as a 
framework to the panel of presenters:
• Is a disease management model applicable to Spina Bifida care?
•  What can be learned from other conditions and how can these ideas be  
applied to this population and incorporated into their care? 
•  What collaborative steps can be taken to provide optimal care for  
individuals with Spina Bifida?
Disease Management
The central goals of the traditional disease management model are, in 
order, to decrease cost and to improve health care. Decisions made using 
this model, however, should be based on a scientifically derived base of 
evidence. Additional goals to improve outcome and adherence to care plans 
are also essential. The impact of co-morbidities must also be considered in 
the model. Ideally, what results is a model of care that is timely, efficient, 
evidence-based and continuous. In the case of complex lifespan conditions 
such as Spina Bifida, there is an inherent struggle between the need for spe-
cialization and the need for integration. 
Within this care model, it is essential that individuals know how to man-
age their care for optimal results. Successful self management promotes 
autonomy and identifies the patient as the source of control for their health 
care. Optimal patient care includes integration of information from vari-
ous sources and joint decision. Ideally, the resulting system is transparent, 
anticipatory and cooperative. Providing effective care requires develop-
ing a partnership with each patient, developing a care plan, coordinating 
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disparate systems to integrate their care, and providing patient education 
resources and delivery systems.
Common to disease management in any chronic condition are struggles 
with adherence to the plan of care, communication between provider and 
patient as well as between providers and outside sources. Knowledgeable 
providers need to evaluate environmental factors such as geographic loca-
tion and issues related to transportation. Specific difficulties occur when 
implementing a disease management model for individuals with Spina Bi-
fida. A decreasing number of programs adversely affects access. The patient 
population is aging; they are developing “adult diseases” that may be unfa-
miliar to pediatric providers. In addition the co- morbid conditions of their 
Spina Bifida (especially some of the cognitive differences) may be unfamiliar 
to adult providers.
One way to measure “success” within such systems of care is to look at 
specific outcomes through quality improvement initiatives: care delivery, ac-
cess, hospitalization rates, complications, and mortality. Successful systems 
eliminate waste and are not solely focused on cost savings. Successful sys-
tems of care are inherently safe, having been designed to avoid errors, and 
promote early detection and prevention. They cannot be dependent only 
on the actions of individuals. Questions, however, remain: 1. Who will best 
monitor all of these activities? 2. Who decides what “better” care is? Other 
organizations (e.g., Cystic Fibrosis Foundation) have successfully advocated 
for assessment and implementation of care using specific criteria (process 
of care). Their structure includes the ability to measure and compare the re-
sults of changes made in providing care as well as who should provide such 
care. This systematic collection of data on a broad scale is in its very early 
stages for individuals with Spina Bifida through the ongoing Centers for 
Disease Control (CDC) Spina Bifida Association (SBA) Spina Bifida registry 
project.
Care guidelines have been developed for a number of chronic disorders. 
Many are based on expert opinion. Ideally, they should be accessible to 
providers, should direct inpatient and outpatient care, and should promote 
future research efforts. Such documents may be particularly important as 
individuals with chronic disease survive into adulthood. This component of 
an evidence based, disease management practice is already available to pro-
viders caring for individuals with Spina Bifida: Guidelines for Spina Bifida 
Health Care Services Throughout the Lifespan, which is available through 
the SBA. 
Successful disease management requires appropriate coordination of care. 
Unfortunately, no single definition of care coordination exists. Some would 
say that “they know it when they see it!” Nor does agreement exist on whose 
responsibility it is. By default, it often becomes the families or the individu-
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als themselves who takes on these tasks. Even in individuals with routine 
health care needs, care coordination is difficult. The current health payment 
system provides few incentives to coordinate care; increasingly providers 
are advocating for additional funding to provide this service. What may 
eventually make this possible for individuals with chronic health care needs 
and their providers is the concept of a Medical Home. To implement these 
ideas and meet these challenges, changes by patients and providers will be 
needed. However, change is hard. Effective communication and accurate 
outcome data is essential if this change is to be successful. 
What Can We Learn from Others?
Specific clinics for children with Spina Bifida have existed since the early 
1950’s (Wilmington Children’s Hospital). In many institutions, multidisci-
plinary clinics for children with Spina Bifida benefited not only those with 
Spina Bifida but also improved the quality and timeliness of care for other 
children with disabilities. Important innovations and observations origi-
nated in these Spina Bifida clinics. Many of these are now considered core 
care aspects including clean intermittent catheterization and avoidance of 
latex. Data collection and analysis on issues such as selective care of affected 
individuals and methods of delivery were the basis for better evidence based 
treatment decisions. The best example of a coordinated and evidence based 
project is the government sponsored MOMs study, which is evaluating the 
efficacy of prenatal surgery for meningomyelocele.
Cystic Fibrosis Foundation 
In looking for ways to improve the multidisciplinary models and processes 
of care delivery for individuals with Spina Bifida, it is important to look at 
the history of these efforts and to integrate those lessons with those from 
other chronic disease management models (e.g., cystic fibrosis). Since 1955, 
the Cystic Fibrosis (CF) Foundation has served numerous roles: accredita-
tion, registry maintenance, guideline development, professional and patient 
education, research, and care innovations. The practical outcome of this 
process is to help identify and suggest interventions for systemic problems 
by sharing what the best clinics are doing. The recent Spina Bifida Associa-
tion (SBA) effort to describe the levels of clinical care available at different 
locations across the country is a first step toward a similar system.
The CF Foundation has also demonstrated the need and value of a registry 
and the importance of patient care guidelines. Their registry systematically 
collects valuable information and documents variations regarding natural 
history, effectiveness of new therapies / innovations and quality of care us-
ing factor analysis. For this to be successful, clinics have to believe that the 
data are valid; enrollment and data collection must be complete, timely and 
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of the highest quality. SBA and the Center for Disease Control are currently 
piloting a patient registry for Spina Bifida. 
SBA Care Guidelines
The Spina Bifida Association recognized the importance of clinical care 
guidelines in 1990. With publication of the 3rd edition in 2006 of Guidelines 
for Spina Bifida Health Care Services Throughout the Lifespan, an effort was 
made to move away from opinion and toward data and levels of evidence as 
the basis of these guidelines. These are guidelines and not standards of care. 
The strengths of the current model include its brevity and standardized 
format, its functional and developmental orientation across the lifespan, its 
emphasis on continuity of care and its defining of functional outcome goals. 
A weakness is that it does not list the actual documents reviewed to make 
the recommendations.
For families, the guidelines could serve as an instrument to better under-
stand the care delivery systems and the goals of that care. They could also 
be used as part of transition preparation and self care management training 
for adolescents and young adults. Primary care providers, especially adult 
focused providers, might use the guidelines as reference document for ongo-
ing care. Numerous other proposed uses for the guidelines beyond clini-
cal care have been suggested. Clinics might use them as a basis for seeking 
institutional funding or service support or as a basis for service payment. 
They could also be used for program evaluation: does a clinic follow the 
guidelines across the age ranges and does a clinic have all the necessary and 
recommended specialties?
The Medical Home
The Medical Home may be a viable model to provide continuous care and 
disease management for individuals with Spina Bifida across the lifespan. 
An excellent medical home effectively combines place, process, and people 
to allow a patient to receive effective care. It includes families, youth, and 
health care professionals in a system of care; it cannot successfully exist 
solely on the willingness of individual practitioners. Key requirements of 
this care model include communication and a family centered focus. In 
the medical home model, communication between primary care providers 
and specialists is emphasized. Specialty care should supplement and not 
supplant the primary care role. This model organizes assistance in a col-
laborative fashion and in accordance with each individual family’s wishes, 
strengths, and needs. The family is the unit of attention.
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Platform Presentations
The importance and contributions of successful centrally funded, multisite 
studies and advocacy by national organizations for Spina Bifida (SB) is clear. 
They allow implementation and assessment of care models based on objec-
tive measurements and data and not just anecdotal experiences. Quality 
care and management of individuals with Spina Bifida require the integra-
tion and cooperation of numerous specialties and a careful consideration 
of the entire individual and their family. Basic science and clinical research 
can each contribute to future improvements. Each of these core assump-
tions was quite apparent in the session’s platform presentations. Data from 
several multisite studies examined topics as divergent as mental health and 
bowel and bladder continence.
Mental Health
Brei et al. examined mental health from the points of view of the adult care-
giver/parent as well as the adolescent/young adult (AYA). Both groups re-
ported poor mental health adaptation over time, which could certainly have 
implications for successful transitioning to adulthood. The adult reporters 
associated mental health adaptation with neuropsychological deficits and 
lower socioeconomic status while AYA associated lower mental health adap-
tation with less positive adolescent beliefs and low family resourcefulness. 
Because perceptions and the factors associated with mental health adapta-
tion outcomes vary between parent and AYA report, clinicians promoting 
positive mental health adaptation need to evaluate both groups. 
Bowel and Bladder Management
Urinary and bowel incontinence are nearly universal in individuals with 
Spina Bifida. Achievement of bowel and bladder continence is an important 
goal for children with Spina Bifida due to its far reaching impact on both 
physiologic and social outcomes. Continence is difficult to quantify and 
differences exist in definitions and acceptable degrees of wetness or num-
bers of accidents. Untreated, incontinence leads to significant limitations 
and participation in life activities. Achieving bowel and bladder continence 
enables full participation and significantly affects self-esteem and quality of 
life. Smith et al. utilized quantitative and quality of life qualitative methods 
to assess the effectiveness of selected bowel and bladder interventions on 
both physiologic outcomes and quality of life measures. A number of factors 
appeared to influence continence in their study: child and family partici-
pation in the prescribed program, environmental factors, medications 
prescribed, and surgical interventions. Freeman et al. found quality of life 
(QOL) scores were significantly lower for children with bowel incontinence 
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and, to a lesser extent, bladder continence based on parent report. Their 
results support the importance that continence status can have on participa-
tion in meaningful life activities for children with SB and how parental views 
of about continence are addressed. The structure and power of a multisite, 
centrally funded study allowed Merkens et al. to compare rates of bowel con-
tinence among medical and surgical treatment modalities, which has not 
been previously reported. Surgical treatment (antegrade enema instillation) 
was related to better functional continence. Children with bowel continence 
had higher QOL scores, as reported by either the child or parent.
Transition 
As a life span disease, Spina Bifida includes a host of sequelae that adversely 
impact QOL by limiting participation in typical activities. In developing 
a life span care model, management strategies that support transition and 
promote independence are essential. Preparing for transition to adulthood 
is not intuitive. For families raising a child with a disability, everyday life 
demands often take precedence over future planning. Curran et al. pre-
sented Bloorview’s Growing Up Ready framework [http://www.bloorview.
ca/resourcecentre/familyresources/growingupready.php]. This evidenced-
based, comprehensive and auditable framework recognizes the central role 
of families in the process of growing up. When successful, service provid-
ers, families and youth work together using a Shared Management Model 
to gradually shift responsibility for daily life activities and decisions to the 
youth as developmentally appropriate.
Independence
Jones et al. presented strategies from their program in Australia. Their aim 
is to facilitate the development of competent, independent adults who will 
fully integrate into all aspects of their communities. Success requires that 
decisions regarding goal planning be made in conjunction with the health 
team members, the child, the family and others. The value of their approach 
is that it also improves therapy methods, clinical reasoning and the drive 
toward best practice. 
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Hypertension 
As a life span disease, Spina Bifida has some very specific sequelae that 
should also be considered. One example of this is hypertension. Children 
with Spina Bifida have many risk factors for hypertension (HTN) including 
neurogenic bladder, recurrent urinary tract infections, sedentary lifestyle, 
obesity and the presence of a shunt. Miller et al. identified 46% of their SB 
patients to be hypertensive, a rate significantly higher than the 8% preva-
lence in the NHANES controls making it a significant public health problem 
in this population. BMI was the only identified risk factor for HTN in their 
study.
Overuse Injuries
Gueron et al. reported that upper extremity overuse injuries in individuals 
with SB are not uncommon and their impact is significant. In addition to 
chronic pain and an inability to transfer independently, such injuries were 
also the cause of lost employment and independent housing. Individuals re-
ported increased function and energy levels, with decreased U/E pain after 
receipt and use of their power chairs. While prevention of common overuse 
injuries is essential, the introduction of powered or power-assist mobility 
should be introduced early on, in the late teens or early twenties. In addi-
tion, regular performance of targeted stretching and strengthening exercises 
may help reduce pain and to prevent injury for patients with SB.
Basic Science and Primary Prevention
It is known that 60% of cases of neural tube defects are preventable by ma-
ternal folic acid (FA) supplementation prior to conception, but prediction in 
individual cases is not possible. A basic science study by Mayanil et al. used 
an animal model to study the de-methylation of histones H3K4 and H3K27 
as a potential epigenetic marker for the underlying mechanisms of Spina 
Bifida. Identifying such markers might eventually lead to better predictive 
tools and the ability to identify potential therapeutic targets to treat this 
defect in utero.
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The Management of Myelomeningocele Study
Elizabeth Thom PhD 
Eunice Kennedy Shriver National Institute of Child Health  
and Human Development  
Maternal-Fetal Surgery Units Group
The Management of Myelomeningocele Study (MOMS) is a Eunice Ken-
nedy Shriver National Institute of Child Health and Human Development 
(NICHD) funded randomized trial of prenatal versus postnatal myelom-
eningocele repair that is ongoing at three clinical centers; the University of 
California San Francisco (UCSF), The Children’s Hospital of Philadelphia 
(CHOP), and Vanderbilt University Medical Center (VUMC), with a central 
data and study coordinating center at the George Washington University 
Biostatistics Center. This report provides an update of the trial status in ad-
dition to a description of methods and policies in place to ensure that the 
study is of the highest standard scientifically and that the study results will 
be fully interpretable. 
Repair of myelomeningocele in utero via hysterotomy began in 1997 based 
on evidence that neurologic function deteriorates during gestation and that 
in animal models similar surgery was associated with an improvement in 
neurologic function. Three centers, VUMC, UCSF, and CHOP, pioneered 
this technique and as of December 31, 2002, 234 women had received open 
fetal repair of myelomeningocele. The most striking result was the apparent 
reduction in placement of ventriculo-peritoneal shunt by one year of age: Of 
the 181 infants who had reached this age, 89 (49%) had had a shunt placed. 
This compared very favorably with the generally accepted rate of 80% to 
90%. Supporting this result, both the Vanderbilt and the CHOP group 
demonstrated a marked improvement in the degree of hindbrain herniation 
following in utero repair. 
While these results were promising they were not conclusive. Adequate con-
trol groups with which to compare the prenatally repaired infants were not 
available and the results were subject to bias and confounding. Follow-up 
was not complete and the outcomes reported were only short-term. Temper-
ing enthusiasm for the procedure, concerns were raised regarding the risks 
to both mother and baby, particularly uterine rupture or adverse outcomes 
in future pregnancies for the mother, and prematurity with its sequelae for 
the infant. To determine definitively whether fetal repair of myelomenin-
gocele, with its attendant maternal and neonatal morbidity, is warranted 
required a randomized trial. In 2002, the three maternal-fetal surgery cen-
ters and an independent data coordinating center, the George Washington 
University Biostatistics Center, were funded by the Eunice Kennedy Shriver 
National Institute of Child Health and Human Development (NICHD) to 
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conduct a randomized controlled trial to compare the safety and efficacy of 
in utero repair of open neural tube defects with that of the standard post-
natal repair. Centers other than these three that were interested in devel-
oping a maternal-fetal surgery program for in utero repair of spina bifida 
voluntarily agreed to postpone their efforts until the results of the trial were 
known.
Recruitment began in 2003, with a sample size goal of two hundred. Pa-
tients diagnosed with myelomeningocele are referred to the coordinating 
center for initial screening via telephone by a trained coordinator (currently 
a genetics counselor). After obtaining consent for screening, the counselor 
reviews the women’s medical records. Even those who contact or are re-
ferred by a physician to one of the three clinical centers are required to pass 
through the initial screening process at the coordinating center. By this 
method we are assured of consistent counseling for the women regarding 
both spina bifida information, the logistical implications of participating in 
the trial, which are complex, the potential risks and benefits of prenatal sur-
gery based on data published before the trial, and the concept and reasons 
for randomization. This additional step gives women time to process infor-
mation and to consider their options at a most difficult point in their lives. 
We are also assured of consistency in applying the eligibility criteria. 
Women at least eighteen years of age carrying a singleton fetus with a my-
elomeningocele lesion starting from T1 to S1 with evidence of hindbrain her-
niation, normal karyotype and whose pregnancy has not progressed beyond 
25 weeks are potentially eligible for the trial. Women have to be resident in 
the USA, not necessarily a citizen, but with the ability to attend follow-up 
when their child is 12 and 30 months. Because prenatal surgery is associ-
ated with an increased risk of preterm birth, those with an already increased 
risk of spontaneous preterm delivery are excluded, e.g., those with a previ-
ous spontaneous preterm delivery and those with a short cervix less than 
20 mm. Two other major exclusion criteria are contraindication to surgery, 
which encompasses conditions such as prior classical cesarean section, or 
open fetal surgery, and a body mass index of 35 or higher, again because of 
potential complications with surgery. 
Those eligible and interested are assigned by the counselor to one of the 
three clinical centers where final detailed evaluation and screening is 
conducted over two days. Patients who still satisfy the eligibility criteria 
and consent to the study are centrally randomized via a secure website to 
prenatal or postnatal surgery. The randomization sequence is unpredictable 
and stratified by center. The advantage of this method is that the investiga-
tor cannot predict the next surgery assignment, which eliminates selection 
bias. If a patient is randomized to prenatal surgery, she receives the surgery 
within three days of randomization and once discharged stays in nearby 
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accommodation, with weekly visits to the MOMS maternal fetal medicine 
specialist until cesarean at 37 weeks if still undelivered. While this proce-
dure is a potential burden on the patient, it ensures appropriate care in case 
of threatened preterm delivery or other problem. If a patient is randomized 
to postnatal surgery she returns home for prenatal care, and returns to the 
MOMS clinical center at 37 weeks of gestation for cesarean delivery and neo-
natal repair of the myelomeningocele defect by the MOMS neurosurgeon. 
Besides consistent neurosurgical repair for the postnatal group, delivering 
at the MOMS center ensures consistent neurosurgical and urologic manage-
ment with respect to the need for shunt and clean intermittent catheter-
ization for both groups, as well as complete and consistent data collection, 
including required radiological images. Costs for study procedures such as 
radiological imaging are covered by the study if the patient delivers at the 
MOMS center. 
This trial has two main primary endpoints. The first is the need for ventricu-
lar decompressive shunting by 12 months of age defined by objective criteria. 
These criteria are communicated with the community neurosurgeons by the 
MOMS clinical center neurosurgeons, although actual management is of 
course in the hands of the infants’ caregivers. All infants return for a follow-
up visit at 12 months of age and their medical records are obtained. Of note, 
infants without a shunt who have died before twelve months are automati-
cally considered to have satisfied the criteria for the outcome, since it is not 
possible to determine whether they would or would not have needed a shunt 
had they survived. This eliminates the potential bias in case there is a dif-
ferential in survival between those assigned to prenatal or postnatal surgery. 
The records and images of all infants, including those for who no shunt has 
been placed, are reviewed by an independent committee of neurosurgeons, 
blinded to treatment assignment, to determine whether criteria have been 
met. 
The second primary endpoint is based on a combination of neurodevelop-
mental outcome as measured by the Bayley Scales of Infant Development 
Mental Developmental Index (MDI) and motor outcome as measured by 
the difference between the anatomical lesion level and the motor function 
level. All infants return to the center for developmental testing and a physi-
cal examination. The Bayley score is determined at 30 months of age by an 
independent psychologist trained specifically for the study and blinded to 
treatment assignment. The difference between the anatomical and func-
tional lesion levels is also determined by trained examiners. Since this is a 
difficult assessment, physical exams to determine motor function level are 
videotaped and reviewed by a single expert for consistency. Likewise radio-
logic images to determine anatomic level are reviewed by an independent 
committee of radiologists. 
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In addition, we received supplemental funding to determine whether pre-
natal surgery confers benefit on urological outcomes. For all infants whose 
mothers were enrolled after the start of funding, urinalysis, renal/bladder 
ultrasounds and video-urodynamics are conducted at discharge as well as 
the 12 and 30-month visits. The primary urological outcome is the need for 
clean intermittent catheterization (CIC) by 30 months of age, including 
recurrent urinary tract infections, as defined by objective criteria. Similar 
to the shunt outcome, if CIC is implemented without meeting criteria, this 
still qualifies as a primary outcome; thus it is important for urologists to use 
criteria. Again, an independent committee of experts, blinded to treatment 
assignment, determines whether criteria have been met. Major secondary 
outcomes include neonatal morbidity and mortality, Chiari II malformation 
and other radiological signs, as evaluated by the independent radiologists, 
other neurodevelopmental /motor testing conducted by the examiners, 
maternal reproductive outcome and an overall assessment of the child and 
family. 
The common thread in the determination of outcome for this trial is the 
use of independent review committees and examiners. Since this is an un-
masked trial, evaluation is potentially susceptible to both investigator and 
ascertainment bias. Even the perception of bias can be damaging. Investiga-
tor bias can occur when there is a lack of equipoise; thus the independence 
of the expert review is important. The review committees consist of experts 
at institutions that are not involved in the MOMS trial; indeed if a MOMS 
child is receiving care at the expert’s institution the expert will recuse him-
self/herself from the review of the case. Ascertainment bias can occur when 
the group assignment is known to those evaluating the outcomes; therefore, 
the examiners and review committees are blinded to treatment assignment 
wherever possible. For example, the neurosurgeons reviewing the shunt out-
come are not given actual neonatal head circumferences to review; instead 
the data are converted into percentiles. Thus small head circumferences 
related to prematurity, which is a common outcome with prenatal surgery, 
are not apparent. 
As with any NIH-sponsored randomized clinical trial, a Data and Safety 
Monitoring Committee (DSMC) has been appointed by the NIH; each 
member has no conflict of interest and none has been involved in the care 
of a MOMS child. This is a multidisciplinary group with expertise in Bio-
statistics, Epidemiology, Maternal-Fetal Medicine, Neonatology, Pediatrics, 
Neurosurgery, Urology and Ethics; in addition a layperson sits on the com-
mittee. The committee is concerned not only with patient safety but also 
with ensuring that the trial’s results are interpretable and that the study is 
conducted as well as possible. The committee makes recommendations to 
the NICHD based on a review of the interim data and has the authority to 
recommend stopping the trial before the planned sample size. Reasons for 
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stopping early include evidence of benefit or evidence of harm. In addition, 
if the trial were deemed to be ‘futile,’ i.e., if very little chance exists of show-
ing a benefit given the data to date, a DSMC might recommend study ter-
mination. The committee also considers any external influences and events 
that alter the premises on which the trial was founded. 
We projected that recruitment into the trial would take eighteen months. 
Unfortunately, this was overly optimistic, and after three years of experi-
ence, the projection was revised to six years. As of this writing, after a little 
over six years, 157 patients out of 200 have been randomized. Although 
many are eagerly awaiting the results and may not understand why interim 
results cannot be released, to preserve the integrity of the trial we cannot 
accede to this desire. Released interim data could induce investigators to 
make premature or incorrect inferences. Such data could affect how future 
participants are treated, which could bias the results or even inhibit the trial 
from finishing. Although this study is unmasked, we follow the procedures 
as though it were a double-masked trial, so that no outcome data are pre-
sented or discussed even with the MOMS investigators. Instead, the DSMC 
will make recommendations regarding any data that should be made avail-
able. In the meantime we continue our efforts to ensure that all women in 
the United States who are interested have access to the trial and encourage 
all with questions, comments as well as potential participants to contact us 
at 1-866-ASK-MOMS. 
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Appendix 1
Hal Pote Memorial Lecture
These remarks were delivered by Judy Woodruff on Wednesday,  
March 18, 2009 to attendees of the First World Congress on  
Spina Bifida Research and Care. 
I’m deeply honored to have been asked to deliver this lecture in memory of 
a dear friend – the man who did so much to raise the profile of Spina Bifida, 
to raise money for research on Spina Bifida, to strengthen the Spina Bifida 
Association and to create the Spina Bifida Foundation.
Hal Pote was a banker and if he had been in charge, I’m confident the bank-
ing crisis would never have happened! He had incredible devotion to the 
cause that brings us all together – and remarkably, it was not because he 
himself was born with Spina Bifida, nor that he was the parent of a child 
with Spina Bifida. In Hal’s case, it was through his extraordinary caring 
and compassion for his nephew.  Hal always said because he was fortunate 
enough to have been healthy and done well in his life, he wanted to give 
back to others. He had a gift of boundless energy and he focused so much 
of that energy on Spina Bifida.  I remember many conversations with Hal, 
his focus and his endless enthusiasm.  We miss him terribly, but the light he 
brought to the work you do, shines on. 
If Hal were here today, he would join me in congratulating you on this 
conference – on what I’m told is turning out to be a very successful first 
World Congress on Spina Bifida: Research and Care. Don’t be modest about 
that! Someone said this morning how pleasantly surprised they were at the 
breakthrough work being discussed here. That is an exciting development. 
I wish I could have participated in more of your sessions than this morning. 
Just being here a short time reminds me of what a great group of people who 
work on Spina Bifida are! It is thrilling for me to know that you are learning 
from each other and that specialists from all facets of the Spina Bifida com-
munity have come together to compare notes and share ideas about research 
and about care. I know you have good reason to do this and I would just add 
that it certainly reflects the lives that individuals with Spina Bifida lead – 
they wake up every morning facing a complicated and cross-cutting set of 
challenges, ranging from how do they get around physically, how do they 
go to the bathroom (in my view, the most important question of the day!), 
to how do they deal with assorted but constant medical issues and a large 
network of physicians and other medical care providers.
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I’ve built a career as a news reporter and interviewer – always trying to keep 
my personal views out of the stories I cover. But it probably won’t come as a 
surprise there is nothing objective or dispassionate about my view of Spina 
Bifida.  It’s a deeply emotional subject for me, one I have lived with for the 
past 27 and 1/2 years, since our older son Jeffrey was born.  Some of you have 
heard me tell the story of how my husband, Al Hunt, and I had never heard 
of Spina Bifida… when, in August of 1981, in the 8th month of my pregnancy 
with our first child, we scheduled a routine sonogram – to give us a better 
idea when the baby would be born. When the technician told us he saw 
something we should discuss with the doctor – enlarged ventricles in the 
baby’s head (ventricles – another term we had not known) and the pos-
sibility of an opening in the baby’s back – with spinal cord damage – they 
couldn’t tell because my rib obscured the lower spine – we were overcome 
with worry and fear. What did this mean? The baby wouldn’t be normal? He 
might need surgery? We had a million questions – and we spent the final 
month of my pregnancy in a state of high anxiety – still excited about the 
coming birth but dreading the news no parent wants to hear. 
Jeffrey was born – on time – a beautiful bouncing baby boy – by C-section, 
at the doctor’s request – with Spina Bifida, an opening in his lower back. 
We cried tears of happiness and privately, of sorrow, for the loss of what we 
didn’t know and in fear of what lay ahead. When Jeff was 12 hours old, Dr. 
David McCullough (the late pediatric neurosurgeon and a wonderful hu-
man being) closed the opening in Jeffrey’s back and did repair work that 
he explained and we didn’t understand very well; it was all a blur. We came 
home from the hospital after a week; we settled into a dizzying routine of 
doctor visits, especially watching, as it turned out, his head because of those 
enlarged ventricles. Eventually Jeffrey’s head became noticeably large and 
at 10 months, even though he was showing no developmental delays yet, Dr. 
McCullough recommended a shunt. I remember that hospital stay like it 
was yesterday – how scared we were and how quickly Jeff recovered. He was 
standing in his crib the day after the surgery: Mr. Personality!
Despite all the warnings we were given, Jeff began to walk on time at 13 
months, and he ran (a little flat footed) and climbed and was the most active 
little boy you could imagine. If it weren’t for that shunt, I would have forgot-
ten about any limits on his mobility. But in the back of my mind was always 
a fear that he’d fall and hit his head. Jeffrey paid no mind; he rode a bike, fell 
and split his chin, went roller-skating with his mother’s “Be careful” ringing 
in his ears – only to crash into the front door and cut his chin again – more 
stitches! He had no fear: climbed trees, got into all sorts of scrapes, learned 
to ski, was a natural! The only things he steered clear of were competitive 
ball sports, like soccer, after about age 6, because he noticed every other 
boy, and even the girls, ran faster than he could. It broke my heart, to watch 
a mandatory foot race at a school field day, when Jeff came in dead last. He 
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didn’t show that it bothered him but it obviously did! He was a smart stu-
dent, despite his learning disabilities– I actually brought him to two Spina 
Bifida national conferences to learn all we could about those frustrating 
“learning differences” – how hard math was, for example, and of course to 
find out anything we could about how to deal with the most embarrass-
ing issue of all – bladder and bowel incontinence. Jeff catheterized himself 
starting at age 5, in pre-kindergarten. He was occasionally teased for being 
wet or having an accident and he mostly handled it remarkably well. But at a 
school where all the other children seemed 100% healthy though, he clearly 
felt different. 
Still, he soldiered on, switched schools to get more academic support and 
grew increasingly interested in a career in medicine. He wanted to find a 
way to prevent Spina Bifida and he became fascinated with the study of 
infectious diseases along the way. He did junior internships at the CDC for a 
few weeks as a 14 year old. He interned at the NIH in a cancer lab as a 15 year 
old and had been hired for an internship at the FDA for the summer after 
10th grade, when the dreaded recommendation came that he should get a 
shunt replacement. He hadn’t had any problems in 16 years – so he was very 
reluctant to go through with the procedure. But he did. 
And there were complications – complications that changed Jeff’s life for-
ever and the lives of all of us who love him.
That was 10 years ago. Fast forward to today: Jeff is 27, attending his 8th 
year of college at a small school in North Carolina. He uses a wheelchair, 
needs help for all transfers, has the use of only one arm and has both vision 
and speech impairments, as well as major short term memory loss. He will 
always need companion care; his life is enormously circumscribed by his 
physical condition. But he has a spirit and a determination that are truly 
inspiring. He is determined to get a college degree and he is on track to do 
so after one more semester. He says his dream job would be to run a recre-
ational and therapeutic facility for children with disabilities. Of course he 
would need considerable help to do that and we are starting to focus now on 
finding the right living arrangement for Jeff post-college that would allow 
him to pursue that dream or any other. And you won’t be surprised to know 
how difficult that is; this country is dreadfully lacking in living and work 
opportunities for individuals with disabilities (I saw the 66% unemployment 
number for adults with Spina Bifida)! They are cute when they’re young but 
a problem when they’re older – that’s the unspoken attitude. Having said 
that, there is something unstoppable about Jeffrey Hunt. And one way or an-
other we want to make sure he has the fullest life he possibly can. We thank 
him for opening our eyes to the world of those with disabilities. That is the 
greatest gift he’s given us, other than himself. 
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Our journey with Jeffrey – a journey that has involved (as all such journeys 
do) our entire family, including his younger brother and sister, has been – 
and continues to be – a long and winding road. Jeff has borne the toughest 
burden of all. And when I have allowed myself to slip into feeling sorry for 
us – to question, “why Jeff?” – I’ve realized there is no answer of course....
just as there is no answer for any of the thousands of parents who ask – why 
my child?
But Jeffrey himself doesn’t dwell on this. And we quickly figured out it does 
no good for ANY of us in our family to dwell on why and what might have 
been. It doesn’t get any of us very far, and it doesn’t serve the needs of these 
children, young people and adults, who live with this maddeningly compli-
cated birth defect over the course of a normal life span.
We owe them much more than any backward look, and that’s why the re-
search and other work you and your colleagues in the scientific and medical 
community do is so important.
It’s also why – not as a journalist who can’t take sides in these debates but, 
as a mother – I am able to celebrate the proposed increases in medical re-
search in the new federal budget, and the funding that was part of President 
Obama’s economic stimulus package which Congress recently passed.
Despite the findings that public and private financial support of biomedical 
research increased dramatically over the decade from 1994 to 2004, there is 
no denying that over the past 6 or 7 years, since the early 2000s – the nation 
has seen a flat-lining in government investment in health-related research 
and development. 
As recently as 2007, the overall trend in funding for research to improve 
health across the board was stagnant. What small spending increases there 
were, were eaten up by inflation. In 2007, the United States invested only 5 
and  1 1/2 cents of every dollar spent on health care, in research.
So it was noteworthy that President Obama proposed and Congress ap-
proved $10 billion for the National Institutes of Health in the Economic 
Recovery and Reinvestment Act – better known as the stimulus package.
And it’s believed the budget proposal for 2010 that President Obama sent 
to Congress a couple of weeks ago, will ultimately include a strong commit-
ment to medical research, although there are few hard numbers available at 
this early stage of the legislative process.
Still, even as we celebrate these positive developments – and the fact that 
since 2002, when the National Center on Birth Defects and Developmental 
Disabilities was established, that it has received more than $750 million for 
its work – still, the amount of money for research into Spina Bifida has been 
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comparatively small: some $50 million in NIH funding over the past 5 years; 
another $24 million for the National Spina Bifida Program, since it was 
established by Congress five years ago, and housed at the Centers for Dis-
ease Control. And to clarify, that money is devoted to, not only research, but 
also work on public awareness and outreach. Separately, another $10 million 
over the past five years has been spent on Folic Acid related work – again, 
research, outreach, and other programs. 
I had a first-hand glimpse of just how much more MIGHT be done, at the 
basic level of research, when I visited a lab recently at the Medical Center at 
the University of Colorado, Denver – the Anschutz Campus, in the Pediat-
rics Department. A scientist, Dr. Lee Niswander, and two graduate students 
were engaged in a fascinating three-pronged study. 
To sum it up roughly, it involves: first, studying the normal process of neural 
tube closure to understand how the cells interact with one another, using 
dynamic imaging. Second, trying to understand the genes that are required 
for neural tube closure by identifying genes that cause neural tube defects. 
And third, trying to understand how genes interact with the environment, 
especially folic acid, in the prevention of neural tube defects. 
Dr. Niswander told me it had been surprising to her to learn how little 
directed research had gone into understanding Neural Tube Closure and 
Neural Tube Defects. She said, it had instead been a rather haphazard or 
random mutation found in one lab or another without a specific interest 
in the subject. She said that was why she and her colleagues decided about 
seven years ago to try to tackle this more systematically by directly screening 
for mutations that affect Neural Tube Closure in the mouse embryo. They 
generated mutations in the mouse genome, and then looked for Neural 
Tube Defects. Using a process of working backwards, they’ve generated a 
large collection of mice, and have had considerable success in identifying 
the mutant genes, as well as figuring out how these genes work to allow 
closure of the neural tube. They have also discovered novel genes not previ-
ously recognized for their role in this process. 
I was particularly interested in the research team’s use of dynamic imaging 
to understand the closure process in mouse embryos. Previously, they said, 
as far as they knew, it had been studied only in non-mammals. Their early 
findings confirm that different parts of the neural tube come together in 
different ways – some by a process like “zippering,” and other – higher up – 
by sending out cellular “feelers” reaching across the gap between the neural 
folds. They told me this suggests that perhaps specific genes control closure 
differently from one region to another. I’ve already gone WAY beyond my 
understanding of what I saw, but what was important, was their effort to 
understand and identify all the genes involved – and building on that – to 
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understand eventually what therapies, in addition to folic acid supplements, 
may help prevent neural tube defects. We know that most, but not all 
NTD’s, can be prevented by folic acid. 
These are uncertain times in Washington. The financial crisis and the 
economic slide have come on fast, and have policy-makers scrambling for 
answers.
Our new President and the team he’s put together are working non-stop to 
deal with collapsing financial institutions, toxic assets in the surviving big-
gest banks, rising unemployment, home foreclosures and a growing credit 
freeze. Just to name a few of the problems on their plate.
It’s gotten ugly. Fingers are pointed in every direction over who is to blame.
But as someone who has covered Washington for over 30 years, even though 
I’ve not covered a recession quite like this one, I believe the worst of this 
mess will get sorted out. The financial landscape will look different of 
course; not every institution will survive and many have already gone under. 
The argument that President Obama makes that this crisis presents an op-
portunity – a moment to address several other festering problems on the 
national agenda, including health care, is being challenged by critics who 
say he should focus single-mindedly on the economy. There’s no doubt in 
all our minds that the economy is number one, but for the long-term well-
being of our society, of the American people, it is hard to believe it’s a good 
idea to delay yet again addressing questions of access and affordability of 
health care and yes, the need for research. From a parochial standpoint, as 
the parent of a child with Spina Bifida, and as a citizen, it’s hard to accept 
the argument that delay makes sense. 
That’s why the work you do at this Congress, which goes on despite the 
recession, is so important. On behalf of family members everywhere – all 
those with a loved one who has suffered because of Spina Bifida – for all of 
us who would give anything to know no one else had to live with this terrible 
complex birth defect and all its complications – on behalf of all of us, thank 
you for all you do and all you will go on to do from here.
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8:50 – 9:30 am  Epidemiology/Genetics Keynote  
  Insufficient Progress in the Global Progress of Folic  
Acid-preventable Spina Bifida  
Godfrey Oakley, MD, MSPH
9:40 – 10:00 am  MOMS Update  
 Elizabeth Thom, PhD
10:00 – 10:15 am  Morning Break
10:15 – 10:55 am  Transition Keynote  
  Transitioning Adolescents and Young Adults  
with Spina Bifida to Adult Care  
Susan Sawyer, MD
11:05 am – 12:30 pm Transition Panel  
 Nienke Dosa, MD, MHP  
 David G. McLone, MD, PhD  
 Shubhra Mukherjee, MD, FRCPC  
 Donna Zahra, PhD, ARNP
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12:30 – 1:45 pm  Lunch
1:45 – 5:30 pm  Concurrent Breakout Sessions  
 Topic areas:  
 • Developmental Pediatrics  
 • Neuropsychology  
 • Nursing/Allied Health  
 • Urology
Tuesday, March 17, 2009
6:45 – 8:00 am  Continental Breakfast
7:30 – 8:00 am  Overview from Previous Day  
 Timothy Brei, MD, FAAP
8:00 – 8:40 am  Nursing/Allied Health Keynote  
  Nursing Response to Families Living with  
Spina Bifida: Past, Present, and Future  
Robin Leger, RN, PhD
8:50 – 9:30 am  Urology Keynote  
 L ower Urinary Tract Refunctionalization by  
Somatic/Autonomic Nerve Root Transposition in  
Children with Spinal Cord Abnormalities  
Chuan-Guo Xiao, MD
9:40 – 10:00 am  SBA/SBF Update  
 Cindy Brownstein and Timothy Brei, MD, FAAP
10:00 – 10:15 am  Morning Break
10:15 – 10:55 am  Neuropsychology Keynote  
  Structural Changes and Dysfunction in  
the Hydrocephalic Brain  
Marc Del Bigio, MD, PhD
11:05 am – 12:30 pm  Tethered Cord Panel  
 Jeffrey Blount, MD, FACS, FAAP  
 Robin Bowman, MD  
 Gregory Olavaria, MD  
 Elizabeth Yerkes, MD
144 The Future is Now
12:30 – 1:45 pm  Lunch
1:45 – 5:30 pm  Concurrent Breakout Sessions  
 Topic areas:  
 • Epidemiology/Genetics  
 • Neurosurgery  
 • Orthopedics  
 • Transition
6:00 – 8:00 pm  Reception 
Wednesday, March 17, 2009
6:45 – 8:00 am  Continental Breakfast
7:30 – 8:00 am  Overview from Previous Day  
 David B. Joseph, MD
8:00 – 8:40 am  Orthopedics Keynote  
  The Orthopedic Care of Children with Spina Bifida:  
What Have We Learned in the Last 30 Years?  
Luciano Dias, MD
8:50 – 9:30 am  Hal Pote Memorial Lecture  
 Judy Woodruff
9:40 – 10:00 am  Award Papers
10:00 – 10:15 am  Morning Break
10:15 – 10:55 am  Dev elopmental Pediatrics Keynote  
Health Care and Spina Bifida:  
The Canary in the Coal Mine  
Gregory Liptak, MD
11:05 am – 12:30 pm  Closing Remarks  
 David Joseph, MD
2:00 – 5:00 pm  Post Graduate Course (for registered attendees only)
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Full abstracts of the work presented during the  
First World Congress on Spina Bifida Research and Care are available at 
http://medicalconference.spinabifidaassociation.org.
